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Abstract 
Target specific delivery of anticancer drugs to the effected site without showing systematic 
toxicity to normal tissues is important. Multifunctional biodegradable delivery systems reduce 
systematic toxicity in an efficient manner. These drug carriers should provide controlled release, 
be directed towards desired site, track payloads via contrast imaging, heat the effected sites and 
trigger drug release. In this context, superparamagnetic iron oxide nanoparticles based drug 
delivery systems are highly desirable. Superparamagnetic iron oxide nanoparticles upon exposure 
of alternate magnetic field could be directed and provide heat to localised areas. Moreover, 
superparamagnetic iron oxide nanoparticles also have image contrast ability for magnetic 
resonance imaging.  
This study aimed to develop biocompatible superparamagnetic iron oxide nanoparticles. These 
nanoparticles were coated by bioinspired materials such as peptides (diphenylalanine) to achieve 
monodispersed dual efficient such as drug carriers and hyperthermia. Thermally responsive core-
shell materials with tubular and spherical morphologies without compromising the inner cores 
properties such as superparamagnetism is highly desirable.  
Two shapes of iron oxide (spherical and tubular) were prepared using co-precipitation of iron (II) 
and (III) ion and oxidative hydrolysis of ferrous sulphate in alkaline solutions, respectively. 
Spherical peptide shells were synthesised using tert-Butyloxycarbonyl modified diphenylalanine 
peptide in ethanol-water (1:1) mixture. Tubular peptide shells were prepared using similar 
diphenylalanine non-modified peptide. The iron oxide nanoparticles (spherical and tubular) were 
encapsulated via template-mediated synthesis using ultra-sonication and vortex-mixing methods.  
These materials were characterised using variety of techniques such as, zetasizer, Scanning 
Electron Microscopy (SEM), Energy Dispersive X-ray Spectroscopy (EDAX), Fourier Transform 
Infrared Spectroscopy (FTIR), Brunauer–Emmett–Teller (BET) analysis, Transmission Electron 
Microscopy (TEM), X-ray Diffraction (XRD), Thermogravimetric Analysis (TGA), Vibrating 
Sample Magnetometer (VSM) and magnetic field induced hyperthermia. The diameter of 
spherical superparamagnetic iron oxide nanoparticles were measured to be ranges from 10 to 35 
nm and rod-shaped core materials showed nearly 10 nm width and several hundred nanometres 
in length. Spherical peptide were approximately 1 µm in diameter. Tubular-shaped peptide  were 
between 100-300 nm in width and several micrometres in length. These peptides were used as 
shells for the preparation of core-shell composites. Both spherical and rod-shaped core-shell 
composites were similar in dimensions to the pure peptide particles. Observational analysis 
confirmed the presence core-shell composition. Spherical iron oxide core materials were 
crystalline magnetite (Fe3O4) structures confirmed by powder XRD. These magnetite 
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nanocrystals were further modified with a biocompatible silica shell. Brunauer–Emmett–Teller 
(BET) analysis revealed a mesoporous shell structure. Spherical peptide shells were found to be 
amorphous and tubular peptide shells were crystalline in nature. VSM of core-shell composite 
materials depicted superparamagnetic nature, hence these materials have ability to heat over the 
exposure of applied external magnetic field for hyperthermia ablation.   
Anticancer drug (doxorubicin, DOX) loading and release profile of bare spherical and rod-shaped 
iron oxide nanoparticle and peptide, silica and peptide-capped silica coated spheres were studied 
for potential therapeutic application. The doxorubicin loading efficiency was observed to be 
ranging from 12 % to 90 % depending on the type materials. The in vitro drug release profiles 
were measured at 37 °C without the exposure of magnetic field in incubation and with applied 
magnetic field. Time-dependent studies showed sustained release of DOX in silica coated and 
peptide- capped silica coated spherical superparamagnetic iron oxide nanoparticles were ranging 
from 0 to 30 % over 72 hours of incubation. Concentration dependent studies revealed that the 
ratio of 1:100 (doxorubicin:superparamagnetic iron oxide nanoparticles) had the maximum 
loading efficiency with minimum release capability. Exposure to Alternate Current (AC) 
magnetic field (200 G; 406 kHz) the spherical materials generated hyperthermia in a time 
dependent manner reaching 50 °C in 3 minutes. Tubular peptide coated iron oxide materials did 
not induce heat even after 25 minutes of exposure indicating weak superparamagnetism. Magnetic 
field triggered drug release was seen only in spherical core-shell nanocomposites with 6X higher 
compared at 37 °C without exposure. 
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CHAPTER ONE 
1. INTRODUCTION 
1.1  Introduction and Background 
Magnetic nanoparticles have attracted considerable attention in recent years for a range 
of applications including magnetic storage, drug delivery and medical diagnostics. They 
are highly attractive due to their tunable size, shape, surface chemistry and the propensity 
to direct them to selected target sites.  For example, nanoparticles of magnetite materials 
display excellent magnetic properties, non–toxicity and biocompatibility. The nanosize 
characteristics induce favourable surface chemistry due to the large surface area making 
them highly suitable for a range of applications. Despite extensive studies, there is still 
need to obtain a better understanding of the various characteristics of nanoparticles and 
their properties such as the relationships of shape, surface chemistry, polydispersity, and 
in particular the magnetic properties of magnetite.  An attractive feature of magnetite is 
the ability to tune the synthesis protocol in order to achieve well-defined structures. 
Current research focuses on the magnetic materials with superparamagnetic properties 
and magnetic susceptibility. These are single domain structures with randomly oriented 
magnetic moments, which rotate rapidly towards the direction of applied magnetic field 
hence increasing the magnetic flux. Once the applied external magnetic field is turned 
off, the particle again become randomly oriented with no magnetic remanence due to the 
Brownian motion (Arruebo et al. 2007). These materials have advantages, if they could 
be designed as seeds with biocompatible materials as a shell. They can be useful in 
magnetic field guided target specific drug carriers, tumour hyperthermia, MRI contrast 
agents for tracking and delivery of a drug (Kumar & Mohammad 2011; Dobson 2006; 
Sun et al. 2008; Arruebo et al. 2007; Brusentsov et al. 2001).  
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1.2  Aims and objectives  
This study will be focused on the synthesis of Superparamagnetic iron Oxide 
Nanoparticles (SPIONs) of two different morphologies. The motivation was to develop, 
characterise and test them as drug delivery systems. The first step will be to develop a 
simple, robust, quick and low cost method for rod-shaped SPIONs. In next step, these 
materials could be coated with mesoporous silica to achieve control release drug delivery 
system. In the final step of synthesis, all materials will be coated with bioinspired 
naturally occurring dipeptide (diphenylalanine) as its native and modified forms with tert-
butyloxycarbonyl (boc) group to tune the desired shape of peptide shells for 
corresponding SPIONs cores. All synthesised materials will be characterised using 
variety of physicochemical techniques. In final step, all materials will be investigated for 
their hyperthermia efficiency, drug loading and release and magnetic field triggered drug 
release. 
The aim of this study is to design and synthesise the peptide shells and use them for 
coating of iron oxide nanoparticles as core-shell structures. Hence, the resultant core-shell 
composites can be used as a magnetic field guided localised drug delivery system.  
Consequently, higher doses of drugs can be delivered magnetically to a tumour site, hence 
reducing the toxicity to healthy tissues compared to non-targets specific cancer therapies. 
In these core–shell structures, peptide shells will separate the structures from biological 
system ensuring biocompatibility in biological fluids. This will prolong sustainability of 
magnetic particles in the blood stream.  
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The specific objectives of this research include the following: 
 To synthesise and characterise monodisperse peptide coated surface stabilised 
iron oxide (Fe3O4) nanoparticles with tunable size and shape while retaining 
magnetic behaviour.  
 To incorporate the model drug within this magnetic core via adsorption or 
attached to the inner layer of the peptide.  
 To study the implication of nanoparticles shapes in the drug delivery system by 
exploiting two different shapes (rod-shaped and spherical core-shell) of peptide 
coated iron oxide particles.  
 To investigate spherical and tubular structural effects on hyperthermia triggered 
drug release profiles.  
1.3 Thesis outlines  
This thesis is contributed into nine chapters. 
Chapter 1 introduces to magnetic nanoparticles within the context of guided drug 
delivery systems.  The research aims and specific objectives of this study are given along 
with an outline of the thesis. 
Chapter 2 presents a detailed literature review of the nanomaterials as drug delivery 
systems and pharmaceutical vehicles. The different types of polymers and their 
advantages and disadvantages are discussed. Background of self-assembling peptides 
structures in biomedical applications is explained.  
Chapter 3 describes the preparation and characterisation of the (iron oxide 
nanoparticles), peptide particles of spherical and tubular morphologies and corresponding 
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core-shell structures.  Characterisation methods include SEM-EDAX. TEM, VSM FTIR, 
TGA, DLS, XRD, BET and hyperthermia are also explained.  
Chapter 4 presents and discusses the results of the investigation on spherical cores of 
iron oxide nanoparticles and boc-diphenylalanine peptide shells. The influence of the two 
synthesis approaches on the coating of the peptide to magnetite will be discussed using 
data from characterisation techniques including, Scanning Electron Microscopy (SEM), 
Energy Dispersive X-ray Spectroscopy (EDAX), Fourier Transform Infrared 
Spectroscopy (FTIR), Brunauer–Emmett–Teller (BET) analysis, Transmission Electron 
Microscopy (TEM), X-ray Diffraction (XRD), Thermogravimetric Analysis (TGA), 
Vibrating Sample Magnetometer (VSM) and magnetic field induced hyperthermia.  
Chapter 5 describes the results obtained from rod-shaped iron oxide nanoparticles, 
diphenylalanine peptide-based tubes and the corresponding core-shell structures. The 
implication of shape on their physicochemical properties and magnetic moment and 
hyperthermia are discussed. 
Chapter 6 presents and discusses the drug loading and release profile of core and core-
shell spherical nanoparticles and nanocomposites. A detailed study of concentration and 
time-dependent loading and release profiles is also presented. 
Chapter 7 similarly discusses the drug loading and release profile of core and core-shell 
rod-shaped nanoparticles and nanocomposites. The effects of loading and release profiles 
of anticancer drug on parameters such as concentration and time have been presented. 
Chapter 8 discusses the hyperthermia ability of core nanoparticles and core-shell 
nanocomposites of spherical and rod-shaped morphologies.  In addition, this chapter will 
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also reveal the comparative analysis of magnetic field triggered drug release profile of 
both spherical and rod-shaped morphologies.  
Chapter 9 gives a summary of the main conclusions and future work suggested for 
further studies. 
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CHAPTER TWO 
2 Nanotechnology-based drug delivery systems: a review 
2.1 Introduction  
This chapter gives a review of the current literature on nanoparticles based drug delivery 
tools. It highlights the relevant factors that may affect the biocompatibility, 
immunogenicity, self-aggregation of nanoparticles. The physicochemical properties of 
multifunctional drug delivery systems will also be reviewed. The major obstacles of the 
nanoparticles arise in drug delivery system have been considered.  
The peptide self-assemblies, especially those classed as amylogenic dipeptide will be 
described in detail along with the possible effects of solvents on the structure and 
properties. An attractive proposition is a possibility of coating the metallic structures with 
self-assembling peptides in drug delivery systems will be considered. Finally, the core-
shell formation of peptides shells and superparamagnetic iron oxide nanoparticles core 
materials will be summarised. 
The review also provides an insight into ways of overcoming the biocompatibility, 
aggregation related drawbacks in magnetically triggered hyperthermia and drug delivery 
systems.  
2.2 Nanotechnology 
Nanotechnology has numerous applications aimed to improve the quality of life and the 
environment. The advantages of nanotechnology include tunable physical and chemical 
properties such as a high surface to volume ratio, and can be surface functionalised with 
ligands, coatings, charge and other alternative tools. Recent studies focus on the oncology 
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based applications of nanoscience (Ahmad et al. 2010). National Nanotechnology 
Initiative terms the “nanotechnology as the engineering of materials conducted at the 
nanoscale (1-100 nm) in any one dimension” (Kim 2008). However, this has been 
broadened by research in different fields referring to materials with average feature size 
in the range 1 to 1000 nm. Engineering nanoscale structures exhibit a multitude of 
functional properties in contrast to the individual molecular behaviour of the 
nanostructure constituents or the behaviour of bulk materials (Alexis et al. 2008). 
The use of nanomaterials in nanomedicine is an exciting prospect. For example, in drug 
delivery, it is possible to alter the properties of the encapsulated drug by tuning 
physicochemical properties such as ionic strength, solubility and reactivity (Strebhardt & 
Ullrich 2008). The commercialisation of variety of nanotherapeutics has made 
nanoparticles based drug delivery a reality.  Many nanoparticle-based drug delivery 
systems are biodegradable, have a low immune response, target specificity and provide 
controlled release of the drug. Nanocarriers encapsulate poorly bio-available drugs and 
increase their half-life (Alexis et al. 2008).  
In cancer treatments, the majority of therapeutics are toxic to normal cells and can be 
readily excreted. Consequently. Kipp (2004) studied that 40 % of all compounds are 
hydrophobic and due to their lower solubility and associated poor bioavailability. They 
did not reach to clinical trials. Recently, a variety of hydrophobic drugs have been 
formulated with nanocarriers such as Food and Drug Administration approved Doxil® (a 
doxorubicin formulation with liposomes shown reduced cardiac cytotoxicity (O’Brien et 
al. 2004). Abraxane also an FDA approved formulation, which consists of paclitaxel with 
albumin with an average diameter of 100 nm has been used commercially. The 
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encapsulation process omits the use an organic solvent thus reducing the risk of 
inflammation or hypersensitivity (Cortes & Saura 2010).   
The ideal anti-cancer formulation should have two properties:  
i) Ensure effective penetration in affected sites with minimal loss of drug for a longer 
period.  
ii) Have the ability to recognise and kill the cancerous cells without affecting normal 
tissues.  
By increasing the intracellular therapeutic level, this reduces dose limiting drug toxicities, 
which in turn increases the patient`s survival rate and the quality of life.    
2.2.1 Diagnosis and imaging of cancer 
Early stage diagnosis is an essential step towards effective treatment of cancers. If cancer 
is diagnosed in early staged can be treated effectively. It is a big challenge; as clinical 
symptoms often are not expressed until a fatal stage is reached. Minimally invasive, cost 
effective and accurate with have enhanced imaging for cancer diagnostics are still in their 
infancy (Misra et al. 2010). Over the last decade, a plethora of nanotechnological tools 
has been investigated for the detection and imaging of various cancer types (Wang et al. 
2008; Li 2014). Specifically, iron oxide nanoparticles with magnetic resonance imaging 
(MRI) have been used in prostate cancer diagnosis (Farokhzad & Langer 2006). Gold and 
quantum fluorescence quantum dots were in clinical trials for the detection of cancer cells 
(Craig et al. 2010; Sukhanova et al. 2016). Gold nanoparticles modified with RNA 
aptamer have also been used for the detection of prostate and circulating cancer cells 
(Kim et al. 2010; Dickey & Giangrande 2016).  
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Engineering nanoparticle based delivery systems will not be effective until an adequate 
drug delivery at a subcellular level are achieved. These properties can be achieved by 
exploiting a strategy called “theragnostic” combining both therapeutics and diagnostics 
(Ilaria Parisi et al. 2016). 
2.2.2 Targeted drug delivery systems  
Nanocarriers encapsulating drug remain in the target tissue for a longer time than the free 
drug thus enhancing its efficiency in normal tissue and yielding reduced cytotoxicity in 
normal cells (Ulbrich et al. 2016). There are two natural ways to target the desired tissues; 
passive targeting and active targeting.  
Nanoparticles with stealth ability can protect themselves from the mononuclear 
phagocytosis system (MPS), therefore allowing their retention in the bloodstream for a 
prolonged period to achieve the best drug efficiency. This can be done by adjusting the 
ionic properties, including size, charge, surface and pH of drug-encapsulated 
nanoparticles. The nanoparticle size should be in the range of 10 to 100 nm for penetration 
into the leaky vasculature of cancer, where the pore cut-off size is approximately 100 - 
700 nm (Cho et al. 2008). The administered nanoparticles should have the size larger than 
10 nm to avoid clearance via renal filtration and leakage from the capillaries (Danhier et 
al. 2010).  
In addition to particle size, the surface properties are also important in the assessment the 
fate of injected nanoparticles. Once nanoparticles reach plasma, opsonisation (adsorption 
of proteins on nanoparticles) occurs. MPS of spleen, liver or bone marrow recognises the 
nanoparticles, where opsonin interact with phagocytes (Petros & DeSimone 2010). To 
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avoid opsonisation of nanoparticles, hydrophilic clouds are designed on the surface on 
nanoparticles.  
2.2.3 Passive targeting     
Accumulation of macromolecules polystyrene-co-maleic acid-neocarzinostatin in 
cancerous tissue has been reported for the first time by (Matsumura & Maeda 1986). An 
albumin-bound anti-cancer drug was utilised, which remained for a longer period in the 
cancer interstitium, where it showed poor lymphatic passage and improper vasculature 
system (figure 2-1). By exploiting this phenomenon enhanced permeability and retention 
can be achieved (Egusquiaguirre et al. 2012).  
In tumours, when uncontrolled cell growth begins, the normal body system is not able to 
supply enough oxygen and nutrients to the newly proliferated cells. The cells do not 
receive sufficient nutrients and oxygen and begin to excrete growth factors. These form 
a different anatomical structure “angiogenesis” resulting in defective, irregular and leaky 
vessels. Poor lymphatic drainage retains molecules levels up to 50 times higher in a 
tumour environment compared to normal vasculature (Iyer et al. 2006).   
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Figure 2-1 Schematic diagram depicts the passive targeting mechanism (a) normal tissues and 
(b) tumour tissues (adopted from Danhier et al. 2010) 
The tumour microenvironment differs in terms of oxygenation, pH and metabolic 
conditions from a normal microenvironment in the defective vascular system, (Cho et al. 
2008). The high proliferation rate of cancer cells leads to insufficient supply of nutrients. 
They are dependent on glycolysis, which produces an acidic environment. The intra-
cellular pH of cancer cells is lower (6 to 7) while in normal cells, it is 7.4 (Danhier et al. 
2010). The pH-sensitive liposomes are stable at pH 7.4 and below pH 7.4 destabilisation 
occurs which triggers to release the cargo (Yatvin et al. 1980).  
2.2.4 Active targeting        
In the active targeting, nanocarriers are functionalised with ligands, such as small 
peptides, proteins, nucleotide base pairs, sugars and vitamins. These molecules can 
recognise the receptors specifically to target sites, which are expressed on the targeted 
cells. Target receptors may also be proteins, sugars or lipids (Saha et al. 2010). In the 
initial stages of active targeting experiments, antibodies attach directly to drug molecules, 
however these were unable to increase the drug efficiency due to rapid clearance by MPS 
a b 
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(Tolcher et al. 1999). Shortly after, various types of vehicle systems were designed and 
synthesised, possessing the ability to prevent MPS and selectively targets the cells.  These 
nanocarriers are comprised of ternary structures i.e. drug molecule, carrier and targeting 
molecule (Wu et al. 2011). Nanocarriers should have two key properties; ability to bind 
to the ligand and have a delivery capacity. The selection of ligands is critical. The receptor 
should be expressed uniformly and on targeted cells only, nanocarrier and ligand should 
not be detached during blood circulation. The schematic diagram of active targeting 
nanocarrier is depicted in figure 2.2.   
 
Figure 2-2 Schematic depiction of receptor mediated active targeting nanocarrier (adopted from 
Salim et al. 2014) 
2.3 Nanoscale drug delivery tools   
Nanotechnology is being studied extensively for controlled drug release such as in 
cardiovascular diseases (Guzman et al. 1996), orthopaedics (Holland & Mikos 2006), 
diabetics (Eerikäinen & Kauppinen 2003) and optometry (Le Bourlais et al. 1998). The 
worldwide market of nanomaterials has expanded significantly over the last decade and 
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is around 60 billion per year, and over 100 million people are using these materials (Karim 
2015). Some of the most commonly used nanomaterials are discussed.   
2.3.1   Polymeric Micelles      
Studies on biodegradable materials have increased exponentially, especially in the field 
of oncology. Nanomaterials carry drugs by encapsulation, trapping, solubilising, ionic 
interactions and covalent attachment. The resulting structures are different such as 
nanospheres, nanotubes and nanocapsule depending on the composition of polymers, 
drug attachment and method of preparation. Polymeric nanoparticles are biocompatible 
and surface tuneable. The method of preparation is simple and cost effective. Polymeric 
nanoparticles increase the pharmacokinetic of the drug by adjusting the release of 
environmentally sensitive drugs (Putnam & Kopeček 1995). Biodegradable cationic 
polymeric nanoparticles have already been used in drug delivery for example, polylactic 
acid (PLA), polyglycolic acid (PGA), proteins, sugars and synthetic materials such as 
polymethyl methacrylate (PMMA), Polyethene glycol (PEG) and poly-glutamic acid 
(Cho et al. 2008). 
Naturally, occurring polymers such as albumin and chitosan have been studied for the 
delivery of protein, DNA and drug. Some of the formulations are in clinical trial in 
different types of cancers such as lung and-and non-blood tumours (Green et al. 2006; 
Nyman et al. 2005), and oral delivery (Gan & Wang 2007). Dendrimers have been 
extensively studied as a delivery vehicle and in diagnostic applications.  These 
macromolecules provide globular structures composed of branches (hydrophilic) attached 
to the core (hydrophobic unit) and surface groups. An individual dendrimer can carry 
three agents such as a therapeutic drug, a diagnostic agent and targeting element (Gillies 
& Fréchet 2005). The release of loaded molecules depends upon the length and rigidity 
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of branches. Gillies et al. (2004) studied the pH and enzymatic stimuli-responsive 
dendrimers to release the cargo at targeted sites. Half-life and clearance from kidney are 
adjustable with the length of branches. The dendrimers with a molecular weight around 
40 kDa showed an increased half-life in the blood stream (van der Poll et al. 2010). The 
conjugated dendrimer with doxorubicin showed tenfold decreased toxicity in mice 
compared to free drug. The half-life of doxorubicin conjugated dendrimers was 16 hours 
when administered intravenously. The uptake of cells for conjugated dendrimers was 
ninefold higher than that at free doxorubicin (Lee et al. 2006).  
Biodegradable polyamide amine (PAMAM) is dendrimer and studied for DNA 
encapsulation delivery. Encapsulation protects the DNA from enzymatic breakdown and 
increases the cell uptake by crossing from cell membrane barriers. A huge variety of 
dendrimers has reported from the core materials to surface groups of alcohol, amine, and 
carboxylic acid. The dendrimer theragnostic nanoformulation was obtained by combining 
the imaging probe, drug and folic acid (Majoros et al. 2006). PEGylated dendrimers also 
have a half-life (increased accumulation at tumour vascular system). PEGylating was 
achieved by attaching PEG molecules to dendrimer surface groups. PEGylated dendrimer 
conjugated with 5-fluorouracil showed no haemolytic toxicity (Guillaudeu et al. 2008).     
2.3.2 Carbon nanotubes 
Carbon nanotubes possess a variety of properties that includes electrical conductivity, 
thermal ablation and have high surface area. Carbon nanotubes are classified in two 
categories single wall carbon nanotubes and multi-wall carbon nanotubes. The single wall 
carbon nanotubes size ranges from 0.5 nm to 2.0 nm in width while 20 nm to 
approximately 1 µm in length and multi-wall carbon nanotubes size ranges from 1.4 nm 
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to approximately 100 nm in width and 1μm to several μm in length (Bianco, Kostarelos, 
Partidos et al. 2005).  
Carbon nanotubes have been studied from field emission displays (Bianco, Kostarelos, 
Partidos et al. 2005) to biological applications. Biological applications include detection 
and separation of DNA and proteins and as drug, proteins and DNA carriers (Bianco, 
Kostarelos & Prato 2005). Applications of carbon nanotubes in cancer treatment include 
thermal ablation and delivery of anticancer drug to the cells. Carbon nanotubes have 
successfully delivered the short length nucleotides to the cells (Kam et al. 2005). Thermal 
ablation therapy of carbon nanotubes has been studied in biological systems. Where 
carbon nanotubes at the near infrared (NIR) region (700 nm–1400 nm) absorb light, hence 
this strong absorbance is used deliver their cargo in a cell by rupturing the membrane 
using NIR energy (Bianco, Kostarelos & Prato 2005). NIR energy creates excessive heat 
that causes the cell damages. Thus, by attaching targeting moieties on the surface of 
carbon nanotubes selectively kill the cells, reducing the toxic effect to normal cells. 
Temperature dependent studies showed that cellular uptake of targeted carbon nanotubes 
was lower, which suggest the energy dependent cellular uptake of carbon nanotubes (Kam 
et al. 2005). Constant exposure of NIR (800 nm laser at 14 kW.m-2) carbon nanotubes 25 
mg.L-1 up to 3 minutes can increases the temperature up to 70 °C if exposure remained 
for a longer time this can reach to boiling of the solution. The folate receptors are 
overexpressed on the surface of cancer cells. Folate functionalised carbon nanotubes have 
shown the maximum cell damage with the NIR exposure, however, the normal cells, 
folate are not expressed did not damage. In addition, carbon nanotubes were localised 
into the cells, when labelled fluorescence tag and showed receptor-mediated endocytosis 
pathway of cellular uptake.  
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Carbon nanotubes have successfully delivered the small interfering RNA (siRNA) to the 
target cells. This successful delivery of siRNA was confirmed via the proliferation of 
tumour cells in a mouse model (Bhirde et al. 2009). 
The biocompatibility of carbon nanotubes has been assessed with human cells. Carbon 
nanotubes have inhibited the cells growth, which was related to time and dose dependent 
manner (Cui et al. 2005). The cells, when treated with carbon nanotubes, released the 
proteins up to 40 kDa. These proteins then interwoven with carbon nanotubes causes the 
cells and carbon nanotubes aggregations. Amphotericin B covalently attached with 
carbon nanotubes containing a fluorescent dye. This complex structure of drug 
fluorescence dye and carbon nanotubes was taken by three fungi species  (Candida 
paraphimosis, Cryptococcus neoformans and Candida albicans) (Wu et al. 2005). This 
amphotericin B functionalised carbon nanotubes showed more antifungal activity then 
event amphotericin B as alone. The anticancer drug (methotrexate) was also delivered 
with fluorescence functionalised carbon nanotubes. This delivery system showed time 
and dose dependent uptake of drug into cancer cells. Methotrexate also found to have 
more cellular uptake when delivered with the carbon nanotubes.  
Carbon nanotubes lack solubility in biocompatible solvent systems. Functionalisation 
improves the carbon nanotubes solubility. In addition, it also decreases the polydispersity 
and aggregation. However, some limitations still need to be overcome such as cost 
effectiveness, reproducibility,  large scale production possible minimal impurities 
(Baughman et al. 2002).  Ecological and environmental hazards such as lungs and 
pulmonary toxicity. Carbon nanotubes, when treated to lung cell, showed dose and time 
dependent inflammation (Lam et al. 2004). There is still a long way to overcome the 
chronic inhalation based serious occupational health hazards of carbon nanotubes. 
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2.3.3 Liposomes 
Liposomes are amphiphilic lipid-based vesicles, resembles with the cell membrane. The 
membranous vesicles are of either one layer or multiple layers also called unilamellar or 
multilamellar respectively. The membranes lipids are encapsulated in bilayers of 
hydrophilic and hydrophobic moieties (figure 2-3). Liposome-based drug delivery system 
reported since 1970s. However their nanoscale size distribution was focused since early 
1990s (Kim 2007).  Liposomes, do not fit within the core of nanotechnology due to the 
nanoscale definition of National Nanotechnology Initiative (NNI) as their size >100 nm. 
In contrast, the redefinition of materials up to 1 µm enables liposome to be studied in 
nanotechnology discipline.  
 The difference in head groups and a variety of fatty acids length alter their transition 
temperature, leading them as an ideal candidate for the tuneable structural configuration 
and control release of drugs to the sites (Simões et al. 2004). The temperature sensitive 
liposomes released the drug at 40 °C. These temperature-sensitive liposomes were made 
from the dipalmitoylphosphatidylcholine and mono palmitoyl phosphatidylcholine. The 
lipid transition temperature liquefies the membrane that releases the encapsulated drug. 
The phase transition temperature can be altered by modifying the fatty acid chain length 
and incorporation of cholesterol.  
The liposomes rapidly cleared in blood circulation via Reticuloendothelial System (RES), 
which is a major drawback. A variety of strategies has been suggested to increase their 
half-life. PEG coating is a key approach for making them hydrophilic and biocompatible 
vesicles. The PEG form a cloudy layer on the surface, which prevents the attachment of 
opsonin and prevents the uptake by MPS (Karanth & Murthy 2007).  PEG attached 
liposomes reached successfully in the clinical trials (Gabizon et al. 2004).  One of the 
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drawbacks of these stealth liposomes is the release of cargo. Recent studies show that 
liposome once reaches at target site via EPR effect (Maeda et al. 2009) the PEG can be 
removed via acidic environment of the tumour. Other polymers have also been studied 
for coating such as poly meth acrylamide (PMAM) (Whiteman et al. 2001), polyvinyl 
pyrrolidone (PVP) (Torchilin et al. 2001; Takeuchi et al. 2001), amino acids such as 
asparagine and glutamine (Metselaar et al. 2003). 
The liposomes can be functionalised with the ligands that recognise the target cell to avoid 
the drug contract with normal cells. Folate and Ig fragment are used as targeting moieties 
attached covalently to the liposomes. If liposomes could not have sufficient time to reach 
the target cell, they can accumulate in the liver.  
 
Figure 2-3 Self-assembly of phospholipids and drug molecules (left) into a liposome containing 
drug molecules (right) (Adapted from Davis et al. 2008) 
The ligand and PEG-functionalised liposomes still do not overcome limitations arising 
immune system, attachment of proper ligand with compromising the integrity of structure 
and aggregation. Agglomerated liposomes again rapidly cleared by MPS. Meanwhile, if 
the ligand is covered with PEG coat, then the ligands receptor proteins interaction will be 
compromised. 
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2.3.4 Self-assembling peptides  
Self-assembly of macromolecules is an attractive approach for nanostructures synthesis. 
This approach has been found useful in a variety of fields such as; bioelectronics to sensor 
devices, drug delivery systems to tissue regeneration. The idea of self-assembling the 
molecules was suggested by (Feynman 1960). It is a common strategy to obtain nanoscale 
structures, which is a “top-down” approach to achieving two-dimensional structures. 
Nanomaterials up to the size of 50 nm have been successfully achieved with lithography. 
The self-assembly at the molecular level is a promising approach to build the nanoscale 
functional materials.  
The self-assembly is referred to the spontaneous diffusion or aggregation of individual 
molecules. The hydrophilic, non-covalent van der Waals and hydrophobic interactions 
govern this process of self-assemblies. The variety of bimolecular self-assemblies has 
been reported such as including; proteins (Ringler & Schulz 2003), peptides (Riley et al. 
2009) and aromatic compounds (Bushey et al. 2003; Petitjean et al. 2002).  
Peptides are sequences of proteins or their de novo designed analogues which can be self-
assembled leading to a variety of structures, spheres, tubes, rods and gels. The majority 
of peptides are analogical sequences of the segments of naturally occurring proteins, such 
as amyloid peptides of amylogenic proteins which have formed aggregates in aqueous 
solutions (Ray et al. 2006). Besides the naturally occurring peptides, these can be 
designed for desired sequences for the aggregation. A variety of synthetic amphiphilic 
peptides has been used to form micro/nanostructures (Aggeli et al. 2001). 
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i) Diphenylalanine peptide nanotubes 
Diphenylalanine (FF) peptide monomers are commercially available with a molecular 
weight of 312.37 g.mol-1. The FF readily formed nanotubes. These self-assembling 
structures are normally referred to as Phe-Phe or FF class, occasionally including other 
hydrophobic amino acids (leucine, isoleucine and tryptophan) along with phenylalanine 
(Görbitz 2007). 
The self-assembly of FF-based Peptide Nanotubes (PNTs) is the simplest way to obtain 
nanostructures (Reches & Gazit 2003). The hydrophobic interactions of the side groups 
of amino acids move to same side groups of peptide backbone forming tubular structures 
with the water molecules interacts with the hydrophilic amino and carboxylic groups. 
Song et al. (2004) Showed that they formed PNTs by dissolving the FF in the HFIP. 
However, the data suggested that FF monomers shared different nanotube properties such 
as straightness, stiffness and number of branches. Various studies have been performed 
on the modification on the amino terminal of FF (Table 2-1).  
Table 2-1 Modified analogues of FF peptide and their nanostructure pattern 
Structure Self-assembling pattern References  
BOC-Phe-Phe-OH Nanotubes, spheres  (Reches & Gazit 2003; Song et al. 2004)  
Fmoc-Phe-Phe-OH Hydrogel  (Mahler et al. 2006)  
Ac-Phe-Phe-OH Nanotubes  (Reches & Gazit 2005) 
H2N-Phe-Phe-OH Nanotubes  
Z-Phe-Phe-OH Amyloid  
 
FF, when modified with BOC group at the amino terminal, resulting two types of 
nanostructures which are reported as nanotubes and nanospheres (Adler‐Abramovich & 
Gazit 2008). In both cases, FF was dissolved in HFIP at a concentration of 100 mg.ml-1. 
Further dilution was performed using water as a solvent for the native structures 
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(nanotubes). However, when these peptides were dissolved in ethanol-water (50 %) 
mixtures after dissolving in HFIP, they showed a spherical structure with average size 
500 nm to 2 µm (Reches & Gazit 2003). Another analogue of FF modified with fluorenyl 
methoxycarbonyl (Fmoc) group. Fmoc-Phe-Phe-OH exhibited a gel-like structure in an 
acidic environment (Johnson et al. 2011). These hydrogels can be potentially used in 
tissue culture scaffolding, biosensing, drug delivery carrier and in batteries (Reches & 
Gazit 2005). Initially, the structural organisation was proposed, similar to that of amyloid 
formation of individual monomers arranged in β-sheets confirmations. The confirmation 
method used in addition to experimental data analysed with FTIR and amyloid disease 
testing methods such as Congo red staining (Reches & Gazit 2003). The FF contains two 
phenylalanine amino acids, which is hydrophobic with amino and carboxylate as 
hydrophilic groups backbone (figure 2-4).  
2.3.1 Doxorubicin  
The cytotoxic drug doxorubicin (DOX) was chosen as a model drug. It intercalates and 
inhibits the DNA and RNA synthesis. It restricts the catalytic cycle of Topoisomerase II 
by stabilising it in cleavable complex and subsequently it breakage the DNA strands 
(Holmgren et al. 2015). DOX can form the reactive oxygen species, which damages the 
cells. DOX can inhibit the nitric oxide synthase activity, which is the result of significant 
damage in tumours (Świerniak et al. 2016). However, the dose-limiting toxicity, 
chemotherapy-induced myelosuppression, rapid elimination from the body and acute 
renal failures restricted its use in clinical applications. Hence, the importance of designing 
new strategies for safe and multifunctional carriers for DOX increased exponentially (Liu 
& Auguste 2015). Loading of the DOX into the peptide coated magnetite nanoparticles 
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was carried out with the combination of two different methods including ultrasonication 
and incubation 
 
Figure 2-4 Proposed model of non-modified FF peptide as linear tubes (where hydrophobic and 
ionic interaction assumed to play role) 
2.3.2 Iron oxide nanoparticles 
Superparamagnetic iron oxide nanoparticles (SPIONs) also have received significant 
attention (figure 2-5), including superparamagnetic features and tunable physicochemical 
properties such as size, shape and constituent of materials.  Additionally, iron oxide is 
known as biocompatible iron ions with biological systems. Size may be controlled from 
several to hundreds of nanometres, smaller than living cells (10-100 µm) being more 
comparable to viruses (20 – 450 nm) or proteins (5 – 50 nm). Proteins, lipids, smaller 
peptides and polymers coated by magnetic nanoparticles can be a useful tool in 
biochemical applications (Bruce et al. 2004a; Mahmoudi et al. 2011; Sen & Bruce 2009; 
Zheng et al. 2013; Elhissi et al. 2012).  
 
 
  
23 
 
i) Magnetite (Fe3O4) 
Magnetite is naturally occurring minerals black in colour with strong magnetic properties. 
Magnetite (Fe3O4) crystal has been seen in certain bacterial, birds and human brain 
(Šafařík & Šafaříková 2002).  Magnetite are inverse spinal in cubic structural 
configuration, which closely packed with oxygen and iron in both tetra and octahedral 
fashion. Thus, magnetite possesses interesting magnetic properties from iron spins in both 
tetra and octahedral interaction sites. In bulk form, magnetite possesses higher Curie 
temperature and are ferromagnetic at room temperature (Lowrie 1990). However, due to 
their nanoscale size distribution possess superparamagnetic behaviour. The arrangement 
of ferric and ferrous ions in both sites creates electron transfer via applied magnetic field. 
If the particle size is > 50 nm, the individual particle has a single randomly oriented 
domain that caused superparamagnetism. Thus, the size and shape influence the 
coercivity and remanence effect (Hergt et al. 1998). The nanomagnetite have a high 
surface-to-volume ratio. Therefore, they tend to aggregate, while decreasing their surface 
energy. During synthesis or storage, magnetite oxidises to maghemite. One of the 
important roles of coating materials is to prevent aggregation and oxidation of magnetite. 
The superparamagnetic behaviour, when modified with biomaterials can be an ideal 
candidate for biomedical applications. Alongside the above applications, the 
nanomagnetite have been used in other applications, such as magnetic seals, contrast 
agents, bio-separation, catalysis, hyperthermia and applied external field directed 
targeting (figure 2-5) (Santhosh & Ulrih 2013; Mahmoudi et al. 2011).     
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Figure 2-5 Biomedical applications of iron oxide nanoparticles 
ii) Synthesis routes of magnetite nanoparticles  
In this section, a different preparation method for magnetite iron oxide proposed so far 
will be discussed.  
a) Co-precipitation: this method is comparably simple, quick and cost-effective for 
the preparation of magnetite and maghemite nanomaterials. This method is involved in 
mixing of ferric and ferrous ions (usually 1:2 or 1:1.5 respectively) in alkaline medium. 
However, the acidic medium can also be used. Ideally, the solution is heated below 80 °C 
(or at room temperature). To avoid the oxidation of magnetite to maghemite inert gas 
environment is used. The parameters such as temperature, pH and molar ratio affects the 
size, shape and type (magnetite or maghemite) of resulting products.  
Though this is the easiest method for the iron oxide nanoparticles synthesis in aqueous 
solution, some researchers also have used the surfactant to the solution to avoid the 
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aggregation and obtaining of narrow size distributed nanoparticles (Mahmoudi et al. 
2011).  
b) Thermal decomposition method: This method involves in thermal 
decomposition of iron (III) (dodecacarbonyl) or iron (III) (acetylacetonate) source in 
absolute ethanol using temperature up to 280 °C. This method though bit complicated but 
yields monodispersed nanoparticles. The nanoparticles cannot be dispersed in aqueous 
medium but only be dissolved in organic solvent along the use of surfactant (Maity et al. 
2009; Amara et al. 2009).      
c) Microemulsion method: This method involves more complex system 
comprising of three main components; polar, nonpolar and amphiphilic mediums.  The 
amphiphilic substances (surfactants) reduces the surface tension of both immiscible 
mediums and produces the transparent medium. The water nanodroplets in bulk oily 
medium provide the “nanoreactors” for the synthesis of resulting iron oxide nanoparticles. 
The shape of water nanodroplets are spherical so provide spherical nanoparticle, 
meanwhile size of these nanodroplets influences the size of resulting nanoparticles. Thus, 
the size and shape of nanoparticles can be tuned according to size and shape of water 
nanodroplets (Laurent et al. 2017).   
d) Hydrothermal method: This method involves the high pressure and temperature 
to hydrolyse the dehydrated salt resulting in the supersaturation of metal salts. The high 
temperature and pressure are used to achieve increased dehydration with good diffusivity 
of salts in water. In this approach, higher supersaturation can be obtained fine grains 
having good crystallinity. The reaction parameters such as time, temperature, pressure 
and iron source can be tuned to obtained desired size and shape of nanoparticles. This 
process does not involve the use organic solvent or surfactant (Cai et al. 2013). 
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e) Sonochemical method: this method involves the use of ultrasound waves arise 
from acoustic cavitation. The formation, growth and implosive collapse of bubble occur 
in the aqueous medium. The implosive collapse creates a confined hotspot through shock 
wave within the bubbles. This hotspot creates extreme conditions in which nanoparticles 
are formed. The nanoparticle formed with this method usually have undefined shapes and 
sizes.   
2.3.3 Hyperthermia and magnetic field triggered drug release from core-
shell materials 
The term hyperthermia indicates the increased temperature based precise therapy of body 
tissues. In cancer applications, hyperthermia is the treatment of cancer exploiting the 
increased temperature. According to initial studies, increased precise heating can cook 
the cancer cells (Hahn 1974; Quinto et al. 2015). The hyperthermia-based treatment could 
be divided in three categories based on the temperature utilisations.  
a) Diathermia: in this type of hyperthermia treatment temperature usually be kept 
lower than 41 °C. This type of treatment is used for physical and occupational therapies. 
The heat is induced from ultrasound, microwave and shortwave.  
b) Moderated hyperthermia: This applies to the treatment with temperature ranges 
from 40 °C-45 °C. This range of temperature is ideal of killing of cancer (Nikam et al. 
2014).  
c) Thermal ablation: In this hyperthermia-based treatment, the temperature reaches 
up to 55 °C. This temperature causes the necrosis of cells, coagulation of body proteins 
and other biomolecules. The hyperthermia can be used into localised area, regional or 
organ based or even for whole body (Majeed et al. 2014).  
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Different techniques can induce the hyperthermia-localised temperatures, including IR 
radiation, ultrasound, microwave, magnetic based materials, and administration of heated 
liquids or direct heating from chamber. The hyperthermia based treatments of cancers, 
however proved effective in initial clinical trials (Cihoric et al. 2015). The molecular 
mechanism behind the cells killing is still not fully understood. Several studies have 
revealed the intracellular mechanism of heat induced cell damages. The hyperthermia 
activate the energy for proteins coagulation (Kampinga 2006). The proteins in nucleus 
are more sensitive to hypothermia induced coagulation compared to other intracellular 
biomolecules (Lepock 2004). Moreover, the nucleus is more efficient place for heat-
induced protein denaturation (Nishita et al. 1998). Meanwhile, studies have revealed the 
good correlation of heat-induced cell damaging and nuclear proteins denaturation 
(Kampinga & Dikomey 2001; Kampinga 2006).     
The relation between immune system and hyperthermia was studied (Shen et al. 1994). 
According to these studies, hyperthermia was assumed to have increased the whole body 
temperature after applying the localised hyperthermia. However, it promotes the defence 
system by inducing the immune system. The killing of cells starts at 40 °C. In vivo studies 
confirmed the accumulation of dead cells in cancer sites after localised hyperthermia 
(Burd et al. 1998). Another important application of magnetic field triggered drug release 
and targeted region (localised hyperthermia), which also triggers the drug release to 
specific sites.  
i) Methods for induction of Hyperthermia 
a) Heated water circulations: this is the oldest techniques used for induction of 
hyperthermia, in which whole body is kept in insulated chamber where circulating warm 
water increases the heat inside the body. This technique was initially used in replacement 
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of chemotherapy or radiotherapy. To achieve the hyperthermia different instruments were 
design in a systematic way, where patient whole body is kept inside chamber except its 
head (Pettigrew et al. 1974). This type of hyperthermia approach is recommended to high-
risk patients after surgery. This technique has a drawback of the non-uniform distribution 
of heat inside the body, which causes the lesions and surface burning. This approach could 
not reach to the patients because of its side effects such as on cardiac arrest, red blood 
cells and platelets deficiency and biomolecules coagulations. In general, this approach 
has led to the investigation of localised hyperthermia.  
b) Non-invasive wireless induced hyperthermia: In this approach, localised 
regions are targeted via applying waves; these waves cause heat generation over targeted 
region. The various applicators are studied and commercially available for treatment of 
localised cancers. Such heat inducing applicators include; high energy focused ultrasound 
waves, non-invasive electromagnetic radiofrequency waves, infrared frequency based 
microwave, electromagnetic frequency waves based on inserting the antennas to avoid 
the un-even distribution of heating in localised hyperthermia, macroscopic 
radiofrequencies electrodes induced heating for localised hyperthermia, few centimetres 
ferromagnetic materials implantation in a magnetic field and nanoparticles (Varon & 
Acosta 2008; Vaupel et al. 1989; Wust et al. 2002; Lele 1990). 
c) Nanoparticles induced hyperthermia: In nanoparticles induced hyperthermia, 
heat is produced from loss of hysteresis or relaxation over applied Alternate Current (AC) 
magnetic field. This approach of hyperthermia-based treatment is more precise, where 
nanoparticles are systematically administered to body and can be targeted via magnetic 
field or attachment of selective moieties or by exploiting enhanced permeability and 
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retention effect. Nanoparticles upon systematic administration in body can be directed 
and excited via applying external magnetic field. In comparison other studied approaches 
such as radiofrequency electromagnetic waves, microwaves and high energy focused 
ultrasound could not be directed by any means to the desired sites (Jordan et al. 1999). 
Magnetic nanoparticles also are MRI contrast materials, hence can be tracked and 
visualised for their localised distribution inside the targeted sites before starting the 
hyperthermia treatment (Mornet et al. 2004). 
A systematic hyperthermia triggered controlled release drug systems were designed, 
where magnetic nanoparticles were coated with certain thermo-sensitive polymers and 
drug molecules. For this purpose, gels were used to coat the magnetic materials. These 
gels have shown morphological alteration when exposed to different temperatures (Ang 
et al. 2007). In addition, gels also work as sponge material for controlled release of 
payloads. In a drug delivery application, magnetic nanoparticles via thrust force can be 
propelled to targeted sites, where they can increase the temperature of hydrogel, thereby 
releasing the cargo molecules inside.  
d) Heat induction from magnetic nanoparticles in alternating magnetic field: 
The heat induction from magnetic nanoparticles is caused by either hysteresis loss, Nėel 
relaxation or Brownian relaxations phenomenon. The relative strength of these 
mechanism depends on the different factors such as; size, shape, chemical composition 
and strength of the nanoparticles.  
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e) Magnetic domains 
Large size particle contains more than one domain to reduce the magnetostatic energy. 
This energy comes up from magnets own field. The magnetostatic energy (ME) is defined 
in following terms:   
                                         𝑀𝐸 = (
1
2
) 𝑓𝐻2 𝑑𝑣                                Equation 2.1 
where dv denotes the volume, H defines the applied magnetic field 
Figure 2-6 explains the materials of numerous domains reducing the magnetic field H. 
The magnetostatic energy of particles reduces as domain volume increase. The domains 
are separated with a domain wall. A huge amount of magnetic movement m is produced 
from each domain.  
 
Figure 2-6 Schematic diagram of magnetostatic energy reduction as number of domains 
increases 
The magnetic materials then can be classifies such as ferrimagnetic, ferromagnetic, 
antiferromagnetic and paramagnetic according to the orientation of their magnetic 
moment. The theory and mechanism for formation of these magnetic materials could not 
be possible to explain in this section; however, figure 2-7 displays the magnetic moment 
orientation of different magnetic materials. The magnetic moment orientation of 
ferrimagnetism, ferromagnetism and antiferromagnetism is aligned in one direction under 
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the Curie temperature. Magnetic moment orientation varies from domain to domain; 
however, the domains are aligned in one orientation, when external field is not applied, 
this orientation is called “easy axis”.     
 
Figure 2-7 Schematic diagram of magnetic moment orientation of different magnetic materials 
(a) ferromagnetic, (b) antiferromagnetic, (c) ferrimagnetic and (d) paramagnetic materials 
ii) Hysteresis  
The application of moderate magnetic field H, magnetic moment of particle energy 
control over the anisotropy energy (Harris 2002). This change is energy reciprocally 
rotate the magnetic moment of domains into the new orientation, these orientation are 
moving with exposure of applied external magnetic field. The changes in magnetic 
moment of domain walls are somewhat comparable to the anisotropy energy. Thereafter, 
as applied external magnetic field modify the balance of energies causing the moment’s 
re-orientation. Increased magnetic field led to achieve saturation magnetisation (Ms) of 
magnetic materials (figure 2-8). The magnetic moment reversed and slowly aligned with 
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applied magnetic field amplitude direction causes the hysteresis of sample of single 
domain (Jiles 2015). Hence, Ms value for microsize materials is different compared to 
nanosize materials. The observed experiment Ms values for nanosize magnetic materials 
were in range of 30-60 emu.g-1, compared to bulk magnetic materials, where Ms value 
were 90 emu.g-1 (Harris 2002). The nanosize magnetic particles containing single domain 
of less than 50 nm approximately called superparamagnetic iron oxide nanoparticles 
(SPIONs). In SPIONs, the higher magnetic moment and lower potential energy in volume 
is significantly smaller compared to their thermal energy. Therefore, thermal energy itself 
creates the magnetic moment of nanoparticles with applying magnetic field (Brown Jr 
1963). This behaviour of iron oxide materials causes the lack of hysteresis losses. Where 
coercive fields do not reaches to zero, lacking hysteresis loss creating the heat release 
within nanosize magnetic materials.  
 
Figure 2-8 Hysteresis curves of (a) several domain bulk magnetic materials and (b) single 
domain superparamagnetic nanoparticles (adopted from Frey et al. 2009) 
Figure 2-8 (a) shows zero magnetisation (M=0) of non-magnetised ferri or ferromagnetic 
materials. When external field applied (arrows), these materials aligned with magnetic 
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field until they reach to Ms (saturation magnetisation) plateau. The Ms is defined as in 
following equation: 
                                  𝑀𝑠 =
𝑀
𝑝
    [
𝑒𝑚𝑢
𝑔
]             equation 2.2  
where, 𝑝 is the density of magnetised materials M is applied magnetic field  
2.3.4   Core-shell nanocomposites  
Iron oxide nanoparticles have been used as Magnetic Resonance Imaging (MRI) agents 
due to their slower excretion from glomeruli filtration compared to other contrast agents. 
SPIONs can also be used as drug delivery vehicles. Drug loaded SPIONs (drug being 
bound irreversibly or co-attached with coating), can be targeted using external magnetic 
fields to specific regions and tracked using imaging (Neuberger et al. 2005). 
To attain magnetic based target, specific drug delivery SPIONs should be biocompatible, 
have a long half-life in blood circulation, high dispersion rate and stability against 
enzymes of serum and immune system. Coating of SPIONs also reduces the van der 
Waals attractions based aggregation (Deng et al. 2014). Aggregates of SPIONs are 
cleared from blood rapidly after systematic administration by macrophages 
reticuloendothelial system (RES) (Jain et al. 2008). SPIONs may be coated with 
biocompatible molecules such as cyclo(Arg-Gly-Asp-D-Phe-Cys) peptide (cRGD) to 
give them “stealth property” and targeted specificity (Richard et al. 2017). Proline-rich 
peptide coated SPIONs also showed improved MRI capability (Ozdemir et al. 2016). 
Coating with hydrophilic polymers such as dextran or starch and targeted to peptide for 
the better colloidal stability and longer circulation kinetics, have already been reported 
(Kim et al. 2003). However, limited drug loading and release efficiency was observed. In 
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addition, polylactide and dendrimer-based coating for SPIONs have been reported 
(Strable et al. 2001), however suffer from associated loss of magnetisation.  
Lipids have also been reported as potential coating materials for SPIONs (Zhang et al. 
2006), for example oleic acid coated SPIONs have shown excellent colloidal stability. 
However, the poor aqueous solubility is still a challenge to overcome.  A thermally 
responsive polymer such as; poly-ethyleneimine-modified poly-ethylene oxide poly-
propylene oxide poly-ethylene oxide (PEO−PPO−PEO) a block copolymer based coated 
magnetic nanoparticles have been reported (Chen et al. 2007). They have limitation 
related to their biocompatibility and biodegradability. Easy preparation method with high 
SPIONs, drug loading and controlled release of the drug is a highly challenging problem 
that needs to be overcome.  
This literature review shows a summary of various nanoscale based drug delivery tools, 
which can be used once the aggregation and biocompatibility related issues addressed, 
thus it is not far that these will be in use in the future and have an impact on society. 
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2.4 Conclusions 
This review has covered various ways in which nanoscale carriers can be used for targeted 
drug delivery. To overcome the limitations of the common materials currently employed, 
core-shell structures have been considered in detail. The researchers are studying the 
different core-shell structures and shapes via different synthesis routes. Template 
mediated synthesis is a useful approach for the organic shell and SPIONs core (core-shell) 
materials. However, all methods have shown some limitations such as loss in particle`s 
functional properties, difficult to separate, high cost and reaction step are complicated.     
SPIONs as core material are useful for their hyperthermia response; magnetic field 
triggered and targeted drug delivery system. The advantage of peptide shells over other 
organic polymers is the ability to control the shape and structure by alternating in primary 
sequence or by modification to any terminal of amino acids.  
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CHAPTER THREE 
3 Materials and Methods 
3.1 Introduction  
This chapter describes materials and methods employed in this study. It also gives the 
basic principles of the characterisation techniques used. It is divided into two sections: 
Section A and Section B. 
Section A describes the type of materials used in this work. It also briefly explains the 
protocols performed for the synthesis of peptide self-assemblies, SPIONs of different 
shapes and the coating of self-assembled peptide to core-shells nanocomposites. This 
approach will aid the understanding of self-assemblies of short derivative peptides into 
nanoscale to microscale structures in an aqueous medium.  
Section B describes the instrumental techniques used to characterise the stability, and 
conformity of synthesised structures at chemical, molecular and elemental level, 
quantitatively or qualitatively. These approaches will provide the base of their functional 
properties in targeted drug delivery applications.  
3.2 Materials 
All chemicals used in this project were of high purity and analytical grade and 
commercially available. They were used without further modification unless otherwise 
stated. 
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3.2.1 Diphenylalanine peptide analogues  
Two synthetic analogues of butyloxycarbonyl-diphenylalanine (BOC-FF) with a 
molecular weight of 412.49 and FF molecular weight of 312.37 were purchased from 
Bachem (Bubendorf, Switzerland) purity > 95 %.      
3.2.2 All other chemicals  
HPLC grade absolute ethanol, Iron (II) chloride, hexadecyltrimethyl ammonium bromide 
(CTAB), tetraethyl orthosilicate (TEOS), ferrous sulphate heptahydrate and doxorubicin 
hydrochloride were purchased from Sigma-Aldrich (Poole, UK).  1,1,1,3,3,3-hexafluoro-
iso-propanol (HFIP), Dimethyl sulfoxide (DMSO) and Iron (III) chloride were purchased 
from Alpha-aeser (Lancashire, UK). Aluminium stub, carbon tabs and carbon coated 
copper grids for SEM and TEM, respectively were from Agar Scientific (Essex, UK). 
Ammonium hydroxide was purchased from VWR (Leicestershire, UK). Phosphate buffer 
saline tablets, methanol and potassium hydroxide were purchased from Fisher Scientific 
(Loughborough, UK). Milli-Q water was used in all the experiments with 18 MΩ∙cm 
resistances or otherwise discussed.   
3.3 Methodology   
3.3.1 Preparation of analogues of diphenylalanine based peptide into various 
structures in different environmental conditions 
i) Synthesis of peptide nanotubes in hexafluoro-iso-propanol -water mixture  
Lyophilised peptide boc-diphenylalanine (BOC-FF) and non-modified diphenylalanine 
(FF) powder were dissolved in HFIP at the concentration of 100 mg.ml-1 as a stock 
solution. For each set of experiments, fresh stock solutions were prepared to avoid pre-
aggregation as reported (Jeon et al. 2013). The stock solutions were subsequently diluted 
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in Milli-Q water with 18 MΩ∙cm resistances to a final concentration of 2 mg.ml-1 and 
vortex mixed. The flow chart gives an indication of peptide nanotubes (PNTs) preparation 
(figure 3-1). 
Scheme 3-1  Shows the chemical structure of (a) BOC-FF and (b) FF (adopted from Bachem 
2016) 
 
ii) Synthesis of spherical boc-diphenylalanine peptide in ethanol-water mixture  
 Boc-diphenylalanine was dissolved in 10 mg.ml-1 of absolute ethanol and then diluted to 
2 mg.ml-1 in ethanol-water (1:1). After dilution, the sample was kept in an ultrasonic bath 
for 15 minutes. The solution was then left at room temperature for 15 minutes then further 
characterisation was performed.  
iii) Synthesis of diphenylalanine peptide nanotubes in water and ethanol-water  
 Initially, diphenylalanine peptide was dissolved in absolute ethanol at the concentration 
of 10 mg.ml-1 (stock solution). The stock solution was further diluted to 5 mg.ml-1 with 
ethanol-water (1:1) mixtures. Experiment were performed using various concentration 
ranges from 2, 6, 8, and 10 mg.ml-1 with ethanol-water ratios of 25 %, 50 %, 75 % and in 
100 % ethanol. The experiment was repeated by diluting into the water after dissolving 
in HFIP keeping similar condition to those discussed for BOC-FF peptides.  
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Figure 3-1 Proposed methodological diagram for obtaining peptide self-assemblies 
3.3.2 Preparation of iron oxide nanoparticles involving oxidative alkaline 
hydrolysis of ferrous ions 
Rod-shaped iron oxide (FM-ION-RS) nanoparticles were prepared by oxidative 
hydrolysis of ferrous sulphate (FeSO4.7H2O) in an alkaline medium. Briefly, ferrous 
sulphate heptahydrate (FeSO4.7H2O, 17.71 g) was dissolved in 400 ml of deionised water 
degassed with nitrogen in three-neck round bottom flask with a magnetic stirrer, nitrogen 
gas flow and condenser. The solution was heated in an oil bath connected to 90 °C with 
continuous nitrogen flow while stirring. Once the temperature reached 90 °C, 100 ml of 
150 mM potassium hydroxide (13.8 g) and 50 ml of 5 mM potassium nitrate (oxidising 
agent) prepared separately were added to a flask containing ferrous sulphate solution 
under continuous stirring (pH 13).  The temperature (90 °C) was maintained for a further 
two hours in nitrogen flow until a jet-black precipitate appeared. The solution was left to 
cool at room temperature under nitrogen. Afterwards, the solution was transferred to 2L 
conical flask. This material was initially washed twice with 2 L of deionised water, then 
once with 2 L of diluted nitric acid and again several times with deionised water until the 
pH value reached to 7.0. The whole washing process was performed through magnetic 
separation using slab magnet, and the supernatant was aspirated using the water pump. 
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The final product obtained from this method was jet black, and the supernatant was clear. 
The final volume was adjusted to 1 L with deionised degassed water. For the density 
measurement, three empty Eppendorf tubes were weighed and labelled. 1 mL of well-
mixed FM-ION-RS was added to each tube. Water was removed through magnetic 
separation and left at 60 °C for overnight. The final mass of FM-ION-RS  was expressed 
in mg.ml-1 for further characterisation. This method yielded 25 grams. The reaction 
scheme for this synthesis of maghemite is illustrated in Scheme 3-2 
Scheme 3-2 showing oxidative hydrolysis of ferrous sulphate into FM-ION-RS (adopted from 
Ketebu et al. 2015)  
6KOH + 3FeSO4 → 3Fe(OH)2 + 3K2SO4  
3Fe(OH)2 + NO‐3 → Fe3O4 + NO‐2 + 3H2O  
2 Fe(OH)2 + 2NO‐2 → Fe3O4 + 2NO + 2H2O + 2OH- 
15Fe(OH)2 + 2NO → Fe3O4 + 2NH3 + 2H2O 
2Fe3O4 + 
1
2
O2 → 3Fe2O3 
3.3.3 Synthesis of iron oxide nanoparticles involving precipitation of ferrous 
and ferric chloride in alkaline medium   
Ferrous and ferric chlorides (in hydrates) were precipitated as iron precursors in a molar 
ratio of 1:2, respectively. The precipitation was carried out using ammonium hydroxide 
(Bruce et al. 2004b). Briefly, iron (II) chloride tetrahydrate (3.9762 g, 0.02 mol) dissolved 
in 10 mL HCl (2 M). To this solution, Iron (III) chloride hexahydrate (FeCl3. 6H2O, 
10.8120 g, 0.04mol) was added (dissolved in 40 ml of deionised water, degassed with 
nitrogen whilst stirring). The solution was heated to 80 oC with continuous nitrogen 
purging to remove the oxygen from the solution to avoid oxidation of magnetite. This 
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solution was continuously stirred. A small amount of HCl was used to increase the 
chloride ions dissolution whilst heating the solution. When iron precursor solution was 
reached at 80 °C, 25 ml of 28 % of ammonium hydroxide solution was added dropwise 
over a period of 45 minutes. The solution colour became reddish brown to black, due to 
the nucleation of magnetite nanoparticles. The reaction was left for additional one hour 
under the same conditions, then the heating was turned off, and the solution was left to 
reach the room temperature. The solution was then transferred to 1L conical flask on slab 
magnet to sediment the particles. The sediment product was washed several times with 
deionised water to remove unreacted material and impurities. The washing process was 
repeated until it reached to pH 7.0. The method has produced ultra-small spherical 
nanoparticle with an average size around 15 nm to 25 nm. The product was labelled as B-
SPION-SS. The mechanism of precipitation of iron oxide with ammonia is depicted in 
scheme 3-3  
Scheme 3-3 Co-precipitation of iron (II) and (III) ions in alkaline medium for synthesis of 
spherical nanoparticles 
2FeCl3 + FeCl2 + 8NH3 + 4H2O → Fe3O4 + 8NH4Cl 
3.3.4 Synthesis of mesoporous silica-coated superparamagnetic iron oxide 
nanoparticles  
Mesoporous silica-coated SPIONs were made according to the method (Sharifabad et al. 
2014a; Bruce et al. 2004b; Sen & Bruce 2009; Sen et al. 2006). Briefly, 1 g of FM-ION-
RS was dispersed in ethanol-water (1:1). 30 mL of 28 % ammonium hydroxide was added 
to the solution and stirred for 10 minutes. Subsequently, 2 g of hexadecyl-trimethyl 
ammonium bromide (CTAB) powder was added to the mixture. It was stirred for a further 
5 minutes and sonicated in an ultrasonic bath for 15 minutes, and the solution was heated 
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to 60 °C in a nitrogen flow. 12 mL of silica precursor tetraethyl orthosilicate (TEOS) was 
added drop-wise under continuous stirring for 24 hours. The black product obtained was 
transferred to the 1 L conical flask. The material was then washed initially with 500 mL 
of deionised water (two cycles) using slab magnet, two cycles of acidic ethanol using 
ultrasonic bath and then several cycles of water until the pH of the mixture was reached 
to pH 7.0. The product was then labelled as Si-SPION-RS. A schematic depiction of 
mesoporous Si-SPIPN-SS is given in figure 3-2.    
 
Figure 3-2 Silica coating on bare SPIONs (modified from Barbosa et al. 2016) 
3.3.5 Coating of rod-shaped iron oxide nanoparticles and spherical iron 
oxide nanoparticles  
BOC-SPION-SS were achieved in a mixture of ethanol-water (1:1) using the combination 
of ultrasonication and vortex mixing techniques, according to method published by 
Dalton et al. 2004; Talelli et al. 2009. Briefly, solutions of 20 mg, 50 mg, 100 mg and 
200 mg of peptide were prepared in HFIP at the concentration of 100 mg.mL-1. Then, iron 
oxide nanoparticles were taken from the stock solution, and water was removed via 
magnetic separation. The final iron oxide to peptide ratio was made 1:1, 1:5, 1:10 and 
1:20 with ethanol-water mixture (1:1). The mixture was vortex mixed for 5 minutes. The 
samples were sonicated using ultrasonic bath for 30 minutes, yielding the dense black 
solution. The sonicated samples were then magnetically separated from the supernatant 
containing unutilised peptide was removed. The magnetically separated material was then 
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re-suspended in the ethanol-water mixture (1:1) and transferred into clean vials for further 
studies. 
The BOC-FF coating to B-SPION-SS was also performed as previously described via 
template-mediated polymerisation (Wu et al. 2008). Briefly, 200 mg of BOC-FF was 
dissolved in 20 mL of ethanol and added to a 3-neck round bottom equipped with a 
magnetic stirrer. The solution pH was then raised to a pH of 7.5 using 1 M sodium 
hydroxide, to get negatively charged carboxyl groups on peptide structures, to increase 
the incorporation of positively charged Fe ions into the peptide. In another beaker, Fe (III) 
and (II) chlorides were dissolved in 25 mL ethanol-water mixture (1:1) and mixed for 30 
minutes. The peptide solution was heated to 60 °C and Fe solution was added dropwise 
under continuous nitrogen purging and vigorous stirring where ferrous ions were bound 
to the carboxyl groups of BOC-FF resulting in the formation of a dark green suspension. 
Magnetic nanoparticles were separated using slab magnet and supernatant containing free 
peptide was removed.  
3.3.6 Doxorubicin loading to nanomaterials     
i) Preparation of standard calibration curves for doxorubicin loaded in 
nanomaterials   
Accurate amount 5 mg of DOX was weighed and dissolved in 50 ml of DMSO-water 
(1:1) to obtain a stock solution of 100 µg.mL-1. The standard solutions were prepared by 
taking 2, 4, 6, 8, 10 ml into the 10 ml volumetric flask. Volume of volumetric flask was 
made with either DMSO-water (1:1) for loading or with PBS for release experiments to 
achieve final DOX concentration of 20, 40, 60, 80, 100 µg.mL-1, respectively. 
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ii) Drug loading in bare spherical and rod-shaped iron oxide nanoparticles   
The DOX loading was performed by dispersing different ratios (1:25, 1:50, 1:75 and 
1:100 drug:carrier ratio). Briefly, 2.5, 5, 7.5 and 10 mg of FM-ION-RS and B-SPION-SS 
were added in 1 mL of aqueous DOX solution (drug concentration 100 µg.mL-1). 
Following the experimental procedure described by (Unsoy et al. 2014; Byeon et al. 
2016). The mixture of iron oxide nanoparticles in DOX was then mixed with rotator for 
5 minutes. The solution was then sonicated for a further 5 minutes in the ultrasonic bath 
to facilitate DOX uptake. At this point, the UV- absorbance of free drug was taken as 0 
hours. The DOX and iron oxide nanoparticles solution was kept in an incubator at 18 °C 
for 48 hours. During this period of incubation, at fixed time intervals, the iron oxide 
nanoparticles were separated from the liquid using the magnetic stand and the optical 
density of DOX in the supernatant was measured at λ485 nm by UV–vis 
spectrophotometer. After each measurement, iron oxide nanoparticles were re-dispersed 
in supernatant containg DOX solution for further adsorption. After 48 hours of adsorption 
time, there were no further changes in the measurement of DOX. At this point, the loading 
capacity of the iron oxide nanoparticles had reached to saturation. DOX-loaded 
nanoparticles were magnetically separated and washed with deionized water prior to use 
in the drug release experiments. The drug loading efficiency (DE), denotes to the 
percentage of drug loaded into the iron oxide nanoparticles relating to the total drug in 
added initially and drug loading capacity (LC), denotes to the drug content in the system 
were calculated using the following formulae: 
           DE % =
TD−FD
TDvol
× 100             (Equation 3-1) 
LC % =
TD−FD
TDwt
× 100    (Equation 3-2) 
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where TDvol refers to the total DOX added initially to nanoparticles, FD refers to the 
DOX content in the supernatant and TDwt refers to the weight of nanoparticles. 
iii) Doxorubicin loading in mesoporous silica-coated iron oxide nanoparticles  
The density of Si-SPION-SS were measured by drying 3×1 mL of suspension at 60 °C 
overnight. Four different ratios were taken (1:25, 1:50, 1:75 and 1:100) for DOX and Si-
SPION-SS. Briefly, 2.5, 5, 7.5 and 10 mg of SiSPION-SS were taken in Eppendorf tube. 
The suspensions were mixed using vortex for 5 minutes and sonicated in an ultrasonic 
bath for 5 minutes. The mixture was then separated using magnet and absorbance of free 
DOX was measured at λ485 nm using UV-vis spectrophotometer. The mixture was then 
left at 18 °C in the end-over-end rotator for further 48 hours. The samples were 
magnetically collected and stored at – 4 °C for DOX release studies. 
iv) Doxorubicin loading in peptide coated spherical and rod-shaped iron oxide 
nanoparticles 
The mesopores of Si-SPION-SS were capped with BOC-FF to improve the controlled 
release profile. In actual process, Si-SPION-SS, 10 mg were weighed and dispersed in 
DOX solution (1 mL of 100 µg.mL-1). This solution was then left at 18 °C in the end-
over-end rotation for further 48 hours. After 48 hours, peptide solution was added to the 
drug and Si-SPION-SS mixture and ultrasonicated to achieve a homogeneous solution. 
The DOX loading profile was assessed at different time intervals using UV-vis absorption 
at λ485 nm. The DOX-loaded nanoparticles were then collected and stored for DOX 
release studies. A schematic process of DOX loading to mesoporous Si-SPION-SS along 
with peptide capping is depicted in figure 3-3.  
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Figure 3-3 Schematic diagram of different coating on SPIONs for drug loading (adopted from 
Sen 2016) 
3.3.7 Doxorubicin release profile of iron oxide nanomaterials  
DOX release profile was assessed in PBS buffer (pH 7.4) under continuous end-over-end 
rotation at 37 °C in incubation and under the influence of an AC magnetic field.  
i) Doxorubicin release from superparamagnetic iron oxide nanoparticles at 37 
°C  
The DOX release from B-SPION-SS and FM-ION-RS were assessed in 1 mL PBS buffer 
(pH 7.4) at 37 °C (body temperature). The DOX-loaded nanoparticles of the various ratios 
(1:25, 1:50, 1:75 and 1:100 DOX: B-SPION-SS or FM-ION-RS) were kept in an 
incubator at 37 °C temperature on an end-over-end rotator (40 rpm) for 48 hours. During 
this period, 200 µL of supernatant (free DOX) were withdrawn via magnetic separation 
at defined time intervals. The supernatant volume was replaced with an equal volume of 
fresh buffer, and the absorbance was noted at λ485 nm. The DOX released from B-SPION-
SS and FM-ION-RS was calculated using the pre-established standard curve of DOX in 
PBS. The results were plotted as percentage total DOX released as a function of time.  
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ii) Doxorubicin release in the presence of an AC magnetic field 
DOX release profile was also generated under an AC magnetic field (DM100, nB 
nanoscale Biomagnetics, Spain) to investigate the temperature triggered DOX release. 
DOX-loaded iron oxide nanoparticles (1 mL of PBS buffer) were kept in an AC field 
applicator using a frequency of 406 KHz and magnetic field strength 200 G for 15 
minutes. A schematic diagram is depicted in figure 3-4. The DOX release profile was 
obtained by measuring UV absorbance at λ485 nm of supernatant via magnetic separation. 
DOX content was measured using the standard curve in PBS. The results have been 
plotted as percentage DOX release over time and temperature (see section 8.3.1 and 
8.3.2). 
 
Figure 3-4 Schematic diagram of DOX release after exposure to magnetic field 
iii) Doxorubicin release from silica-coated iron oxide nanoparticles at 37 °C 
DOX release from silica-coated iron oxide nanoparticles (Si-SPION-SS) was performed 
in PBS buffer (pH 7.4). After the removal of the free DOX from loaded nanoparticles, 1 
mL of PBS buffer was added, and the solution was vortex mixed and sonicated for 5 
minutes in an ultrasonic bath. The initial absorbance of free DOX was taken using 
magnetic separation. The solution was then kept in an incubator at 37 °C on an end-over-
end rotation for 48 hours. 200 µl of supernatant from magnetic separation was withdrawn 
at various time intervals, and DOX content released into the solution was calculated. The 
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calculation of DOX in the solution was carried out using the standard curve of DOX in 
PBS buffer (Giri et al. 2005). 
iv) Doxorubicin release from the core-shell magnetic nanocomposites 
DOX release profile of core-shell (peptide-capped mesoporous silica-coated iron oxide 
nanoparticles and peptide coated nanocomposites was evaluated in PBS buffer (pH 7.4) 
at 37 °C in incubation and under the exposure of magnetic field. DOX-loaded 
nanocomposites were dispersed in 1 mL PBS buffer (pH 7.4) by vortex mixing and 
ultrasonication for 5 minutes and initial OD at λ485 was taken. The dispersion was then 
kept at 37°C in an incubator with end-over-end rotation for 48 hours. At each time interval 
(0, 6, 12, 24, and 48 hours), 200 µl of the supernatant was taken after the separation of 
nanocomposites via magnetic separation for UV-vis absorption measurement at λ485 nm. 
The DOX content was calculated using the standard curve of DOX in PBS.  
Similarly, DOX release profile under AC magnetic field was studied. Briefly, DOX-
loaded nanoparticles in PBS buffer solution were placed in an AC magnetic applicator 
using a frequency of 406 kHz, and magnetic field strength was 200 G over 15 minutes. 
The concentration of the free DOX was calculated by magnetic separation, and UV-vis 
absorption was measured at λ485 nm.  
3.4  Characterisation techniques  
A variety of physicochemical properties were investigated using different instruments 
such as Zeta-sizer, Scanning Electron Microscopy (SEM), Energy Dispersive X-Ray 
Spectroscopy (EDAX), Transmission Electron Microscopy (TEM), Fourier Transform 
Infrared Spectroscopy (FTIR), X-Ray Diffraction (XRD), Thermogravimetric Analysis 
(TGA), Brunauer–Emmett–Teller (BET) analysis, Vibrating Sample Magnetometer 
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(VSM) and magnetic field induced hyperthermia.  This section describes the principles 
behind the instruments and parameters used for corresponding sample analysis.  
3.4.1 Scanning Electron Microscope 
Scanning Electron Microscope (SEM) is a high-resolution technique used to study the 
surface characteristics of specimens. The electrons, instead of light, are used to give much 
higher magnification and resolution. The incident electron energy can be varied from 100 
eV to 30 keV. The incident electrons travelled from condenser lenses in the column and 
focused into beams, forming a spot size on the sample. At the end of column scanning 
coils direct the focused beam in a raster fashion on the surface of sample (figure 3-5 a). 
The emitted secondary electrons are collected via a detector and the intensity is displayed 
as an image. Vacuum is used in this process. The images produce the morphology of 
sample surfaces. Non-conducting materials are coated with gold or platinum using 
sputtering system. Similarly, Energy Dispersive Analysis using X-rays (EDAX) was 
performed for elemental analysis. As electron beam shines on the sample surface, this 
leading to the excitation of an electron to a higher level where the gap is filled by an 
electron of higher energy level. The number and energy as X-ray are measured with a 
detector (figure 3-5 b). 
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Figure 3-5 Schematic diagram of (a) SEM instrument set up (b) and energy dispersive X-ray 
spectroscopy. In EDAX, radiant X-ray ejects an inner shell electron; an outer shell electron, 
releasing a characteristics photon fills vacancy (SubsTech 2016). 
The sample size, morphology and elemental composition were obtained by drying 10 µl 
of the sample on carbon tape on aluminium stub at room temperature. Dried sample was 
then coated using low vacuum fine coater at an ionic current of 25 mA for 30 seconds in 
each cycle in two cycles (JFC-1200, JEOL, Japan). The images were taken using Quanta-
200, (FEI, UK) at different magnifications (50x to 50000x) operating at 20 kV. 
3.4.2 Transmission electron microscopy  
Transmission electron microscopy (TEM) was used to study the detailed structure and 
crystallinity of materials at the nanoscale with enhanced contrast and resolution. The 
electron gun at the top of instrument emits the electron flows travelling through a 
vacuumed column. Electromagnetic lenses condense the emitted electrons into an 
electron beam. This beam transmits through the sample; some of electron diffracts from 
sample, depending on samples electron density. Detector located at the bottom of 
instrument, collects the transmitted electrons from the sample. Depending on electron 
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density of sample, different shadow images appear reflecting the various shadow 
morphologies of sample contrast shadow of each shell.  
TEM images of synthesised materials were taken using a JEOL JEM2000FX (JEOL, 
Japan) instrument at 200 kV. The images were taken using Gatan digital camera. Samples 
were prepared with diluted solution, a tiny drop of sample was placed on 200 mesh carbon 
coated copper grid (Agar, Scientific) and left to dry at room temperature.        
3.4.3 X-ray diffraction  
X-ray diffraction is useful technique to identify the atomic or molecular level structure of 
regular organised (crystalline) sample. X-rays wavelength falls in the range of interatomic 
distances, when X-rays are bombarded on the crystalline sample; the atoms of that sample 
diffract the X-rays into constructive interferences. The measurement of diffracted 
incident beams angle is detected from rotating sample. The intensity of diffracted X-ray 
angles is collected.          
 
Figure 3-6 Schematic diagram of X-ray powder diffractometer 
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Bruker D2 diffractometer (Bruker AXS, Cambridge, UK) has been used to scan the 
materials. The characteristic X-ray source was CuKα radiation with a wavelength of 0.154 
nm. The voltage of 30 kV and the filament current was 10 mA. The sample was either 
packed into glass sample holders with proper distribution and flat surface in hollow space 
or spray dried on a flat Si surface sample holder. All samples were scanned from 5° to 
80° (2Θ), whereas Si-SPION-SS were scanned from 1.5° to 10° (2Θ). Step width was 
0.01 and 0.45-second time count.       
3.4.4 Dynamic light scattering and laser diffraction  
Dynamic light scattering (DLS) is a rapid and non-destructive technique for obtaining the 
size of particles size ranging from 1 nm to 1 µm. The technique involves a colloidal 
suspension, where light beam targets the sample and is scattered in various directions. It 
relies on the hydrodynamic radius of nanoparticle. The incidence beam fluctuates over 
time due to the Brownian motion. A photon detector at set scattering angle detects the 
fluctuations of the beam providing information on the particle size. This information is 
useful for the nanoparticle size determination, where nanoparticles are stable in buffers 
or solvent systems.         
  
53 
 
 
Figure 3-7 Experimental setups of DLS instrument (modified from Horiba Scientific Horiba 
2017) 
The size of structures greater than 1 micron was measured by laser diffraction (LD), 
where a laser beam is focused on material which in turns scattered to certain angles. The 
smaller the size, the higher the diffraction angles which is detected by series of 
photodetectors. The data was obtained from the Dispersion Technology Software (DTS) 
provided by (Malvern Mastersizer 2000 Instruments, Worcestershire, U.K.). The 
equipment was cleaned with distilled water after each measurement to avoid the cross-
contamination. Zeta potential of FF was measured with Zetasizer Nano ZS (Malvern 
Instruments, Worcestershire, UK). 1 ml of (2 mg.mL-1) each of the peptide solutions 
(water, ethanol and water/ethanol mixtures) were used for each measurement. Peptide 
solutions were transferred in zeta potential folded capillary cuvette (Malvern, 
Worcestershire, UK). Zeta potential was measured by applying the constant voltage 
supplied from the electrodes of the instrument sample chamber. Zeta potential was 
measured from electrophoretic mobility of the charged particles using Smoluchowski 
formula (Rutgers & De Smet 1947). The results are shown in mV from an average of 
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three independent samples. For each sample, three measurements were performed with 
20 scans at 25 °C. The acquisition time was set 120 seconds. The temperature was set at 
25 °C and acquisition time was 120 seconds. Ten runs were performed with an average 
of three measurements.   
3.4.5 Fourier transform infrared spectroscopy  
Fourier Transform Infrared Spectroscopy (FTIR) technique deals in the infrared region 
of incident beams. In this region, high energy electromagnetic radiation excites the 
vibrational mode of an individual atom in the molecule by identifying these energies 
provides molecular fingerprints of materials.  
FTIR spectra were measured on IR 200 (Thermo Scientific, USA) spectrometer. FTIR 
spectra were processed and analysed using the software package Omnic (8.0 software). 
FTIR system measures the infrared radiation of sample against wavelength. The infrared 
bands give the molecular structure and their bonding positions. A simple FTIR instrument 
consists of the interferometer, source, sample compartment, detector and amplifier. An 
interferometer modulates the wavelength and detector measure the transmitted or 
reflected light.       
3.4.6 Magnetic field induced hyperthermia  
Magnetic hyperthermia involves the transformation of magnetic energy into heat 
generated from the thermal fluctuation of magnetic nanoparticles in an AC magnetic field. 
The heat may be utilised both for the destruction of tumour cell directly (thermal ablation) 
or in combination with chemotherapy (figure 3-8).  
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Figure 3-8 Schematic diagram of magnetic hyperthermia based treatment (adapted from 
Malekigorji 2014) 
Specific Power Absorption (SPA) of B-SPION-SS, Si-SPION-SS, BOC-SPION-SS and 
BOC-Si-SPION-SS was determined in a commercial AC field applicator (DM100, nB 
nanoscale Biomagnetics, Spain, see figure 3-8). The frequency and magnetic field 
strength were set as ƒ = 418.5 kHz and 200 G, respectively. All measurements were 
performed within a thermally insulated working space of about 1 cm3, using a closed 
capped vials of 1.0 mL volume.  
3.4.7 Vibrating sample magnetometer  
Vibrating Sample Magnetometer (VSM) was used to analyse the magnetic behaviour of 
magnetite and coated hybrid materials at room temperature. A typical magnetisation 
hysteresis loop was obtained which depicts the magnetic behaviour of a sample 
corresponding to the applied external magnetic field. There are various factors which can 
alter the hysteresis loop of magnetic materials. These includes; size, shape, interaction 
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and chemical structure of sample also the orientation of the magnetising field (Simeonidis 
et al. 2013; Jiles 2015). The parameters used to express the magnetic capacity of materials 
includes the saturate magnetisation (Ms), the saturation field (Hsat). These are needed to 
obtain saturation magnetisation, the remnant magnetisation (Mr) the magnetisation 
amount of material, when applied field is removed and the coercivity (Hc) the magnetic 
field at the zero magnetisation. Another parameter for magnetisation is the moving field 
(Hs) of magnetisation hysteresis loop.  
 
Figure 3-9 Instrument setup of VSM 
In this research, the saturation magnetisation of magnetite and core-shell material was 
performed on; in-house UCLan built VSM as shown in figure 3-9. This instrument is 
based on the Faraday’s Law of Induction. According to this law, changes in the magnetic 
field produce the electric field. The electric field is then measured, this provides the 
information regarding the magnetic behaviour of magnetic particles. Measurements were 
performed at room temperature using 7 kOe magnetic field. All samples were dried and 
ground into a fine powder then packed into plastic tubes of length ~10 mm and internal 
diameter ~1.9 mm. For each measurement ~ 150 mg of magnetite materials were used. 
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The saturation magnetisation values were expressed as Electro Magnetic Unit per Gram 
(emu.g-1).   
3.4.8 Surface area measurement using Brunauer, Emmet and Teller  
Silica-based materials have an open porous framework, which led them as an ideal 
candidate for drug delivery applications. In these materials, gases or liquids can penetrate 
via the interconnected open pores framework. The physisorption isotherms are classified 
according to IUPAC in six types. In this work, type four (like hysteresis loop) isotherm 
was used. This type four is the characteristic isotherm for materials of mesoporous size. 
Hysteresis loop also reveals capillary condensation in the mesopores where the first 
fragment of the curve depicts the monolayer adsorption (Marsh 1987; S. Li et al. 2016). 
The pores size distribution in any porous materials is classified corresponding to mean 
pore diameter (Table 3-1). According to this classification, silica layered materials are 
primarily mesoporous and microporous. 
Table 3-1 The pore size distribution based on IUPAC classification 
Type of pore Micropor
e 
Mesopore Macropore 
Pore size (nm) < 2 2-50 > 50 
 
The methods used for the characterisation of porous matter are mainly based on 
adsorption phenomena. There are two adsorption processes, chemisorption and 
physisorption.  In chemisorption, chemical bonding is involved, wherein physisorption, 
an adsorbate and adsorbent interact directly through chemical linkage. Hence, 
chemisorption can only be performed in a monolayer at saturation pressure. In the 
physisorption (physical adsorption), the pores are filled by the adsorbate saturation, where 
multilayers are produced. 
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In 1938 Brunauer, Emmett and Teller (BET) established an equation based method for 
the specific surface area measurement (Brunauer et al. 1938). BET equation helps the 
measurement of adsorption of gas on a sample surface. The BET gas adsorption technique 
is used as a routine procedure for the measurement of the surface area of most of the 
porous materials. In 1951, Barret, Joyne and Halenda (BJH) had extended the Kelvin 
equation and proposed a new model for the determination of pore size corrected for 
multilayer adsorption (Barrett et al. 1951). BJH is commonly used for the mesopore size 
calculations and partly for macropore range. 
In this work, BET method of the nitrogen adsorption-desorption isotherms to silica coated 
materials is used to calculate the surface area, pore volume and pore size. The mesoporous 
area is calculated from BJH method.  The pore diameter is calculated from pore volume 
and surface area values taken after the saturation pressure.   
The surface area of bare SPIONs and silica coated SPIONs ~ 200 mg were weighed (up 
to four decimal places) and kept in the sample vial. All samples were dried overnight at 
50 °C and degassed at 80 °C, prior to measurement. The materials were vacuumed and 
then kept at 270 °C for 4 hours. All experiments were performed in a Micromeritics 
Accelerated Surface Area and Porosimetry System (ASAP 2010, USA). BET analysis 
and BJH calculation were performed using built-in Micromeritics ASAP 2010 software.   
3.4.9   Thermogravimetric analysis  
The principle behind Thermogravimetric Analysis (TGA) is heating of mixture to a higher 
level temperature so that one or some of the elements degraded into a gas. During the 
whole process of combustion, the changes in mass of sample relative to the temperature 
are measured under the controlled environment. The resulting thermogram depicts loss in 
  
59 
 
mass of a sample in relation to the increased temperature. As this technique involves the 
changes in weight and temperature, it is obvious to have a good precision in both 
parameters; weight and temperature. Hence, prior to analysis the instrument was 
calibrated for both parameters weight and temperature. Initially, the temperature was 
calibrated with nickel at the cure point (350 °C). This was the reference for calibrating 
the temperature scale. In the next step, two reference weights of 5 mg and 25 mg were 
calibrated with software connected balance of TGA. The thermal profile of sample 
materials was tared the TGA with provided software (TGA/SDTA-85). 
TGA is a useful technique for determining the composition and purity of a sample. This 
technique uses heat and stoichiometry ratios to determine the percent mass of different 
compounds in a mixture. Thermal stability of BOC-FF, SPIONs and composites were 
characterised with Mettler-Toledo equipment (TGA/SDTA-851, Mettler-Toledo Ltd., 
Leicester, UK). A schematic diagram is depicted (figure 3-10). Prior to the sample 
analysis, the empty aluminium pan was run on a whole range of temperature, and this was 
set as blank.  
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Figure 3-10 Schematic diagram of TGA (adopted from Radcham 2016) 
The sample was then measured approximately 5 mg in the same aluminium pan. The pan 
was kept carefully on the balance arm in a closed chamber of the furnace. The chamber 
was filled with nitrogen gas. The heating temperature was set at a rate of 10 °C per minute, 
starting from 25 °C to 500 °C. The weight of the sample was recorded by software 
connected balance. The exact output of analysis was plotted with a loss in weight 
percentage over the range of temperature analysed.  
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           CHAPTER FOUR 
4 Characterization of core-shell structures of spherical peptide 
shell and SPIONs core 
4.1 Introduction  
The physicochemical characterisation of the core-shell nanocomposites of spherical 
morphologies of bare SPION, silica coated SPION, boc-diphenylalanine coated SPION 
and boc-diphenylalanine-capped silica-coated SPION (B-SPION-SS, Si-SPION-SS, 
BOC-SPION-SS and BOC-Si-SPION-SS, respectively) synthesised in this research will 
be discussed in this chapter. Various characterisation techniques including zeta-sizer, 
SEM, EDAX, FTIR, BET analysis, TEM, XRD, TGA, VSM and magnetic field induced 
hyperthermia have been used to understand and confirm the desired nanomaterials. The 
characterization techniques used for each material synthesised have been summarised in 
Table 4-1. 
Table 4-1 Summary of the characterisation techniques used for spherical materials 
Characterisation 
Sample SEM/EDAX FTIR XRD DLS TGA VSM 
B-SPION-SS  √ √ √ √ √ √ 
Si-SPION-SS  √ √ √ √ √ √ 
BOC-FF √ √ √ √ √  
BOC-SPION-SS  √ √ √ √ √ √ 
BOC-Si-SPION-SS  √ √ √ √ √ √ 
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4.2 Iron oxide nanoparticles core materials     
4.2.1 Morphological analysis of spherical superparamagnetic iron oxide 
using scanning electron microscopy 
SEM analysis of B-SPION-SS shows the spherical shapes with a mean diameter in the 
range of ~ 20 - 35 nm (figure 4-1).  
 
Figure 4-1 SEM image of bare spherical Superparamagnetic Iron Oxide Nanoparticles SPIONs 
(image is representative of three independent samples) 
The shape and size distribution is narrow for B-SPION-SS. These images are taken after 
sonication for 15-30 minutes in ultrasonic bath, B-SPION-SS showed good stability and 
reduced aggregation. After observing SEM images of bare SPIONs synthesised via co-
precipitation method using iron (II and II) chloride, a decision was made to use these 
nanoparticles to be coated with silica due to their narrow size distribution and ordered 
spherical shape. B-SPION-SS after coating with mesoporous silica further hybridised 
with BOC-FF, were well-separated and stable in 50 % ethanol water mixtures. Bare 
SPIONs were coated with a thin layer nonporous silica on individual magnetite particle 
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seeds, forming the Fe3O4 composites with core-shell pattern spheres. This nonporous 
layer was important for further coating of mesoporous silica. Briefly, it facilitates the 
interaction between CTAB and silicate materials. Hence, it favours the deposition of 
CTAB and then SiO2. In addition, it reduces the chances of Fe3O4 core from being rapidly 
etched under acidic environment. It protects the Fe3O4 magnetite cores to oxidise as 
maghemite by retaining its magnetic property in the final step of the removal of CTAB 
templates. After removal of CTAB, discrete mesoporous core-shell structured 
nanospheres with size ~ 500 nm were obtained (figure 4-2).  
 
Figure 4-2 Mesoporous silica-coated iron oxide (Si-SPION-SS) core-shell nanocomposites 
(image is representative of three independent samples) 
Elemental analysis using Energy Dispersive X-ray Spectroscopy (EDAX) confirmed the 
presence of constituent elements. Figure 4-3 (a-b) show the elemental analysis of bare 
SPIONs and mesoporous silica coated core-shell nanoparticles, respectively. As expected 
iron and oxygen peaks were observed on the collected spectrum along with a carbon and 
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gold peaks, eliminating from the carbon tape and gold coating respectively. Similarly, 
mesoporous silica coated nanoparticle showed the silica peak in the spectrum.  
 
Figure 4-3 EDAX analysis of (a) B-SPION-SS (b) Si-SPION-SS (graphs are representative of 
three independent samples) 
For each sample, EDAX spectra from three representative areas were recorded and the 
results were averaged for each element identified. Tables 4-2 shows the detected 
elemental compositions and mass percent, however these result could not reflect the 
stoichiometry of formulated elements.  
Table 4-2 EDAX data of bare SPIONs and mesoporous silica coated core-shell nanoparticles 
(constituents in mass percentage) 
                           B-SPION-SS Si-SPION-SS 
Elements Weight 
(%) 
Atomic 
(%) 
Weight 
(%) 
Atomic 
(%) 
C  7.78 18.91 24.7 38.98 
O  26.76 48.85 35.78 42.38 
Au 5.31 0.79 5.57 0.54 
Fe 60.15 31.45 14.29 4.85 
Si   19.64 13.25 
 
Gold and carbon were present as shown in the Table 4-2 and figure 4-3, in the sample 
from coating and carbon tab of the aluminium stub. Table 4-2 shows the bare magnetite, 
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where, it did not reflected the predicted iron and oxygen contents, this might be due to 
the interference atmospheric oxygen.  
i) Transmission electron microscopy  
Figure 4-4 reveals the spherical shape of B-SPION-SS. TEM images showed size 
distribution of these core nanoparticles approximately 10-35 nm in diameter with average 
size if 35 nm in diameter. The SPION size distribution and shape obtained were in good 
agreement with already published data (Sharifabad et al. 2014b; Sen et al. 2006; Sen et 
al. 2012). The nanoparticles showed relatively narrow uniform spherical shape and size 
distribution. Hence, these materials were further used for the coating with mesoporous 
silica and peptide spherical shells.    
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Figure 4-4 TEM images of spherical B-SPION-SS synthesised via co-precipitation of iron (II) 
and (III) ions in alkaline medium (these images were taken at Liverpool university)  
The Si-SPION-SS showed nearly 200 nm size in diameter as shown in figure 4-5. Figure 
4-5 depicts the TEM images, showing the core-shell structure.  The core-shell structure 
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comprises of multiple small SPIONs cores and a layer of mesoporous silica with average 
diameter of approximately 150-200 nm. Mesoporous nature of silica layer has been 
further confirmed by BET. The size and shape of synthesised materials are in good 
agreement with published studies (Sen et al. 2012; Bruce et al. 2004b; Bruce & Sen 2005). 
 
Figure 4-5 TEM images of mesoporous Si-SPION-SS (these images were taken at Liverpool 
university) 
 
  
68 
 
ii) Size measurement using dynamic light scattering  
Size measurement using Dynamic Light Scattering (DLS) was performed to measure the 
hydrodynamic size of synthesised nanoparticles. Hydrodynamic size significantly differs 
from SEM measured size due to aggregation particularly for B-SPION-SS and 
functionalized with mesoporous Si-SPION-SS. 
A mean hydrodynamic size value for B-SPION-SS is 115.2 nm ± 19.1 nm. It can be 
concluded that due to its aggregation and a significant amount of solvent adsorb on the 
surface of SPIONs and possibly some irregular shaped nanoparticles may also contribute 
to the increased hydrodynamic diameter of B-SPIOPN-SS.  
An average hydrodynamic size for mesoporous Si-SPION-SS core-shell nanocomposites 
is 449 ± 52.4 nm, which is different to calculated sizes from the SEM images. This 
possibly due to the aggregation of nanocomposites. The average size significantly differs 
from dispersed bare SPIONs size. It is almost 5 times larger. Core-shell materials with 
hydrodynamic diameter greater than 1 µm are not considered in average size calculations, 
probably because of the possible aggregation. The hydrodynamic size distribution is 
larger than the SEM calculated value. Possibly, silica interacts with water in a different 
way compared to bare magnetite.  
iii) Chemical conformational analysis Fourier transform infrared spectroscopy  
B-SPION-SS and Si-SPION-SS were also characterised using FTIR to confirm the 
bonding of FeO. The FTIR spectrum of both core and core-shell materials is depicted in 
figure 4-6.  
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Figure 4-6 FTIR spectrum of (a) B-SPION-SS nanoparticles and (b) Si-SPION-SS 
nanocomposites (graphs are representative of three independent experiments) 
In Figure 4-7 (a), the peaks at 545 cm-1 and 553 cm-1 are assigned to the Fe-O bond of 
Fe3O4. However, the characteristic bands for a Fe-O bond of bulk Fe3O4 are stated as 570 
cm-1, a shift in the bands of the Fe-O were around 545 and 553 cm-1, respectively, as 
reported for the Fe3O4 nanoparticles (Bordbar et al. 2014). This shift is probably due to 
the nanosize of materials, where certain bonds of surface atoms are broken and causing 
the rearrangement of electrons on the particle surface. The successful deposition of silica 
on the bare magnetite material, namely mesoporous silica-coated iron oxide nanoparticles 
(Si-SPION-SS) was also confirmed by FTIR analysis. The silica-coated material was 
compared to bare magnetite nanoparticles. From the literature findings the FTIR spectrum 
of silica coated magnetic nanoparticles are shown in figure 4-7 (b), and the assignment of 
the bands shown in Table 4-3. The characteristic bands nearly at 1085, 800 and 553 cm-1 
are corresponding to the stretching and bending of Si-O and Fe-O bonds, respectively. 
The main sharp peak of the Si-O vibrational band at 1085 cm-1 shows a stoichiometric 
arrangement of the silicon dioxide structure. Some impurity vibrational bands are also 
seen in the FTIR spectrum shown in Table 4-3. These are small compared to the main 
peaks. The peaks at 1624 cm-1 are corresponding to vibrations of carbon impurity atoms. 
The FTIR spectrum (figure 4-7) for the deposited silica also showed a wide peak of OH 
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groups at around of 3200 cm-1 to 3400 cm-1. These results reveal the presence of OH 
molecules on the surface of the mesoporous silica-coated iron oxide nanoparticles.  
Table 4-3 Band assignment in FTIR spectrum of iron oxide nanoparticles 
Wavenumber (cm-1) Possible assignment 
550 Fe-O-Fe bending 
800,  802  Si-O bending 
939, 932  Si-OH stretching 
1083, 1089  Si-O-Si stretching 
1630, 1628  C-O bending 
3200 - 3400  …-OH stretching 
iv) Crystalline structure magnetite confirmation using X – ray diffraction 
analysis    
X-ray diffraction (XRD) pattern of the B-SPION-SS is shown in figure 4-7. XRD analysis 
was performed, and the lattice constant values (a) were obtained, and spectra were 
matched with International Centre for Diffraction Data (ICDD) database to predict the 
type of the nanoparticles.  
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Figure 4-7 XRD pattern of spherical B-SPIONs-SS (graph is representative of three independent 
experiments) 
The data from figure 4-7 were used for interplanar spacing (d) calculation in the atomic 
lattice, and the lattice constant (a) calculations for the identification of crystal structure 
using software (DIFFRAC.EVA, Bruker, UK).   
The lattice constant value (a) is used to identify the magnetic type of the iron oxide 
nanoparticles. For maghemite, this value is 0.833 nm, and for magnetite, it is 0.839 nm 
(Mineralogy Database accessible from Bruker software). From the data of figure 4-8, the 
calculated value of B-SPION-SS was 0.839 nm. The resulting core magnetic 
nanoparticles were magnetite (Fe3O4) possessing cubic spinal structures. The bare 
magnetite produced multiple peaks with hkl value of 220, 311, 400, 422, 511, and 440 in 
the 2θ (PDF04 005-4319, 01-086-1362), showing good agreement with published data 
(Sen et al. 2006; Bruce et al. 2004a; Sen & Bruce 2009; Sharifabad et al. 2014a; Sen et 
al. 2012). Meanwhile, there was no evidence of impurities observed in the XRD pattern.  
XRD pattern of B-SPION-SS shows the low intensity corresponding to very small size of 
magnetite nanoparticles. The average particle diameter was calculated from the XRD 
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pattern of the wide intense peak (3 1 1). Scherer equation was used to measure the size of 
the nanoparticle. The equation as presented in equation 4-1 (Holzwarth & Gibson 2011; 
Monshi et al. 2012; Burton et al. 2009).  
          𝐷 =  
𝐾𝜆
(𝐵 cos 𝛩)
                (Equation 4-1) 
Where, factor K is 0.9 (as spherical), B structural = B observed – B standard (where B is 
the Full Width at Half Maximum in radians), θ is half of the Bragg angle (in radians), and 
λ is, the wavelength of the X-rays (1.5418 Å) used. The calculated diameter of magnetite 
was about 24 nm in agreement with SEM images (figure 4-1). 
Figure 4-8 shows the XRD patterns where six diffraction peaks (220, 311, 400, 442, 511 
and 440) are seen in the wide-angle region. The peaks are indexed to the crystalline 
structure of pure magnetite nanoparticles along with the wide, intense peak (25° 2Θ) of 
amorphous silica. The XRD pattern confirms mesoporosity of spheres with a similar 
diffraction pattern. The major diffraction peak at 35.5°(311), along with others at 
30.5°(220), 43.5°(400), 57.5°(511), and minor at 63°(440) confirm the presence of 
magnetic core in silica matrix (El Mendili et al. 2016). 
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Figure 4-8 XRD pattern of Si-SPION-SS nanocomposites (graph is representative of three 
independent experiments) 
XRD pattern of mesoporous silica magnetite materials at low angles indicates the 
ordering of the mesopores within the nanocomposite. Low angle XRD was taken at 1.2 
to 40° 2Θ. Mesopores size was determined using the Bragg’s equation:  
                nλ =  2dsinθ                      Equation 4-2 
where n is an order, λ is the wavelength of the X-ray radiation (0.154 nm), and θ is the 
angle of diffraction. 
Low angle XRD patterns for Si-SPION-SS is shown in figure 4-9. The peak index (1 0 0) 
at 2.2° 2θ corresponding to the mesoporous structures, these are in agreement with 
published data (Li et al. 2016; Egodawatte et al. 2015). However, for shell mesoporous 
silica material, the characteristic (1 0 0) peak was noticed at 1.9° 2Θ. In case of magnetite 
material present in the cores, the peak is shifted slightly, as observed in previous 
publications (Datt et al. 2012).  
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Figure 4-9 Low angle XRD pattern of mesoporous Si-SPION-SS nanocomposites (graph is 
representative of three independent experiments) 
v) Saturation magnetisation measurement using vibrating sample 
magnetometer  
The magnetisation properties of B-SPION-SS nanoparticles and Si-SPION-SS 
nanocomposites were measured at room temperature using the 7 kOe magnetic field. The 
saturation magnetisation (Ms) of B-SPION-SS is 64 emu.g-1 (figure 4-10), and Si-SPION-
SS (of around 40 emu.g-1). Bare magnetite nanoparticles saturation magnetisation values 
are in good agreement with the literature (Feng et al. 2008; Banaei et al. 2015; Greene et 
al. 2014). However, the saturation magnetisation was significantly lower compared to 
bulk materials 92 emu.g-1 for bare magnetite crystals (Qu & Tie 2009). The lower value 
of saturation magnetisation possibly because of the size distribution of the nanoparticles 
(Chatterjee et al. 2003; Maaz et al. 2016). A decrease in saturation magnetisation was 
noticed due to coating mesoporous silica.  
In both materials B-SPION-SS and Si-SPION-SS, the 0 coercivity and remanence was 
observed in the hysteresis loops, confirming the SPIONs made via co-precipitation 
methods are superparamagnetic. Size is an important factor for magnetic properties 
(Martinez-Boubeta et al. 2013; Nakamura et al. 2013; Simeonidis et al. 2013).   
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Figure 4-10 hysteresis loops of B-SPION-SS (red-square) and Si-SPION-SS (blue-crossed) 
(graph is representative of three independent experiments) 
Zero remanence value indicated superparamagnetic nature of B-SPION-SS and Si-
SPION-SS, they become magnetised when external magnetic field applied and 
nonmagnetic once the field is removed. Hysteresis loop pattern of Si-SPION-SS is similar 
to the core magnetite indicating the magnetic properties are retained during the procedure 
of silica coating and precipitation. This desired behaviour SPIONs are making them an 
ideal candidate for biomedical applications (Graczyk et al. 2015; Ling et al. 2015; 
Karimzadeh et al. 2016; Kandasamy et al. 2016). As observed from the hysteresis curves 
for bare SPIONs and silica coated SPIONs, both materials reached magnetisation 
saturation at around 2 kOe of applied field. 
vi) Surface area analysis using Brunauer-Emmett-Teller  
Surface area analyses were obtained using nitrogen gas adsorption techniques using 
surface area analysis via BET. The mesoporous silica coated magnetite silica 
nanoparticles exhibited very high specific surface area 791.3154 m2. g-1 compared to bare 
magnetite 85.8505 m2.g-1 (figure 4-11 and 4-12).   
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Figure 4-11 Nitrogen adsorption-desorption of B-SPION-SS with spherical shape (graph is 
representative of three independent experiments) 
The adsorption-desorption isotherm for the silica-coated iron oxide nanoparticles shows 
hysteresis curve, which is IUPAC 4 isotherm. This hysteresis isotherm is characteristic 
of the behaviour of mesoporous materials. No such hysteresis was seen in the adsorption-
desorption isotherms of bare SPIONs (figure 4-11). Hysteresis behaviour only occurs in 
porous materials, where pores cause the adsorption and desorption of gas which reveals 
the type of isotherms to have different path (figure 4-12).  
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Figure 4-12 Nitrogen adsorption-desorption of Si-SPION-SS of spherical shape (graph is 
representative of three independent experiments) 
vii) Thermal stability measurements using thermal gravimetric analysis  
TGA analysis of B-SPION-SS and Si-SPION-SS is useful for qualitative and quantitative 
purposes of volatile elements of the nanocomposite. The TGA curve (Figure 4-13) depicts 
the weight loss of bare magnetite over the temperature range from 25 °C to 500 °C is ~ 
3.5 %, possibly, due to the loss of residual water from the sample. TGA was also 
performed to measure the relative mass proportion of the silica coated materials. It is 
worth knowing the amount of water adsorbed, which can be useful in the design of drug 
carriers.  
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Figure 4-13 Thermogravimetric analysis of bare SPIONs (graph is representative of three 
independent experiments) 
 
Figure 4-14 Thermogravimetric analysis of silica coated spherical SPIONs (graph is 
representative of three independent experiments) 
The removal of water from silica material was accomplished at 120 °C and remained the 
losing of CTAB molecules till 250 °C from porous silica materials. CTAB weight loss 
appeared at 30-500 °C via decomposition (figure 4-14). Thermal profile of CTAB as 
alone showed complete degradation at 400 °C (Wang et al. 2007). Hence, it could be 
possible that CTAB degradation happened gradually by shifting to higher temperature up 
to 500 °C.         
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viii) Chemical confirmation analysis after heating at high temperatures  
TGA and FTIR reveals that most of the CTAB layer was removed at high temperatures. 
The peaks at 3400 - 3200 cm-1 and 1600 cm-1 were assigned to CH groups of Br-OH 
(Boccuzzi et al. 1999; Ping et al. 2001). The percentage weight loss in the TGA curve 
also reveals the amount silica layers on magnetite. The average mass content of silica 
layers on magnetite is about 30 % (figure 4-15). 
 
Figure 4-15 FTIR of Si-SPION-SS (blue line) before and (red line) after the TGA experiments 
(graphs are representative of three independent experiments) 
TGA measurements were also performed to check the atmospheric effect over the 
temperature range 25 °C to 500 °C at 10 °C/min under an air atmosphere. The TGA 
profiles, the weight loss of bare and the silica-coated magnetite are depicted in figure 4-
15. It worth noting that the silica-coated materials revealed a certain amount of absorbed 
water and OH groups, bare magnetite did not show significant weight loss (5 wt%). These 
results have concluded that Si-SPION-SS nanocomposites created the hydration 
compared to the B-SPION-SS nanoparticles. 
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4.3 Boc-diphenylalanine spherical particles  
4.3.1 Characterisations   
i) Morphological analysis using scanning electron microscopy  
 Figure 4-17 shows the SEM images of the boc-diphenylalanine indicating spherical 
morphologies. Studies were performed on the self-assembly of boc-modified aromatic 
dipeptides (boc-diphenylalanine). The SEM shows that the boc-diphenylalanine peptide 
forms spherical nanostructures in an aqueous environment (figure 4-16). Under similar 
conditions, a non-modified analogue of this peptide, FF which also self-assembled into 
tubular structures, (figure 4-17) which is confirmed by looking at the edge (cross section).  
  
Figure 4-16 SEM image of spherical BOC-FF particles prepared in ethanol-water 
mixture (1:1) (image is representative of three independent experiments) 
 
  
81 
 
 
Figure 4-17 SEM image of tubular FF prepared in ethanol-water (1:1) (image is representative 
of three independent experiments) 
Another important finding is the remarkable modulation effect of peptide concentration 
on the aggregated final morphology of the peptides. In previous studies (Huang et al. 
2011; Li et al. 2015; Yan, Zhu & Li 2010a; Maity et al. 2014), HFIP was used as a highly 
volatile crystalline solvent to dissolve peptide, where peptide concentration was not kept 
in attention as stock solvent beforehand. In this study, considerable attention was paid to 
the role of peptide concentration in the aggregation or self-assembly without using HFIP. 
Initially, the peptide was dissolved in absolute ethanol, and further dilution was 
performed in 50 % ethanol in water. The concentration of peptide was set as 1, 2, 4, 6, 8 
and 10 mg.mL-1. SEM images of the self-assembled morphologies of BOC-FF at various 
concentration are shown in Figure 4-18.  
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Figure 4-18 SEM images show the variation of BOC-FF morphologies at various concentration 
(a) 1 mg.mL-1, (b) 2 mg.mL-1, c) 4 mg.mL-1, (d) 6 mg.mL-1, (e) 8 mg.mL-1, (f) 10 mg.mL-1, 
(images are representative of three independent experiments) 
Figure 4-18 (b-f) exhibited spherical morphologies, whereas figure 4-18 (a) showed 
needle-shaped nanoparticles to larger spherical morphology. SEM showed these types of 
structures were obtained when a drop of peptide solution was vaporised at room 
temperature on carbon tab of the aluminium stub of SEM. This revealed that the 
homogenous dispersion and initial saturation is important for the assessment of self-
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assembled architectures. Further studies showed the morphological growth of these 
hierarchical structures were concentration dependent.   
SEM images of BOC-FF of 4 mg.mL-1 showed smooth surface spheres (figure 4-18 (c)). 
However, self-assembly pattern of peptide is concentration driven hence the transition 
from tubular to spherical structures appeared from 2 mg.mL-1 and remained spherical up 
to 10 mg.mL-1. The spheres have varying size distribution ∼ 300 nm to 10 µm nm in 
diameter, which is in good agreement with (Adler‐Abramovich et al. 2010). BOC-FF 
spheres transform gradually into large spheres when the conentration of the solution was 
increased. Yan et al. (2007) confirmed the spherical structures using 3D atomic force 
microscopy. 
For comparison, another analogue of zwitterion FF was chosen. Experiments were 
performed under the similar conditions, where FF self-assembled into tubular 
morphologies (figure 4-17). This self-assembly pattern was similar to that previously 
reported data (Yan, Zhu & Li 2010a; Huang et al. 2014; Görbitz & Gorbitz 2006; Huang 
et al. 2011; Dinesh et al. 2015; Andersen 2013; Levin et al. 2014). Circular dichroism 
spectra of BOC-FF showed a shift in the secondary structure during the peptide self-
assembling process.  
Fabrication of porous flower-like ordered structures was obtained, when solvent system 
was changed to methanol:water (1:1) mixture (figure 4-19) using BOC-FF concentration 
of 2 mg.mL-1. Similar structures were reported for tyrosine amino acid and phenylalanine 
amino acid combination by Koley et al. (2015); Sakurai et al. (2014) using controlled 
applied voltages. Figure 4-20 shows the porous structure of self-assembled BOC-FF 
(average diameter 20 µm), prepared in methanol-water (1:1) without the application of a 
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voltage different from previously reported by Koley et al. (2015); Sakurai et al. (2014), 
where they found multifarious arrangements of the sheet-like petals (thickness of around 
30 – 60 nm). In their study, they used combination of tyrosine and phenylalanine using a 
complex methodology.  
It was reported that sself-assembly driven structures were only somewhat dependent on 
the electric field, electric current and temperature (Sakurai et al. 2014). In this study, 
multifarious structures were found for samples in alcoholic solution after drying on a 
glass substrate (without using any voltage).  
 
Figure 4-19 Figure 4 20 Figure 4 20 SEM images showing the formation of hierarchical 
structures and high-magnification showing the surface morphology from the methanol-water 
solution (1:1) (image is representative of three independent experiments) 
 
ii) Chemical confirmation of self-assembled spherical peptide using Fourier 
transform infrared spectroscopy 
Fourier Transform Infrared Spectroscopy (FTIR) was used to further study the self-
assembling pattern of BOC-FF. The dried samples of the spherical peptide in ethanol-
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water mixture (1:1) and commercially available lyophilised powder were investigated. 
The N-H stretching vibrations were observed at 3317 cm-1. These confirmed the backbone 
of the peptide (Hopkins et al. 1991). 1700-1600 cm-1 is a characteristic region for Amide– 
I, which was used to confirm the peptide backbone. This did not have significance on the 
length or sequence of amino acid residues. In this region peaks positions were depicted; 
β-sheets at 1637-1615 cm-1 and 1696-1685 cm-1 (Chirgadze et al. 1976). While, β-turns 
can be observed at 1680 cm-1. Similarly α – helix can be differentiated at 1665-1650 cm-
1. The region 1580-1510 cm-1 depicted the Amide-II bond, which is characteristic of the 
plane N-H bending (Kong & Yu 2007) (Table 4-4). 
Table 4-4 FTIR spectral peak position and their possible reflection to bonding positions 
Wavenumber (cm-1) Possible assignment 
3280 H-bonded OH groups, NH2 stretching 
2960–2920  Aliphatic C–H stretching (fatty acids) 
1715 C=O stretching 
(carbonic acid) 
C=O stretching (carbonic acid) 
1600–1700  NH2 bending, C=O, C=N stretching (amides I and II) 
1624-1648 Β-sheets 
1650-1665 Α-helix 
1670-1695 Β-turns 
1450 C–H deformations in aliphatic 
1400 C=O stretching (symmetric) of COO– 
1390–1398  C–H bending, –CH3 stretching (fatty acids) 
1240–1310  C–N stretching (amide III) 
1000–1200  C–O, –, C–C stretching, C–O–H, C–O–C deformation 
(boc-modification) 
 
In the BOC-FF samples; the Amide - I (associated with the – N - H stretching vibrations) 
was observed in water at 3280 cm-1, confirming the hydrogen bonding in NH groups. 
BOC-FF in spherical self-assemblies (ethanol-water mixture) showed band at 3320 cm-1. 
In Amide-I region (also showing the existence of C=O stretching vibrations) showed 
peaks at 1666 and 1658 cm-1 for lyophilised peptide. The Amide-I peak of the peptide in 
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the ethanol-water mixture was observed at 1685-1606 cm-1, while in water Amide–I peaks 
were found at 1629-1655 cm-1, The splitting of the some peaks appeared, due probably to 
the interactions of self-assembling monomers (Doyle et al. 1975).  
The FTIR data (figure 4-20) reveal the presence of Amide–I region 1700-1600 cm-1 
(Table 4-4). Amide-I peaks in the region of 1648-1624 cm-1 and 1665-1650 cm-1 of 
peptide sample can be assigned to β-sheet and α-helix secondary structures, respectively. 
The peak from 3300-3200 cm-1 reveals the NH stretching. Amide III band can be seen 
from1300-1200 cm-1.  
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Figure 4-20 FTIR spectra of BOC-FF; (a) lyophilised powder (commercially available), (b) 
water alone and (c) ethanol-water mixture (1:1) (graphs are representative of three independent 
experiments) 
In spherical morphologies, however the peaks around 1685 cm-1 were attributed to β-
sheets secondary structures but the presence of other frequencies could be due to a 
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mixture of different secondary structures configurations (figure 4-20). The circular 
dichroism technique may be helpful to confirm the quantitative secondary structure 
compositions.  
iii) Crystalline confirmation studies using X-ray diffraction analysis  
X-ray Diffraction (XRD) was performed to study the crystallinity of BOC-FF particles 
along with their secondary structure. The presence of amino acids in self-assembled 
peptide structures in an ordered repeating distance can diffract X-ray beam. Self-
assembling alignment of the peptide in different solvents may reveal structural 
information. For example, β-sheet showed two main diffraction peaks at ~4.7 Å and ~ 10 
Å (Makin et al. 2006). The broad peak at 18 2Θ is the characteristic distance (4.7 Å) of 
the hydrogen bonding between β-sheets in ordered nanostructures, while the peak at (2Θ) 
value of 8.5  corresponds to the distance (10 Å) showing the distance between two 
separate β-sheet layers stacking on top of each other. Figure 4-22 shows the schematic 
depiction of β-sheet layers.   
Figure 4-21 shows the XRD patterns of spherical BOC-FF. Along with the all 
characteristics peaks of the BOC-FF, a sharp peak also appeared at 11.3° (2θ), which can 
be attributed to the colloidal spheres (Li et al. 2013).  
Figure 4-21 displayed the helical arrangement of residues. Each residue possibly be 
extended to some extent curved as α - helix attracted to carboxyl terminal in the core. In 
similar order, many helical residues interact each other to form the curved structures (Yan, 
Zhu, Fei et al. 2010; Maity et al. 2011; Li et al. 2013). These types of self-assemblies 
have been reported alongside α-helices and β-sheets. The spherical assemblies displayed 
XRD pattern of α-helices (5 A° = 17.7° (2Θ)) characteristic. The typical XRD patterns 
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arise from stacking of α-helical in a coiled-coil configurations, where they contribute to 
the spherical axis.  
 
Figure 4-21 XRD pattern of BOC-FF in ethanol-water (1:1) mixture (graph is representative of 
three independent experiments) 
Figure 4-22 schematic diagram of typical distances. Aligned layers of β - sheets are 
perpendicular to each other. The inter-residue space of π–π interaction is 4.7 A°, while 
layer-to-layer space is approximately 10 A°.  
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Figure 4-22 Schematic diagram of repeat unites of β-sheets 
Figure 4-22 displayed the oriented arc at 18 (2Θ), corresponding to the distance of 4.72 
Å, (characteristics β-sheet hydrogen bonding distance). Another arc characteristic to the 
interlayer spacing is seen at 8 (2Θ), where distance is 10 Å. Similar XRD peaks were also 
found in tubular structures. The peak, at 20 (2Θ) 4.4 Å, corresponds to the β-sheet. The 
slight shift in the position of the peak from 4.72 Å revealed the increased β-sheet spacing. 
This also correlates with a shift in peak position in FTIR (figure 4-20) indicating the 
changes occurred in the tubular structure. The typical distance (~10 Å) was observed for 
phenylalanine, glutamate and lysine based peptide self-assemblies (Wang et al. 2005). 
The substitutions of the nonpolar amino acid altered the distance of interlayer sheets to 
~11 Å. The studies proved that the phenylalanine amino acid possibly involving in the 
formation of stacked sheets. This was usually proposed in a self-assembling mechanism 
for number of peptides residues. The molecular dynamic simulations on the BOC-FF also 
showed that π–π stacking and bulky nature of phenylalanine rings, which facilitate the 
self-assembling process (Yan, Zhu & Li 2010b). This would prevent the twisting of the 
fibril, as in case of spherical structures. 
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Figure 4-23 XRD pattern of BOC-diphenylalanine tubular structures in water (graph is 
representative of three independent experiments) 
XRD data from the peptides showed a huge difference in the molecular arrangement when 
they self-assemble into different morphologies. For spherical BOC-FF peptide, the major 
peaks appeared at 2θ 8.7 and 18.04, and some minor peaks also appeared at 11, 14 and 
23, whereas for BOC-FF in water showed major peaks at   6°, 7.5°, 8.8°, 18.8°, 20° and 
23.2° (figure 4-23).  
4.4 Peptide-coated spherical core – shell composites 
Superparamagnetic iron oxide nanoparticles with different surface modifications have 
been studied in various applications; such as MRI contrast agent, in tissue repair, 
immunoassay, fluid separation, hyperthermia triggered drug delivery and in cell 
separation and identifications, etc. (Cai et al. 2013; Mahdavi et al. 2013; Ling & Hyeon 
2013; Mahmoudi et al. 2011). These diverse applications required high saturation 
magnetisation values of smaller and uniformed particles size. 
Ideal nanoparticles should have good dispersion in an aqueous environment to achieve 
desired results. These applications of magnetic nanoparticles require coatings with 
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minimal toxicity during targeting and tracking in the desired area. To achieve nanoparticle 
dispersions, numerous studies have been performed with water-soluble polymers 
(polysaccharide), (Guardia et al. 2012) dendritic stabilisers (poly amidoamine), 
(Nordmeyer et al. 2014) thiols (siloxanes), (Rajabi et al. 2013) and proteins (Sakulkhu et 
al. 2014). Among all these polymers, proteins got great attention as stabilisers due to their 
range of desired properties, such as stimuli responsiveness against pH or temperature and 
specified nanoparticle surface for effective cellular communications. Therefore, proteins 
nanoparticles are considered as biomimetic type of functional materials. However, due to 
high cost, complicated synthesis and further modifications processes and commercial 
scale productions have limited their applications.  
Peptides are studied as simple alternatives of proteins. They possess different versions, 
based on sequences of amino acid (acidic, basic, polar, or nonpolar). Compared to 
proteins, peptides are commercially available leading them an attractive material for 
advanced materials science (Rad-Malekshahi et al. 2015).  
Peptide-based spheres also showed stimuli-responsive to pH and temperature and a novel 
adaptive encapsulation property for functional inorganic materials (Yan, Zhu & Li 
2010b). Based on the adaptability to hybrid materials, the self-assembling peptides had 
opened new horizons for a variety of guest materials. These hybrid materials include; 
charged or uncharged, hydrophilic to hydrophobic inorganic materials. This approach has 
been exploited in this work and can be extended to variety of bioactive molecules and 
functional inorganic materials to design multifunctional biomaterials. The adaptation of 
functional materials as core materials in the hybrid structures possibly will lead to the 
new avenues for encapsulation of functional inorganic materials into bioactive and 
biocompatible self-assemblies. The flexible biocompatible organic–inorganic hybrid 
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materials with novel functionalities will help in solving problems associated with 
biocompatibility, aggregation, solubility and bioavailability in drug delivery system. 
Peptides have promising properties; a little is known for the functional properties of 
peptide - inorganic materials. Self-assembling peptides usually are based on tryptophan, 
tyrosine, phenylalanine and lysine (Chavarria et al. 2015). The mechanism to control the 
self-assemblies of the peptide is still needed to be explored. However, fabrication and 
self-assemblies on stabilised metal nanoparticles have been well studied (Sakulkhu et al. 
2014; Rajabi et al. 2013; Nordmeyer et al. 2014; Guardia et al. 2012; Cai et al. 2013; 
Mahdavi et al. 2013; Ling & Hyeon 2013). Similarly, this needs to be explored that how 
these peptides transform into properties of the functional hybrid materials. It is crucial to 
understand how to control and regulates the self-assemblies of hybrid materials.  
4.4.1 Characterisations   
i) Morphological study using scanning electron microscope  
The iron oxide and peptide based core–shell materials were prepared using two different 
methods. BOC-FF self-assemblies were achieved in ethanol-water mixture; hence, the 
solvent was kept idintical in both methods. The aim of using two approaches for coating 
of bare magnetite is to study whether the pre-established peptide self-assemblies 
influence on the coating of magnetite nanoparticles. Finally, optimisation of the best 
method to coat magnetite cores with the peptide. These two different approaches were i) 
one – pot synthesis of both core-shell materials and ii) a template-mediated method, 
where peptide was added dropwise to synthesised magnetite nanoparticles. After addition 
of peptide, materials were sonicated (power 40 W) for 10 minutes using probe sonicator. 
The ratio of magnetite nanoparticle to peptide was kept identical in both methods.  
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Figure 4-24 shows the core–shell morphology of nanocomposites produced by one-pot 
fabrication method. The size of core–shell structures was found approximately 400 nm in 
diameter. These were the smaller compared to core–shell structures prepared using 
template mediated method (figure 4-25). 
 
Figure 4-24 SEM image of peptide coated iron xide nanoparticles by using one pot fabrication 
method (Image is representative of three independent experiments) 
In template mediated synthesis approach, the resulting BOC-SPION-SS were spherical, 
with size distribution ranging from 400 to 800 nm (figure 4-24). The core–shell materials 
were different in size from the bare iron oxide nanoparticles.The change in size 
distribution indicates the presence of peptide shell on iron oxide nanoparticles while 
retaining the magnetic properties. However, SEM could not differentiate the core-shell 
structure to confirm the number of B-SPIOPN-SS encapsulated. The core–shell structure 
could not be differentiated with SEM images, hence Energy Dispersive X–Ray 
Spectroscopy (EDAX) was used to confirm their chemical composition.  
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The SEM image (figure 4-25) showed a bi-phasic mixture of peptide particles and 
magnetite (Fe3O4) crystals.  It is clear that wrinkled spheres are the attachment of iron 
oxide nanoparticles on the surface of the peptide. The images (figure 4-25 and 4-26) were 
taken from different places of same experiment (one-pot fabrication method). Hence, 
once the peptide assemblies formed it could not coat the SPIONs efficiently leaving a bi-
phasic mixture of both individual components.  
 
Figure 4-25 SEM image of SPIONs coated the peptide spheres using one-pot fabrication method 
(image is representative of three independent experiments) 
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Figure 4-26 SEM image of BOC-SPION-SS by using template-mediated method (image is 
representative of three independent experiments) 
Energy dispersive X-ray (EDAX) spectra were recorded from various places of the 
materials of both one-pot fabrication and template mediated synthesis method. The K 
lines are strongly energetic consisting of Kα1, Kα2, Kβ1, and Kβ2 radiations. Santra et al. 
(2001); Z. Z. Xu et al. (2004) have reported a similar pattern of EDAX spectrum for 
polymer coated magnetic nanoparticles. 
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Figure 4-27 EDAX representative spectrum from BOC-SPION-SS nanocomposites (graph is 
representative of three independent experiments) 
Peak intensities corresponding to C, O, Fe and Au were observed similar in both methods 
(figure 4-27). In both cases, as predicted, the peaks corresponding to Au have been found 
because of the coating to get clear visuals in SEM. Generally, for quantification of oxygen 
based materials, oxygen values would not be considered accurate due to the presence of 
carbon dioxide and adsorbed water molecules on the surface of materials. Thus, the 
quantification was obviated for core – shell materials, focusing only on identification.  
ii) Size analysis using dynamic light scattering  
The zetaiszer size distribution of core–shell materials BOC-SPION-SS synthesised via 
one-pot fabrication method measured to be in the range of 50 nm to 2 µm in diameter 
with high polydispersity. The iron oxide nanoparticles, when coated with peptide using 
template mediated synthesis method, the size distribution was predominantly uniform in 
diameter (400 nm). The difference between the two methods with zeta sizer is not 
comparable as to certain extent both materials showed aggregation (figure 4-28). 
However, ultrasonication could narrow down the material size distribution. 
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 Figures 4-24 to 4-26 showed the effect of the both approaches of core–shell magnetite 
coated with peptide shells. The size distribution, for bare magnetic nanoparticles where 
core size even after aggregation, is 114 nm. The zeta sizer results of core–shell particles 
show different size distributions with an average size is, however greater than core 
materials. 
iii) Chemical composition confirmation using Fourier transform infrared 
spectroscopy   
FTIR studies performed for peptide-coated magnetite. The characteristic bands of the 
analysed materials including; OCO, CO, NH, FeO, CC were shown in Table 4-4. Figure 
4-28, displays the FTIR spectra of bare iron oxide in the basic form Fe3O4 and peptide 
carbonyl capped iron oxide nanoparticles.  
FTIR spectra of iron oxide skeleton show strong bands at 600-450 cm-1. However, below 
1000 cm-1, the iron oxide has a weak band. The spectrum of bare magnetite (Fe3O4) 
displayed the corresponding signals at 550 and 450 cm-1 (Bruce & Sen 2005). The peptide 
characteristic vibrations include the NH bending and OCO. These stretching vibrations 
were seen at 1700-1400 cm-1. Comparing bare and peptide coated magnetite, the peaks at 
1637, and 1413 cm-1 can be observed confirming peptide coating. Peaks found in region 
1637 and 1020 cm-1 corresponded to the CCO and CO stretching of the peptide. Bands at 
2965 and 1000 cm-1 were referred to CH2 stretching and CH out-of-plane bending 
vibrations, respectively. These peaks of functional groups peptides revealed that iron 
oxide is covered with the peptide. 
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Figure 4-28 Infrared spectra of B-SPION-SS (red) and BOC-SPION-SS (blue) (graphs are 
representative of three independent experiments) 
From FTIR data, it can be assumed that the presence of peptide surface will translate into 
a coating to iron oxide. FTIR peaks at 1465 cm-1 and 1700 cm-1 backing the assumption 
that the magnetic core interacts with to the carboxylate groups.  
iv) Crystalline confirmation studies using X-ray diffraction of core–shell 
structures  
Figure 4-31 shows the X-ray diffraction (XRD) patterns for the peptide coated SPIONs. 
The characteristic peaks of magnetite in coated materials could not be observed at 2θ, 
confirming the peptide after coating has amorphous structures. Hence, the 
functionalisation has altered the arrangement of the lattice which led to the disordering of 
the crystalline nature of bare magnetite. The spherical peptide shells overshadow the 
intensity of crystalline magnetite diffraction peaks (figure 4-29).  
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Figure 4-29 XRD pattern of BOC-SPION-SS (graph is representative of three independent 
experiments) 
v) Saturation magnetisation measurement of core–shell nanocomposites using 
vibrating sample magnetometer 
The magnetic behaviour of peptide coated iron oxide nanoparticles was assessed using 
field-dependent VSM. The hysteresis curves of core-shell nanocomposites were 
compared to B-SPION-SS. When the applied field was zero, basic magnetic domains are 
aligned irregularly with overall magnetisation value of zero. In this study, a reasonable 
high magnetic field (7 kOe) was used. There is evidence of saturation magnetisation in 
the peptide coated iron oxide nanoparticles compared to bare magnetite, showing the 
magnetic domains again aligned randomly when the magnetic field is removed. The 
dependence of peptide coated iron oxide materials` magnetisation on the applied 
magnetic field and lower magnetisation values compared to bare magnetite confirming 
that core – shell domains were aligned with the applied field. 
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Figure 4-30 shows the saturation magnetisation curves of B-SPION-SS, and BOC-
SPION-SS. The saturation magnetisation values of B-SPION-SS, and BOC-SPION-SS 
were found to be 65 emu.g-1 and 18 emu.g-1 respectively. A reduction in saturation 
magnetisation values is due to presence of nonmagnetic peptide shell with Fe3O4 
nanoparticles. The ideal saturation magnetisation value that applies to biological 
applications should be in the range of 7 – 22 emu.g-1 (Brusentsov et al. 2001; C. Xu et al. 
2004). The saturation magnetisation achieved for peptide coated iron oxide nanoparticles 
(18 emu.g-1) was reasonable for biological applications. VSM data also proved lack of 
hysteresis loss as both eminence and coercivity being zero, confirming the coating did 
not have any effect on the superparamagnetic behaiviour (figure 4-30). Due to this 
saturation magnetisation ability, the core–shell materials possibly have high enough 
contrast to be used in magnetic resonance imaging (MRI).  
 
Figure 4-30 Magnetisation saturation curves of B-SPION-SS (blue dash line) and BOC-SPION-
SS (orange dotted line) (graphs are representative of three independent experiments) 
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vi) Thermal stability measurements of core – shell structures using 
Thermogravimetric analysis  
TGA curves of B-SPION-SS and BOC-SPION-SS nanocomposites were were obtained                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
using TGA instrument under nitrogen atmosphere with heating rate of 10 °C.minute-1. 
Figure 4-31 shows the variations in the residual masses of the materials over a range of 
temperatures. The peptide was completely burnt into gas products without any residual 
mass. The BOC-SPION-SS composites were burnt into magnetite at after 320 °C, 
respectively. The amount of remained magnetite can be quantified from the composite 
residual mass, where pure B-SPION-SS nanoparticles (figure 4-31) had a total weight 
loss less than 10 % over the temperature range analysed. This loss of weight is possibly 
due to the adsorbed water. The peptide started to burn above 150 °C. It can be estimated 
that the weight loss of total peptide coated on the iron oxide nanoparticles is nearly 55 % 
(figure 4-31 dashed line). The TGA curves for BOC-SPION-SS and pure peptide and B-
SPION-SS are similar (figure 4-31). The first weight loss step is less than 130 °C, this 
can be attributed to the evaporation of water from peptide matrix, while second step 
beginning at from 158 °C, due to the burning of the peptide. TGA curve of peptide coated 
iron oxide nanoparticles estimated that the iron oxide amount at be around 45 %.  
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Figure 4-31 TGA curves of B-SPION-SS (black dotted line), BOC-FF peptide (solid blue line) 
and BOC-SPION-SS (orange dashed line) (graphs are representative of three independent 
experiments) 
4.5 Peptide-capped mesoporous silica-coated iron oxide core-shell 
composites  
Mesoporous silica-coated iron oxide nanoparticles have been studied as a potential drug 
delivery carrier. The mesoporous silica coated iron oxides have a high surface area to 
volume ratio with internal porosity can be used to achieve controlled drug delivery 
system. Controlled drug delivery system provides efficiency to restrict and permit the 
release of drugs. The synthesis of mesoporous silica-coated iron oxide nanoparticles 
capped with peptide were characterised and discussed for potential use in drug delivery 
system. The system consisted of a BOC-FF capping the mesoporous entrance of 
mesoporous silica-coated iron oxide with an average of particle size ranges of 400 nm. 
The average pore size is around 2.7 nm. By inserting the dry mesoporous silica coated 
particles to an aqueous solution of peptides, the mesopores were capped with self-
assembling process of peptide.  
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i) Morphological studies of peptide-capped silica-coated iron oxide materials 
using scanning electron microscopy  
SEM image of mesoporous silica-magnetite core-shell nanocomposites before and after 
peptide capping are shown in figure 4-32. Both materials have the spherical morphology 
of almost 1 µm in diameter. The SEM image of the peptide-capped silica-coated iron 
oxide displayed excellent dispersibility due to peptide-capped layer.  
 
Figure 4-32 SEM images of (a) mesoporous Si-SPION-SS and (b) BOC-Si-SPIONs-SS 
structures (Images are representative of three independent experiments) 
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EDAX analyses were also performed to confirm the elemental composition of 
mesoporous silica-coated iron oxide nanoparticles. Figure 4-33 displays the EDAX 
spectra of silica coated core-shell with peptide capped materials. The EDAX peaks to the 
corresponding elements Si, O and Fe are labelled, confirming the composition associated 
with core Fe3O4 and mesoporous SiO2 shell.  
 
Figure 4-33 EDAX spectra of BOC-SPION-SS compositions (graph is representative of three 
independent experiments) 
ii) Chemical composition confirmation of peptide-capped silica-coated iron 
oxide particles using Fourier transform infrared spectroscopy  
Figure 4-36 showed the FTIR spectra of the Si-SPION-SS nanoparticles and the BOC-
Si-SPION-SS composites. Vibration bands in the region of 1200 -1000 cm−1 and 800 cm−1 
are characteristic of the Si-O and O-Si-O groups respectively. The band at 650 cm-1 could 
be due to the symmetric SiOSi stretching of four membered siloxane ring on the surface 
of iron oxide while 950 cm−1 band reveals the existence of the Si-O-H group. In 
mesoporous silica, the OH bands were found at 3600-3100 cm-1, due to the presence of 
adsorbed water in siloxane rings. The intensity of the SiOH band at 950 cm-1 is reduced 
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in peptide capped core-shell structures. This indicates that SiOH contributes to the 
interaction with the peptide. The bands at 1180-1040 cm−1 correspond to stretching 
vibrations of the CO and CC groups of carboxyl and phenyl ring of the peptide, 
confirming the presence of peptide. In general, FTIR spectra of peptide capped materials 
were characteristics of carboxyl, amide and with a high concentration of siloxane groups. 
FTIR results of silica without peptide but with another organic polymers also looks 
similar to Yang et al. (2008) due to symmetrical and asymmetrical stretching of CC and 
NC of the polymers (figure 4-34).  
 
Figure 4-34 FTIR spectrum of Si-SPION-SS (blue line) BOC-Si-SPION-SS nanocomposites 
(orange line) (graphs are representative of three independent experiments) 
iii) Thermal stability measurement using thermogravimetric analysis  
Figure 4-37 shows the TGA curves of Si-SPSION-SS (black line), pure peptide (blue line) 
and BOC-Si-SPION-SS composites (red line) are shown in figure 4-35. Step-1 is the 
removal of adsorbed water below 150 °C. In this step, initial weight loss is approximately 
10 weight %. From 150-500 °C, the total weight loss of peptide capped silica-coated iron 
oxide nanoparticles is 23 %. BOC-FF decomposes between 160 and 358 °C. Peptide-
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capped core-shell composites decomposes with similar profile characteristics as the 
combination of pure peptide and uncapped core-shell composites.  The total weight loss 
is around 55 % due to the peptide cappinhg around core-shell composites between ~ 180 
and 330 °C (figure 4-35).  
 
Figure 4-35 TGA curves of peptide (blue solid line), Si-SPION-SS (black dotted line) and BOC-
Si-SPION-SS (dashed red line) composites (graph are representative of three independent 
experiments)  
iv) Saturation magnetisation measurement using vibrating sample 
magnetometer   
The magnetic properties of Si-SPION-SS core-shell and BOC-Si-SPION-SS composites 
were performed on vibrating sample magnetometer (VSM). Figure 4-36 displayed the 
characteristic hysteresis curves showing the zero coercivity and remanence confirming 
the superparamagnetism. The saturation magnetisation value of Si-SPION-SS was 45 
emu.g-1. However, the bare magnetite gives a value of 65 emu.g-1 (figure 4-36). The 
saturation magnetisation of BOC-Si-SPION-SS core-shell composites was approximately 
10 emu.g-1. The presence of both silica and peptide is responsible for the lowering of 
saturation magnetisation values due to non-magnetic property.  However, the morphology 
and the magnetic properties in the context of coercivity and remanence were not altered.  
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Figure 4-36 VSM saturation magnetisation curves of Si-SPION-SS (square) and (cross) BOC-
Si-SPION-SS nanocomposites (graph are representative of three independent experiments) 
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4.6 Conclusions  
Novel spherical superparamagnetic core-shell composites were prepared with magnetite 
(Fe3O4) core and peptide shells. All materials synthesised retained the superparamagnetic 
property. The objective was to encapsulate the magnetite core with high surface area 
mesoporous silica and peptide shells via template-mediated coating and to stabilise the 
spheres as core-shell materials. FTIR, XRD and EDAX have confirmed the presence of 
magnetite (Fe3O4) nanoparticles. Meanwhile, morphology and size were analysed using 
SEM and DLS respectively. The size distribution of spherical iron oxide cores was 20-35 
nm in diameter, while coated materials were of almost 1 µm. TGA Thermal profile of 
individual and composite materials have confirmed the peptide coating on SPIONs and 
silica-coated SPIONs. The presence of characteristics FTIR bands for NH, OCO and FeO 
also confirmed the peptide coating on magnetite nanoparticles surface. Saturation 
magnetisation values for bare SPIONs, peptide coated SPIONs, mesoporous silica coated 
SPIONs and peptide-capped silica-coated SPIONs were 65, 18, 45 and 10 emu.g-1 
respectively. The core-shell composites have shown to be superparamagnetic in nature. 
The saturation magnetisation values were measured to be lower than core (Fe3O4) due to 
organic shells without affecting the superparamagnetism.   
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    CHAPTER FIVE 
5 Characterization of core-shell tubes peptide as shell and 
SPIONs as core material 
5.1  Introduction  
The shapes of nanoparticles play a key role in changing their physicochemical properties, 
which ultimately drives their functionality. The nanoscale iron oxide particles are the key 
in developing low-cost, functional materials for a variety of applications. The magnetic 
property of these materials make them ideal candidates for a variety of technological 
applications (Xie et al. 2009; Hutchings et al. 2013). Low cost and simple protocols are 
needed to engineer tuneable iron oxide nanoparticles to achieve most of their healthcare 
benefits. A number of protocols have been suggested for the synthesis of controlled shape 
nanoparticles including sol-gel, reverse micelle, co-precipitation and solvothermal 
methods. (Wilcoxon & Provencio 1999; Seip & O’Connor 1999; Jiang et al. 2004; Hyeon 
et al. 2001; Vayssieres et al. 2005).  The co-precipitation method was used to synthesise 
both rod-shaped rod and spherical-shaped iron oxide nanoparticles.  
Currently, it is challenging task to have a concise protocol to achieve controlled size and 
shapes of prepared nanoparticles. This work also aided in the better understanding of the 
synthesis of rod-shaped iron oxide nanoparticles. Iron oxide nanorods have already been 
synthesis by different protocols (Woo et al. 2003; Huang et al. 2011; Vayssieres et al. 
2005; Sarawade et al. 2014; Polshettiwar et al. 2009; Fihri et al. 2012). This method is 
relatively simple, quick and does not require microwave or other sophisticated 
techniques. The spherical and rod-shaped iron oxide nanoparticles were synthesised with 
similar protocol simply by changing iron oxide salts. This new synesthetic approach to 
achieve different shapes of iron oxide nanoparticles is unique and not found in the 
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available literature. The size, shape, thermal degradability, magnetic susceptibilities and 
crystallinity of the iron oxide nanoparticles were characterised.         
This chapter focuses on the physicochemical characterisation of the tubular peptide, rod-
shaped iron oxide and iron-shaped core-shell nanocomposites. A variety of 
characterisation techniques including; SEM, EDAX, TGA, XRD, FTIR and VSM were 
performed. These techniques were carefully chosen to study best materials for drug 
delivery applications.  
Sample preparation for each experiment and the equipment settings and parameters were 
described in section 3.4. Table 5-1 shows the concise list of the characterisation 
techniques used for each synthesised material. 
Table 5-1 Characterisation techniques used for spherical materials 
Sample SEM/EDAX FTIR XRD DLS TGA VSM 
FM-ION-RS  √ √ √ √ √ √ 
FF √ √ √  √  
FF-FM-ION-RS  √ √ √  √ √ 
 
5.2 Iron oxide as core materials  
5.2.1 Characterisation   
i) Morphology of the core materials nanoparticles using scanning electron 
microscopy 
Figure 5-1 showed the morphology of rod-shaped iron oxide nanoparticles. The rod-
shaped nanoparticles showed lower aggregation and uniform size in both length and 
width. They were approximately 500 and in length and 10 nm in width, respectively 
(figure 5-1). The tiny rods have a high aspect ratio hence it was difficult to focus in SEM. 
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XRD data showed the clear lattice fringes, confirming the crystalline structure of the rod-
shaped iron oxide nanoparticles (figure 5-7).  
 
Figure 5-1 SEM images of Ferromagnetic Iron Oxide Nanoparticles Rod Saped (FM-
ION-RS) synthesised via co-precipitation of ferrous sulphate route (Image is 
representative of three independent experiments) 
 
 
Figure 5-2 Energy dispersive spectroscopy of FM-ION-RS nanoparticles (graph is 
representative of three independent experiments) 
Elemental analysis was performed on rod-shaped iron oxide nanoparticles using Energy 
Dispersive X-ray Spectroscopy (EDAX) to confirm the presence of iron and oxygen. 
Figure 5-2 shows the elemental analysis of bare rod-shaped iron oxide nanoparticles. As 
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expected, iron and oxygen peaks were observed due to the core iron oxide along with 
carbon and gold peaks due to carbon tape and gold coatings, respectively from sample 
holder. For each sample, EDAX spectra were recorded from three representative areas 
and the results were averaged for each element identified. Tables 5-2 showed EDAX 
elemental compositions and mass percent. The data showed the bare iron oxide magnetite 
was composed of iron and oxygen. 
Table 5-2 Energy dispersive spectroscopy of rod-shaped iron oxide nanoparticles 
 FM-ION-RS 
Elements  Weight (%) Atomic (%) 
C 7 19 
O 23 44 
Au 5 1 
Fe 65 66 
 
ii) Transmission electron microscopy  
The method used to achieve rod-shaped iron oxide nanoparticles is novel, however 
ferrous sulphate based iron oxide have been published (Sayed & Polshettiwar 2015) but 
the method was fairly complicated. They used urea, CTAB and process involved 
microwave radiation. The method used in this study was relatively simple and quick. 
Synthesised rod-shaped magnetic materials showed a narrow size distribution. Figure 5-
3 shows the TEM images of FM-ION-RS nanoparticles. The brief preparation method is 
described in section 3.4. Size distribution of rod-shaped iron oxide nanoparticles is nearly 
10 nm in width and several hundred nanometres in length. Detailed analysis of the rod-
shaped nanoparticles with higher magnifications has been presented in figure 5-3 (a-b). 
A nice crystalline structure with atomic resolution indicating well-ordered structure, 
which has been confirmed further via XRD analysis.   
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Figure 5-3 (a-b) TEM images of FM-ION-RS nanoparticles at different magnifications (Image 
is representative of three independent experiments and these images are taken in Liverpool 
University)      
iii) Chemical confirmation of core materials using Fourier transform infrared 
spectroscopy  
FTIR was used to characterise the iron oxide nanoparticles, to confirm the iron oxide 
bonding. FTIR spectrum of the bare core material is shown in figure 5-4. In figure 5-4, 
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the peaks at 550 cm-1 assigned to the Fe-O bond of iron oxide. However, the characteristic 
bands for a Fe-O bond of bulk Fe3O4 are stated as 570 cm
-1. A shift of Fe-O vibration 
band to to 550 cm-1 has been reported for the Fe2O3 nanoparticles (Bordbar et al. 2014). 
Hence, XRD analysis has been carried out for further confirmation.  
 
Figure 5-4 Fourier transform infrared spectrum of FM-ION-RS (graph is representative of three 
independent experiments) 
FTIR (figure 5-4) confirmed the presence of FeO vibration band at 534 cm-1. The peaks 
at 530 cm-1 and 440 cm-1 are assigned to the Fe-O bond. However, the characteristic bands 
for a Fe-O bond of bulk Fe3O4 are stated as 570 and 400 cm
-1, a shift in the bands of the 
Fe-O were around 545 and 440 cm-1, respectively, as reported for the Fe3O4 nanoparticles 
(Bordbar et al. 2014). This shift is probably due to the nanosize of materials, where certain 
bonds of surface atoms are broken and causing the rearrangement of electrons on the 
particle surface. The successful deposition of silica on the bare magnetite material, 
namely mesoporous silica-coated iron oxide nanoparticles (Si-SPION-SS) was also 
confirmed by FTIR analysis. 
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iv) Crystalline analysis of core materials using X–ray diffraction   
XRD pattern of the bare iron oxide nanoparticles is shown in figure 5-5. XRD pattern of 
FM-ION-RS materials have multiple diffraction lines corresponding to crytal phase of 
maghemite (Fe2O3) (figure 5-5). Figure 5-5 shows the characteristic peaks of Fe2O3 could 
be seen indicating a high degree of purity of bare iron oxide. Supporting the atomic scale 
resolution of TEM data 
 
Figure 5-5 XRD plots of FM-ION-RS (graph is representative of three independent 
experiments) 
v) Saturation magnetisation measurement using vibrating sample magnetometer  
The magnetic properties of iron oxide nanoparticles may be affected by various factors 
such as; size, shape, crystallinity, preparation conditions, the cations substitution and 
surface modifications (Sarawade et al. 2014; Hyeon et al. 2001; Jiang et al. 2004; J. Huang 
et al. 2011). Figure 5-6 showed the VSM hysteresis curves indicating small ferromagnetic 
behaviour.  
The magnetisation properties of core rod-shaped material of magnetic nanoparticles were 
measured at room temperature using the 7 kOe magnetic field. The saturation 
magnetisation (Ms) of core rod-shaped materials was 45 emu.g-1, and silica hybrid iron 
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oxide was measured to be 19 emu.g-1 (figure 5-6). The coercivity was 0.05 emu.g-1. The 
coercivity was largely influenced by different factors such as size, shape and surface 
modification. The previous study showed that coercivity in one-dimensional 
nanostructures is increasing, due to shape anisotropy of materials (Jain & Jothi 2015). 
Spherical nanoparticles as already discussed (figure 4-10) showed zero coercivity 
compared to the rod-shaped iron oxide nanoparticles. This may be due to the one-
dimensional structure. In rod-shaped structures, the magnetic spins aligned with long axis, 
while in reversing to their opposite directions at reverse applied field, they require higher 
energy compared to spheres. The ferromagnetic behaviour of rod-shaped nanoparticles 
might be due to large size of particles as well as one dimension at over domain size.  
As discussed earlier, spherical nanoparticles are superparamagnetic with no hysteresis, 
while the rod-shaped iron oxide nanoparticles are, ferromagnetic in nature.  
 
Figure 5-6 Hysteresis curve of FM-ION-RS nanoparticles (graph is representative of three 
independent experiments) 
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vi) Thermal stability measurements using Thermogravimetric analysis  
Thermogravimetric analysis (TGA) of FM-ION-RS was performed for the identification 
of degradable elements of the nanocomposites. TGA experiments performed on the rod-
shaped iron oxide over the temperature range from 25 °C to 500 °C.  The total weight 
loss detected was approximately 11 % (figure 5-7). The loss in weight might be due to 
the loss of residual water in the sample.  
 
Figure 5-7 Thermogravimetric analysis of FM-ION-RS (graph is representative of three 
independent experiments) 
5.3 Diphenylalanine as shell materials  
5.3.1 Characterisation of tubular diphenylalanine self-assemblies  
Peptide nanotubes are promised biocompatible, thermally and mechanically stable 
materials, which can be used in bionanotechnological applications (Kol et al., 2005; Lihi 
Adler-Abramovich et al., 2006). The hydrophobic peptides self-assemble into nanotubes 
via non-covalent interactions of repeating units of amino acid (Adler-Abramovich et al., 
2009). The peptide-based nanotubes can be used as electrochemical biosensors, energy 
storage devices and various other applications (Matos & Alves, 2011). The self-
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assembling pattern of FF peptide with the iron oxide nanoparticles into tubular 
morphology was studied. 
i) Morphological analysis using scanning electron microscopy  
Two analogues of FF (H-Phe-Phe-OH and BOC-Phe-Phe-OH) were used in this study. 
The H-Phe-Phe-OH and BOC-Phe-Phe-OH analogues used were abbreviated as FF (non-
modified) and BOC-FF (boc-modified). Both self-assembled into long, stable bundles of 
tubes and fibres (Diaz & Çağin 2010). The self-assembly of both peptides was carried by 
dissolving in hexafluoroisopropanol (HFIP) and further diluting in either pure water or 
ethanol-water (1:1). Formation of fibrillar and discrete tube bundles proceeded over at 
room temperature. SEM images showed the diversity of elongated structures with a range 
of dimensions. 
BOC-FF in ethanol-water mixture showed spheres (discussed in detail in chapter 4). The 
same material in water, showed aggregated fibres (figure 5-8). This sample was prepared 
in HFIP-water mixture (initially, 100mg.ml-1 in HFIP then 2 mg.ml-1 in water). The 
nanofibers were closely interconnected having lengths up to several microns. SEM 
images showed fibre bundles intertwined rather than thick discrete sheets of each fibre.  
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Figure 5-8 SEM micrograph of Boc Modified Diphenylalanine (BOC-FF) nanofibers prepared 
in an HFIP/water mixture (Image is representative of three independent experiments) 
Figure 5-8 showed SEM images of dried sample of BOC-FF nanofibers. The length of 
nanofibers was up to several micrometres. Some individual nanofibers of up to 100 nm 
in width also appeared (figure 5-8 green arrow). However, the majority of these 
nanofibers were interconnected (orange arrow) forming long nanotubes with open ends 
(yellow arrow).  The elongation of a fibre possibly results in peptide additions at one end. 
The SEM confirmed that microscale fibres are made of several short nanofibers 
assembling edgewise. The hydrogen bonding network may be involved via a shift in the 
Amide I band predictable with FTIR, corresponding to the β-sheets (figure 5-12) (Keten 
et al. 2010). It is difficult to confirm whether this addition is monomeric or polymeric. 
SEM images also showed that BOC-FF fibres assembled structures are of two distinct 
types. Some structures were not bundled having the diameters of up to 100 nm while 
some were bundled showing diameters of up to several microns. The bundles composed 
of several ~100 nm (diameter) assemblies. In bundles, the gaps in between of fibres can 
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be seen, (highlighted in figure 5-8 orange arrow), confirming the attachment of individual 
fibres in the bundle. This bundling may have occurred via hydrophobic interaction of 
peptide assemblies, or it might be the function of evaporation of solvent during the 
synthesis process. This data is in good agreement with the suggested pattern of peptide 
stacking of β-sheets with TEM of individual fibres of 2 nm in diameter (Mart et al. 2006). 
This data confirm that the BOC-FF fibres are composed of individual nanofibers. From 
above evidence, it can be concluded to that large structures have three level assemblies; 
from the individual fibres of approximately 2 nm in diameter, stacking into the fibre of 
approximately 100 nm in diameter and then bundled fibre of approximately 1μm in 
diameter (figure 5-8). Even though in this study, it was not be possible to confirm the first 
stage of fibre formation in solution however the second level fibre transition to bundled 
fibres can be clearly seen. The previous study showed stable individual fibres during 
modification of peptide with polymers (Xu et al. 2011). It can be concluded that without 
protecting with polymers, first level fibres continue to stack into larger fibres.  
Figure 5-9 showed the low magnification SEM image of a FF nanotube in HFIP-water 
(100 mg.ml-1 in HFIP then diluted to 2 mg.ml-1 in water). The nanotubes are stacked 
closely up to hundreds of microns in lengths. The results are comparable to published 
work on FF nanotubes (Adler-Abramovich et al. 2006).  
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Figure 5-9 Image of Diphenylalanine (FF) nanotubes prepared in an HFIP-water mixture (Image 
is representative of three independent experiments) 
Figure 5-10 shows the ‘crystal-like’ features stacked into bundles. This is a pattern of 
tubes initiation from a nucleating point and extending outwards. Red arrows depict the 
nucleation points in figure 5-10. Image were consistent with the data obtained by (XU 
2011). Tubes initiating from nucleating points showed variations at the end. Some tubes 
are straight, others have curved morphology ending and some tubes merge within the 
surface of the substrate (figure 5-10).      
In addition, when FF was dissolved directly in water at 1 mg.ml-1 showed a ‘feather-like’ 
morphology with number of small tubular structures (figure 5-11 (a) and (b)). Figure 5-
11 b showed some rod-shaped structures with lengths from 5 μm to 50 μm besides the 
feather-like morphologies. The end of these both branches was needle-like, (annotated 
with red arrows). The small round shape morphologies with diameters up to 10 μm are 
also found, a representative of which is annotated with blue arrows.  
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Figure 5-10 SEM images of FF dissolved in water alone from two representative area (a and b) 
(Images are representative of three independent experiments) 
SEM images of FF in ethanol-water (1:1) showed the presence of nanotubes with hollow 
structures (figure 5-11). The length of nanotubes was up to several micrometres. In 
contrast to FF in water formed nanofibers, FF assembled into discrete nanotubes. Shao & 
Parquette (2009) found, using tapping-mode AFM, a cross-sectional space of 20 nm with 
average lengths of several micrometres. The AFM revealed that the long axis of the tubes 
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was smooth and consistant. These findings were consistent with the nanotube formed in 
this work. The average diameter (6 nm) of the peptide nanotubes were reported as smallest 
β-sheet based nanotubes of octapeptide (Valéry et al. 2003).  
 
Figure 5-11 SEM images of FF in ethanol water (1:1) mixture (a) long discrete nanotubes (b) 
end of nanotubes with hollow space(Images are representative of three independent 
experiments) 
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Figure 5-11 showed SEM image of the FF nanotubes in ethanol-water (1:1) mixture . 
Nanotubes formed with ethanol-water mixture showed well-defined nature and were 
loosely packed and well scattered on the substrate. The nanotubes were not stacked on 
each other without nucleation point of growth. A low-magnification image of the 
nanotubes (as shown in a small rectangle in figure 5-11(a)) revealed the range of tubes of 
several hundred nanometres in diameter and up to hundreds of microns in length. The 
results are consistent with previously published work, where researchers found tubes 
diameter ranging from 10 nm to 100 nm and an extended length of up to 100 μm (Song 
et al. 2004). The hollow ends of each FF nanotubes can be seen clearly (figure 5-11 (b)).  
ii) Chemical confirmation analysis using Fourier transform infrared 
spectroscopy  
Figure 5-12 shows the Fourier transform infrared spectroscopy (FTIR) spectra of dried 
FF in water and ethanol-water (1:1) mixtures. FF confirmed the CO stretching (amid 
band) at 1512 – 1494 cm-1, characteristics bands of β-sheets. In addition, nanotubes 
showed broad bands at 1660 - 1512 cm-1 and a sharp peaks at around 1674 cm-1 (figure 
5-12). FTIR spectra of both structures showed mixture of β-turns and β-sheets secondary 
structure configuration. While FF in water only showed a peak at 1685 cm-1, which is 
characteristic to antiparallel β-sheets (Martinez & Millhauser 1995). Considering both, 
peptide nanotubes self-assembled as results of π-β conformation (Baldassarre et al. 2016; 
Aggeli et al. 1997). Remarkably, the band at 1685 cm-1 found in FF in water reported to 
be stacked fibres (Gallagher 1997). Thus, the lack in the antiparallel β-sheet characteristic 
band for FF in ethanol-water revealed stacking and discrete structure, which is governed 
by hydrophobic π-π interactions. The difference in morphology of both structures of FF 
in water and ethanol-water mixtures was clearly visible in the SEM (figure 5-11).   
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Figure 5-12 FTIR spectra of FF in water (red line) and ethanol-water (1:1) mixture (blue line) 
(graphs are representative of three independent experiments) 
iii) Crystalline analysis using X-ray diffraction  
X-ray diffraction (XRD) was used to characterise the dried tubular morphologies of FF 
prepared in both solvents systems (water and ethanol-water mixture) to study the 
difference in the crystalline structure. Figure 5-13 shows the XRD patterns of the 
nanotubes prepared by two different conditions. Both conditions provided nanotubes, 
which are crystalline in nature. However, there is a distinct difference in their crystalline 
structure.     
The results obtained in this study were compared with published work (Görbitz & Gorbitz 
2006). The diffraction pattern of peptide nanotubes was compared to simulated diffraction 
pattern of tubular structures where XRD pattern showed the curves were similar to the 
single crystal simulated curves. This pattern is in good agreement with published XRD 
data on FF nanotubes (Görbitz & Gorbitz 2006). 
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Figure 5-13 XRD pattern of (orange dotted) FF in ethanol water and (blue solid) in water alone 
showing d spacing in (Å) (graphs are representative of three independent experiments) 
XRD patterns of FF in ethanol-water mixture and water alone revealed the presence of 
ordered β-sheets within the nanotubes (figure. 5-13). XRD data was further investigated 
to extend the understanding of the supramolecular order of FF nanostructures. As a 
backbone of similar material, characteristic amyloid peaks confirmed the peptides self-
assemblies of elongated structures (Görbitz & Gorbitz 2006). The characteristic peaks at 
4.1 Å, and 3.4 Å showed the self-assemblies of phenylalanine monomers interacting via 
π–π stacking. The peaks at 4.7 Å and 5.09 Å are characteristic of inter-sheet distances. 
12.02 Å and 12.5 Å, which can be assigned to peptide lengths, as confirmed by computer 
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simulation (Görbitz & Gorbitz 2006). The intense peak at 12.5 Å, and a weak peak at 
12.02 Å for discrete and bundle-like structures suggesting the typical space between 
individual structure (Marchesan et al. 2015). X-ray diffraction pattern with d-spacing was 
found to be 4.5 Å (a) and 5.09 Å (b), both were the typical inter-strand spacing of “cross-
β” patterns, while the typical spaces in the helical structures were 3.4 Å and 3.1 Å. The 
discrete nanotubes in ethanol-water mixture were tightly packed with antiparallel β-sheets 
in a higher supramolecular order compared to stacked bundles in water. Anti-parallel β-
sheets have a more intense XRD signature compared to the peptide displayed disorder 
secondary structure configuration. This revealed that stacked bundled structures are not 
only composed of disordered β-sheets, but may have peptide folding with other secondary 
level configuration. 
iv) Thermal stability analysis using Thermogravimetric analysis   
Thermal stability of self-assembled FF in water and ethanol-water was measured using 
TGA. TGA provided the information of changes in mass of peptide during thermal 
degradation. These studies confirmed the onset degradation is similar in both structures 
(stacked bundles to discrete tubes) of FF in water and ethanol-water (1:1) mixtures, 
respectively.  Figure 5-14 shows TGA profile of both materials, where initial weight loss 
corresponded to the possible removal of adsorbed water below 130 °C. This weight loss 
of almost 12 % was consistent with the hollow structures of both materials. These results 
also confirmed that the framework remained stable up to 270 °C, before it can be fully 
decompose at 350 °C. 
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Figure 5-14 TGA profile of FF in ethanol-water (orange dashed line) and FF in water (solid blue 
line) (graphs are representative of three independent experiments) 
5.4    Peptide-coated core-shell magnetic nanorods  
5.4.1 Characterisations  
The rod-shaped iron oxide cores were coated with tubular FF in order to achieve core-
shell nanorods. The concentration ratio of iron oxide cores to peptide was (1:5).  The bare 
rod-shaped iron oxide cores tend to aggregate and settles in bottom. The stable iron oxides 
were obtained after coating with the FF nanotubes in uniform dispersion in ethanol-water 
system. The coated product was then obtained via magnetic separation. The magnetic 
materials then re-suspended again in ethanol-water. Physical observations confirmed the 
dispersions and the ability to separate out by magnet. The success in achieving the core-
shell structure can be due to the self-assembly of FF on iron oxides cores. The resulting 
modification achieved via non-covalent interactions of peptide and the surface of the 
nanorods of iron oxide cores. The biologically derived peptide sequence was used gave a 
positive reinforcement to this approach for designing core-shell materials.  However, 
there are some specific sequences designed to interact with specific metallic cores (Wang 
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et al. 2003). In addition, the phenylalanine amino acid side may interact with the iron 
oxide surface due to stronger π-π interaction.      
i) Morphological analysis using scanning electron microscopy  
Figure 5-15 showed the SEM images of coated rod-shaped iron oxide nanoparticles. 
Images of dried sample of core-shell materials were taken on carbon tape at room 
temperature. Figure 5-15 revealed that the most of the coated iron oxide nanorods were 
separated into short length rod-shaped structures. they were closely packed possibly due 
to hydrophobic force on the surfaces. This effect can be reduced by optimising the 
hydrophobicity by modifying their side chain or by replacing with another amino acid of 
different polarity. Figure 5-15 exhibits the FM-ION-RS was around 7 nm in width coating 
thickness of around 3.5 nm clearly seen from the contrast different shown in figure 5-16 
(b). The atomic scale of fine crystal pattern of core FM-ION-RS are not visible due to 
peptide coating.          
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Figure 5-15 SEM image of the (a) FF-FM-ION-RS and (b) EDAX analysis of FF-FM-ION-RS 
(graph and image is representative of three independent experiments) 
Energy Dispersive Spectroscopy (EDAX) studies of the FF-FM-ION-RS confirmed the 
presence of iron and oxygen, gold peaks appearing from the gold coating via sputtering 
(figure 5-15 (b)). 
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ii) Transmission electron microscopy  
Figure 5-16 revealed the peptide coated rod-shaped iron oxide nanocomposites (FF-
FMION-RS). Peptide shell has have successfully encapsulated the rod-shaped iron oxide. 
Figure 5-17 showed the difference in thickness of coated and uncoated rod-shaped iron 
oxide nanoparticles along with their fine structure. FM-ION-RS exhibited a well-ordered 
structure in atomic length scale (Å) with a rod width of approximately 7 nm. The size of 
nanocomposite was also large (approximately 25 nm in width) compared to bare iron 
oxide rods (10 nm in width). In low and high magnification peptide coated iron oxide 
materials showed different surface morphologies. 
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Figure 5-16 (a-b) TEM images of FF-FM-ION-RS core-shell nanocomposites at different 
magnification (Images arerepresentative of three independent experiments and these images are 
taken at Liverpool university) 
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Figure 5-17 TEM images of (a) bare rod-shaped iron oxide nanoparticles and (b) peptide coated 
tubular iron oxide nanoparticles (Images are representative of three independent experiments 
and these images are taken at Liverpool university) 
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iii) Chemical confirmation analysis using Fourier Transform Infrared 
spectroscopy  
Figure 5-18 revealed the infrared spectrum of dried FM-ION-RS, peptide and FF-FM-
ION-RS nanocomposites. The infrared spectrum of the iron oxide skeleton showed strong 
bands at 791 to 528 cm-1. In addition, iron oxides have a weak band below 900 cm-1. 
Bruce & Sen 2005 reported the iron oxide show signal at 410 and 550 cm-1. The peptide 
has characteristic vibrations, the NH and OCO bending, these bending vibration were 
seen at around 1700 to 1400 cm-1. The peptide are composed of FF residues, the phenol 
and aromatic hydrocarbon also have intense peaks below 1000 cm-1. Comparing bare iron 
oxide and peptide coated iron oxide, the vibrations at 530, and 730 cm-1 were 
characteristics of iron oxide along aromatic hydrocarbon, confirming peptide coating. 
Characteristics peaks at 1637 and 1020 cm-1 were also found for the CCO and CO 
stretching. The bands at 2965 and 1000 cm-1 were referred to –CH2 stretching and –CH 
out-of-plane bending vibrations, respectively. The presence of characteristics peaks of 
peptide functional groups revealed that the peptide is covering the iron oxide. 
 
Figure 5-18 Shows the FTIR spectra of FM-ION-RS (blue) FF (black) FF-FM-ION-RS (orange) 
(graph are representative of three independent experiments) 
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FTIR data confirmed the presence of both iron oxide and peptide characteristics bonds 
for the product obtained after coating. The infrared spectrum of carboxylate group via 
symmetric stretching at 1465 cm-1 supporting the assumption that iron oxide core interact 
with hydrophilic carboxylate groups of the peptide. However, the presence of a peak at 
1700 cm-1 indicated the presence of free carboxylic acid groups possibly located on the 
outer surface of the particles. 
iv) Crystalline analysis using X-ray diffraction  
X-ray Diffraction (XRD) pattrens of FM-ION-RS, pure FF and FF-FM-ION-RS core-
shell nanocomposites are presented figure 5-19.  The characteristic peaks of  FM-ION-
RS were at 2 Θ = 31°, 37°, 43°, 55.3°, 58.9° and 64.4°, which is characteristic pattern of 
maghemite as described earlier. Pure peptide nanotubes also exhibited multiple peaks due 
to crystalline structure (figure 5-22 a). FF-FM-ION-RS exhibited multiple peaks which 
are in combination with FM-ION-RS and pure peptide indicating that FF-FM-ION-RS is 
a hybrid nanorods with crystalline structure.     
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Figure 5-19 XRD pattern of pure FF (black dots), FM-ION-RS (orange dashes) and FF-FM-
ION-RS (solid blue line) (graph are representative of three independent experiments) 
v) Saturation magnetisation measurement using vibrating sample 
magnetometer  
It is well-known that magnetic properties of iron oxide nanoparticles can be influenced 
by coating of organic polymers (Sarawade et al. 2014; Hyeon et al. 2001; Jiang et al. 
2004; Huang et al. 2011). Figure 5-20 presents the VSM hysteresis loops when 7 kOe 
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magnetic field was applied. Both of the materials showed a small ferromagnetic behaviour 
possibly due to a slight disarrangement of the spin axis of rod-shaped domains from exact 
anti-parallelism. 
The magnetic properties of core-shell tubular nanoparticles were measured at room 
temperature in UCLan custom-built VSM. The saturation magnetisation (Ms) of FM-
ION-RS was measured to be 45 emu.g-1 and FF-FM-ION-RS was 16 emu.g-1 (see figure 
5-20). Studies showed that the coercivity of one-dimensional nanostructure can be 
influenced by crystallinity and shape anisotropy (Jain & Jothi 2015). Spherical 
nanoparticles showed zero coercivity compared to rod-shaped nanoparticles. 
As discussed earlier, spherical nanoparticles were superparamagnetic in nature with no 
hysteresis observed, while in the case of rod-shaped iron oxide nanoparticles, the 
ferromagnetic behaviour (hysteresis) was found clearly. Notably, a small but noticeable 
saturation magnetisation appeared in FF-FM-ION-RS due to diamagnetic peptide. 
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Figure 5-20 Magnetisation saturation of FM-ION-RS (blue line) FF-FM-ION-RS (orange cross) 
(graphs are representative of three independent experiments) 
vi) Thermal tability measurement using Thermogravimetric analysis   
Thermogravimetric analysis (TGA) curves of Ferromagnetic Rod-Shaped Iron Oxide 
Nanoparticles (FM-ION-RS) and Non-modified Ferromagnetic Rod-Shaped Iron Oxide 
Nanoparticles (FF-FM-ION-RS) composites are shown in figure 5-21. The core-shell 
composite showed the removal of adsorbed water below 150 °C. In this step, initial weight 
loss was approximately 10 %. From 150-500 °C, the total weight loss of peptide coated 
iron oxide nanoparticles was almost 50 % due to decomposition of peptide. FF 
decomposed completely at 350 °C, where the maximum slope was appeared at 300 °C. 
FF-FM-ION-RS decomposed with similar profile as individually decomposed materials 
and showed 80 % weight loss between ~ 350 to onwards 500 °C (figure 5-21).  
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Figure 5-21 Thermal degradation profile of FF-FM-ION-RS (graph is representative of three 
independent experiments) 
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5.5 Conclusions  
This chapter focused on developing the rod-shaped iron oxide nanoparticles (FM-ION-
RS) using novel ferrous sulphate as iron source via co-precipitation method.  The 
synthesis of rod-shaped iron oxide nanoparticles has opened new way to synthesise iron 
oxide based materials of different shapes. The shape of iron oxide nanoparticles has 
clearly influenced on the superparamagnetic behaviour of the nanoparticles. The 
saturation magnetisation values were 45 and17 emu.g-1 for bare rod-shaped iron oxide 
nanoparticle and peptide-coeated iron oxide nanoparticles, respectively. Thus the 
physicochemical properties can be modified. For the first time, FF peptide self-assemblies 
demonstrated that they could wrap the rod-shaped iron oxide cores in a tubular core-shell 
morphology.  
SEM-EDAX analysis of coated iron oxide and individual materials provided evidence 
that FF nanotubes can wrap around iron oxide rods. The size of bare rod-shaped iron 
oxide and peptide-coated iron oxide was approximately 10 nm 20 nm in width. The novel 
materials with magnetic properties and crystalline structures can be used in a variety of 
applications including; drug delivery, thermal ablation, magnetic field targeting and bio-
separation. The novel materials had magnetic response, hence can be separated via slab 
magnate. The presence of characteristics FTIR bands for OCO, NH and FeO confirmed 
the peptide coating on iron oxide. TGA profile of core-shell composites showed 
comparable pattern to individual materials. These techniques have successfully identified 
the iron oxide from self-assembled FF tubes. By adjusting the solvent and modifying the 
amino terminal in which peptide self-assembled, it is possible to coat rod-shaped with 
magnetic core with similar backbone peptide (FF).  
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     CHAPTER SIX 
6 Drug loading and release capacities of spherical core-shell 
materials 
6.1 Introduction  
The limited progress in the treatment of cancer has increased the need to explore different 
approaches for designing multifunctional drug delivery system. The ideal drug delivery 
systems should control pharmacokinetics of loaded drugs. Moreover, they should have 
ability to target the effected sites, with lower immunogenicity, higher loading capacity 
and possiblity to track them at active sites (Saikia et al. 2017; Asadi et al. 2016; Woźniak 
et al. 2017). Nanotechnology has opened the ways to design the desired materials with 
these promising properties.  
Superparamagnetic iron oxide nanoparticles (SPIONs) can carry the payloads and by 
applying external magnetic field can be targeted to the affected sites to achieve desired 
drug efficiencies (schematic depiction in figure 6-1). In addition, SPIONs as contrast 
agents can be tracked during the release of payloads. The attracting forces of iron oxide 
and high surface area to volume ratio causes the aggregation of SPIONs, which reduces 
the superparamagnetic behaviour. The SPIONs were coated with biocompatible peptides 
to reduce the aggregation in order to be used in drug delivery applications. Doxorubicin 
(DOX) was used as a model drug, which is an FDA-approved chemotherapeutic 
antitumor drug with a broad spectrum of effects for the treatment of leukaemia and 
tumours (Feng & Zhao 2017). The mechanism of action of doxorubicin includes the 
inhibition of DNA replication and protein translation. It inhibits the topoisomerase II, 
which involves in the DNA unfolding and replication by intercalating with nucleotide 
base pairs (Pérez-Arnaiz et al. 2014). The systematic administration of DOX showed 
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severe cardiac toxicity (Wu et al. 2016). A variety of nanoscale drug delivery systems has 
been studied as model carriers for DOX delivery to the cancer cells. DOX is 
anthracycline-based drug, which have intrinsic fluorescence property to track or locate 
the composite in biodistribution system. DOX possess a net positive charge (pKa 8.6) in 
neutral environment. Amino and carboxyl groups of FF have pKa values (9.31 and 2.2, 
respectively). Thus, peptide as zwitterion possess negative and positive charges 
facilitating the electrostatic interaction of DOX to peptide shell. The hydrophobic 
interaction of fussed ring of DOX and rings of FF also improves the drug loading of 
carriers. Drug loading capacity is a key for an ideal formulation for an effective delivery 
system. 
 
Figure 6-1 Schematic diagram of DOX adsorption on SPIONs 
In this chapter, DOX loading and release profile of BOC-SPION-SS via adsorption 
approach will be studied as a potential drug carrier system (figure 6-1). The hydrophobic 
DOX will be adsorbed on the surface of iron oxide and partitioning into peptide coating. 
This method is based for magnetically separable drug delivery system without using any 
toxic surfactant has been designed and applied. The formulated drug delivery system was 
assessed for drug encapsulation efficiency. The results are discussed in details for drug to 
nanoparticles/nanocomposites ratios with time-dependant loading and release kinetics.  
  
144 
 
6.2 Doxorubicin loading profile of spherical bare and coated 
superparamagnetic iron oxide nanoparticles  
6.2.1 Doxorubicin loading profile of spherical bare superparamagnetic iron 
oxide nanoparticles        
The amount of doxorubicin (DOX) was quantified by measuring the absorbance of the 
free drug at λ485 nm after magnetic separation. The free drug was compared to the total 
drug in a solution of DMSO-water. The quantification was performed from the pre-
established standard curves with known concentration of drug in similar DMSO-water 
(1:1). Standard calibration curves were prepared as 20, 40, 60, 80 and 100 µg.mL-1 (figure 
6-2).   
 
Figure 6-2 Standard calibration curve of DOX in DMSO-water (±SD, no=3) 
DOX loading experiment were performed in DMSO-water (1:1) on spherical B-SPION-
SS with different nanoparticles concentrations (2.5, 5, 7.5 and 10 mg.mL-1) while, 
keeping consistent drug amount (100 µg.mL-1) to find the highest loading efficiency. 
DOX loading capacities for the ratio of DOX to B-SPION-SS 1:25, 1:50, 1:75 and 1:100 
were 46%, 81 %, 85 % and 87 %, respectively after incubating at 18 °C for 48 hours 
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whilst in end-over-end rotation. Figure 6-3 shows the time-dependent drug loading 
capacity of different ratios.  
 
Figure 6-3 DOX loading capacity of B-SPION-SS with reference to incubation time, DOX to B-
SPION-SS ratio (a) 1:25 (b) 1:50, (c) 1:75 and (d) 1:100 (±SD, no=3) 
 Table 6-1 shows the DOX loading content in weight percentage of spherical bare SPIONs 
of different DOX:B-SPION-SS ratios with time-dependent studies. The lowest DOX 
content was seen 13 weight percentage for 1:25 at 0 hours formulation. The highest 
amount of drug was seen in the 1:25 formulation after incubating for 48 hours at 18 °C.   
Table 6-1 DOX loading capacity of B-SPION-SS (spheres) (time in hours) (micromole of DOX 
to milligram of B-SPION-SS) 
DOX:B-SPIOPN-SS 
(mass:mass) 
0.25 12  24  48  
(1:25) 2 18 27 32 
(1:50) 3 17 25 30 
(1:75) 3 15 20 21 
(1:100) 3 14 16 16 
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DOX loading capacities of (1: 25) formulation were found as 3 %, 24 %, 37 % and 46 % 
after incubating at 18 °C for 0 hours, 12 hours, 24 hours and 48 hours, respectively. The 
loading capacities were increasing as SPIONs ratio increased in time-dependent manner 
(figure 6-3). The loading capacity was almost reached to saturation after 12 hours for the 
(1:100) formulation. Similarly, 1:75 formulation was also reached its maximum after 24 
hours. Increasing the amount of B-SPION-SS, increases the loading amount with relation 
to time of incubation. The loading capacity in weight percentage of DOX and B-SPION-
SS is depicted in Table 6-1.   
6.2.2 Doxorubicin loading into spherical mesoporous silica coated 
superparamagnetic iron oxide nanoparticles  
Mesoporous silica offers some advantages on the bare SPIONs over other coating 
materials. Silica showed good thermal and chemical stability, lower aggregation and 
lower immunogenicity upon systemic administration (Wang et al. 2013; Graf et al. 2012). 
Though studies have favoured other polymeric carriers for adequate and controlled 
release of hydrophilic drugs, porous silica layers have shown great ability to encapsulate 
the drugs for sustained release. Silica layered particles could overcome the drug stability 
related limitations over other polymeric particles. In mesoporous silica, mesopores can 
offer full preservation of drug in pores during the circulation. The method of preparation 
of mesoporous silica-coated SPIONs was discussed in section 3.3.6. The silica layer 
thickness was controlled by optimised reaction time and silica source (TEOS). 
The percentage DOX loading capacity in Si-SPION-SS was studied by UV absorption 
measurement at λ485 nm of free drug after magnetic separation. The free drug was 
quantified using pre-established standard calibration curves in DMSO-water. The DOX 
loading capacity and content were measured at 18 °C, over pre-set time intervals for 48 
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hours. Figure 6-4 showed the DOX loading capacity of Si-SPION-SS. DOX loading 
capacity was measured 30 %, 40 %, 55 % and 55 % (for 1:25, 1:50, 1:75 and 1:100 
formulations, respectively) at zero hour time after sonication and vortex mixing. The 
saturation of DOX was achieved from 12 hours for (1:50, 1:75 and 1:100) except the 1:25, 
where it reached after 48 hours.    
 
Figure 6-4 DOX loading capacity of Si-SPION-SS with reference to incubation time, DOX to 
SPIONs ratio at different incubation times (a) 1:25 (b) 1:50, (c) 1:75 and (d) 1:100 (±SD, no=3) 
Table 6-2 showed the DOX loading content percentage of different formulation. DOX 
weight percentage (micromole) content at zero hours was 85 %, 84 %, 75 % and 58 % for 
formulations (1:25, 1:50, 1:75 and 1:100, respectively). The highest DOX loading content 
was calculated for 1:25 formulation after 48 hours and lowest was 58 % for (1:100) 
formulation.  
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Table 6-2 DOX-loading capacity of spherical core-shell Si-SPION-SS nanocomposites  
DOX:Si-PION-SS Time of incubation (hours) 
(micromoles:mg) 0.25 12 24 48 
(1:25) 15 42 56 63 
(1:50) 15 30 31 33 
(1:75) 13 22 21 22 
(1:100) 10 17 16 17 
6.2.3 Doxorubicin loading into core-shell peptide coated iron oxide 
nanocomposites   
After successful DOX loading into B-SPION-SS and Si-SPION-SS, the experiments were 
repeated on the peptide-coated SPIONs (BOC-SPION-SS). BOC-SPION-SS composites 
also showed good magnetic response during the magnetic separation. In addition, by 
optimising the drug:SPIONs (cores) ratio, the highest DOX loading ratio obtained was 
used in these experiments. Keeping the DOX:carrier ratio (1:100 weight percentage) 
consistant, the time-dependent loading studies were performed.   
Figure 6-5 shows BOC-SPION-SS maximum DOX loading after 12 hours. It was 
remained steady until 48 hours. Peptide-coated SPIONs reached to maximum (70 %) over 
the B-SPION-SS (85 %), which revealed the total 15 % reduction of DOX loading after 
coating. This was possibly due to the lower SPIONs availability. The magnetic separation 
assured the attachment of DOX with magnetic nanoparticles. These finding revealed the 
Si-SPION-SS were found promising carrier for DOX. Figure 6-5 showed time-dependant 
DOX loading profile of BOC- SPION-SS at 18 °C of incubation. Samples were sonicated 
for 15 minutes before taking first reading. Readings were recorded after magnetic 
separation in magnetic Eppendorf tube rack. The time-dependent loading studies showed 
that 12 hours were maximum time duration to achieve maximum (70 %) DOX loading 
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into BOC-SPION-SS. Time-dependant studies confirmed the DOX loading with 
magnetic nanoparticles were consistent from 12 hours to 48 hours.       
 
Figure 6-5 DOX loading profile of BOC-SPION-SS at different time intervals (hours) in 
incubation at 18 °C (1:100) (±SD, no=3) 
6.2.4 Doxorubicin loading into the peptide-capped mesoporous silica coated 
superparamagnetic iron oxide nanoparticles  
Mesoporous silica based drug delivery systems were proposed since the beginning of this 
century (MacLachlan et al. 2000; Hao et al. 2017). In this study, peptide-capped silica-
coated particles were studied as potential drug delivery carriers. Peptide capping approach 
was used to achieve biocompatible and gate keepers to control the release of drug 
molecules.   
DOX loading of Si-SPION-SS was studied using combination of ultrasonication and 
incubation approach at 18 °C for up to 48 hours using end-over-end rotation, then peptide 
solution was added to cap the mesopores of silica. The loading capacity and content in 
weight percentage was performed after magnetic separation of free drug. The 
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quantification of drug was measured by recording the absorbance of free drug at λ485 nm 
using standard calibration curves. 
Figure 6-7 showed the DOX loading profile of BOC-Si-SPION-SS up to 48 hours. 
Loading capacity was found 88 %. The saturation of drug loading was obtained after 24 
hours and remained consistent up to 48 hours. Similar results were obtained in case of 
silica coated SPIONs.  
 
Figure 6-6 Visual image of DOX loaded BOC-Si-SPION-SS (a) magnetic separation before 
incubation and (b) after incubation for 48 hours 
 
Coloured DOX before 
loading 
DOX after loading into 
mesopores of Si-SPION-SS  
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Figure 6-7 DOX loading profile of peptide-capped silica coated SPIONs (BOC-Si-SPION-SS) 
at different time intervals (hours) in incubation at 18 °C (1:100) (±SD, no=3) 
6.3 Doxorubicin release profile of spherical bare and coated iron oxide  
Doxorubicin (DOX) loaded B- SPION-SS, Si-SPION-SS, BOC-SPION-SS and BOC-Si-
SPION-SS were diluted in 1 mL of PBS at pH 7.4 at 37 °C in incubater whilst rotating 
up to 48 hours. Free DOX concentration was also diluted in buffer 20 to 100 μg.mL-1, the 
absorbance was recorded for further quantification of released drug from carriers (figure 
6-8). DOX release profile was studied at pre-set intervals after incubation, the absorbance 
of free DOX after magnetic separation was recorded at λ485 nm. Free DOX release 
percentage from magnetic carriers was calculated using free DOX standard calibration 
curve in PBS.  
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Figure 6-8 DOX standard calibration in PBS for release profile studies (±SD, no=3) 
6.3.1 Doxorubicin release from spherical bare magnetite  
Doxorubicin release profile of spherical B-SPION-SS in vitro was investigated for drug 
delivery applications. DOX loaded B-SPION-SS were separated using slab magnate at 
pre-set time intervals of different formulations. Figure 6-9 showed the DOX release 
profile of B-SPION-SS in PBS buffer at 37 °C. DOX loaded B-SPION-SS release profile 
revealed the burst release of DOX in first 12 hours. The DOX release plateau was seen 
after 12 hours. The final drug release after 48 hours was approximately 85 %. The big 
difference in initial burst release of DOX after 12 hours (70 %) and next 36 hours slow 
release (15 %) was might be due to the adsorbed DOX on the surface of B-SPION-SS.    
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Figure 6-9 DOX release profile of B-SPION-SS with reference to incubation time, (a) DOX to 
B-SPION-SS ratio 1:25 (b) 1:50, (c) 1:75 and (d) 1:100, respectively (±SD, no=3) 
6.3.2 Doxorubicin release profile of spherical mesoporous silica-coated iron 
oxide  
DOX loaded mesoporous Si-SPION-SS showed slow and sustained release. Figure 6-10 
showed the sustained release of DOX confirming the DOX incorporation into the 
mesopores of Si-SPION-SS along successful magnetic separation. The initial absorbance 
of free drug was continued with time-dependent manner confirming sustained release 
from mesopores of silica. B-SPION-SS showed the burst release, which appeared due to 
consequence of non-preferable adsorption to the external surface of particles.    
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Figure 6-10 DOX release profile of Si-SPION-SS with reference to incubation time, (a) DOX to 
Si-SPION-SS ratio 1:25 (b) 1:50, (c) 1:75 and (d) 1:100, respectively (±SD, no=3) 
 This study confirmed the successful incorporation of DOX into mesopores without 
adsorption on the surface of silica. Figure 6-10 (a) showed the DOX released behaviour, 
17 %, 21 % and 31 %, in first 12 hours then 24 and 48 hours, respectively. The total 
release of DOX from Si-SPION-SS was 31 %, 39 %, 48 % and 47 % for formulations 
(1:25, 1:50, 1:75 and 1:100, respectively) (figure 6-10).  
6.3.3 Doxorubicin release profile of spherical peptide-coated 
superparamagnetic iron oxide nanoparticles  
The peptide coating could work as a barrier for DOX release, thus the DOX diffusivity 
and solubility within peptide coating is crucial. DOX and peptide interactions can effect 
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the release profile. If DOX interacts with peptide, it may form hydrophobic micelles, thus 
the drug release profile can be compromised (Gao et al. 2014). DOX loaded martials were 
incubated at 37 °C to study the drug release pattern. The release behaviour was monitored 
for 48 hours and absorbance of free DOX was recorded on pre-set intervals. DOX release 
was found slower and lower for coated magnetite compared to bare magnetite. It might 
be due to DOX interactions with the partially charged peptide groups over SPIONs in 
core-shell structures. There was no burst release effect observed in BOC-SPION-SS 
(figure 6-11).  
 
Figure 6-11 DOX release profile of BOC-SPION-SS against different time intervals (±SD, 
no=3) 
As it was expected, the release rate of DOX (figure 6-11) was increasing continuously 
over time (approximately 4 %, 9 %, 18 %, 27 % and 28 %, respectively). The release 
profile curve revealed the total DOX release went to plateau after 24 hours.  The DOX 
release was found in sustainable fashion over 48 hours.  
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6.3.4 DOX release profile of spherical peptide-capped silica-coated 
superparamagnetic iron oxide materials 
The in vitro DOX release formulation of BOC-Si-SPION-SS nanocomposites were 
studied in PBS pH 7.4. The releasing behaviour of DOX in time-dependent manner was 
in sustainable manner (figure 6-12). The release process was similar to BOC-SPION-SS. 
Peptide coatings on bare materials has lowered the release rate than the non-coated 
particles. These results indicated that the peptide was preventing outside diffusion of 
DOX.        
 
Figure 6-12 DOX release profile of BOC-Si-SPION-SS against different time intervals (±SD, 
no=3) 
Physically adsorbed DOX molecules could be released as burst effect, while layered of 
peptide-capped SPIONs showed continuous release over 48 hours at 37 °C of incubation 
in end-over-end rotation. This could be demonstrated as layered incorporated DOX was 
controlled by diffusion through peptide valves. The DOX release could be attributed to 
the weakening of hydrophobic and ionic interactions of drug and peptide side chain 
groups (Pacheco et al. 2016). Thus, loosing of the hydrophobic and ionic interactions was 
  
157 
 
a slow process that led continuous release of DOX over longer periods. The sustained 
release of DOX in the affected site can increase the chemotherapeutic effect in anticancer 
therapy. 
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6.4 Conclusions  
DOX loaded spherical bare and coated SPIONs were prepared to study drug loading and 
release profile for in vitro applications. Peptide and silica coats around the SPIONs 
reduced the aggregation and silica pores have facilitated up to 90 % drug loading.  
The DOX:SPION of 1:10 showed lowed loading efficiency upto 45 % wheras 1:100 
(DOX:SPIONs) showed upto 85 % loading after 48 hours of incubation. The novel drug 
loaded magnetic nanoparticle over exposure of applied external magnetic field can be 
directed to targeted sites where can be triggered for cargo release.  
DOX release profile revealed burst effect in bare SPIONs and sustained release in coated 
materials. DOX was almost 70 % released after 12 hours from bare SPIONs, while coated 
particle showed almost 35 % release capacity even after 48 hours from 1:10 formulation.  
These results showed that the novel peptide-coated silica magnetic particles have great 
potential to be explored as drug delivery system. These magnetic particles can be tracked 
as contrast agent and directed to targeted site by applying external magnetic field. The 
magnetic field also triggered the release of loaded drug and increased the temperature to 
kill the cells, which will be discussed in chapter 08.   
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        CHAPTER SEVEN  
7 Drug loading and release capacities of tubular core-shell 
nanocomposites 
7.1 Introduction  
Magnetic nanomaterials have been successfully studied as an effective and promising 
drug delivery system. A number of studies have been published for designing of magnetic 
field triggered drug carriers for improved loading, control release and enhanced cellular 
uptake. A variety of parameters that can influence the particles size, shape and surface 
chemistry have not been explored thoroughly. More specifically, the magnetic particle 
shape, which can influence the performance of nanoparticles in biomedical applications 
was studied in this chapter. Limited data is available so far, which is possibly due to the 
limited source and availability of strategies controlling shape of nanoparticles from same 
type of source materials.  
The rod-shaped magnetic nanoparticles have been studied compared to spherical shape in 
biomedical applications. A schematic depiction of DOX loading into FF-FM-ION-RS is 
given in figure 7-1. The key important for controlling the shape of magnetic nanoparticles 
includes the reaction condition (time and temperature) and iron source. The formation of 
different ordered shape could be achieved by changing the iron source (ferrous and ferric 
and its molar ratio), variable temperatures, use of surfactant and type of solvents (Lu et 
al. 2007; Lu et al. 2004; Chikazumi et al. 1987). To date, most of FM-ION-RS were 
synthesised via thermal decomposition method, which exploits expensive chemicals 
including organometallic sources and surfactant. The cobalt and nickel based nanorods 
were prepared by exploiting the reduction of organio-metals in a high temperature 
environment (Dumestre et al. 2003; Cordente et al. 2001; Lu et al. 2007). The Fe2O3 based 
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nanorods have been reported in Wang et al. (2004); Cordente et al. (2001); Dumestre et 
al. (2003), where these were synthesised by inducing magnetic field using the template-
assisted method. The controlled-shape synthesises of nanoparticles is a still a big 
challenge to date. The shape anisotropy of magnetic materials led them promising 
materials with interesting properties. A small number of different-shaped magnetic 
nanoparticle have been developed to date, among these, some of the particle either have 
large size distribution or self-aggregation related properties.    
The promising properties of iron oxide based nanoparticles offered various approaches to 
design a tool for cancer treatment having drug delivery with real-time drug tracking. 
Magnetic nanoparticles such as γ-Fe2O3, α-Fe2O3 and Fe3O4 have been studied as 
promising tools for cancer treatment. Magnetic nanoparticles due to the 
superparamagnetic behaviour not only work as contrast agent but also become a localised 
heat source upon exposure of applied external magnetic field via magnetic hyperthermia 
phenomenon (Tietze & Alexiou 2017; Stoehr et al. 2011). The heat produced could be 
utilised as hyperthermia ablation (cooking of cancer cells). Moreover. As nanocarriers, 
they can be triggered to release the cargo inside. Hence, magnetic nanoparticles can be 
used as a single tool for imaging, chemotherapy and thermal ablation for the cancer 
treatment. Thus, they can be named as hyperthermia ablation combined with image-
guided chemotherapy.  
The superparamagnetic nanoparticle with average size distribution less than 45 nm in 
diameter as core materials have potential to be used as contrasting agent and drug delivery 
system. The FM-ION-RS have been studied for their contrasting and magnetic 
capabilities mostly focusing on biocatalysis, magnetic field triggered drug delivery, 
bioseparation, gene delivery and as MRI contrast agents (Wei et al. 2015; Wahajuddin & 
  
161 
 
Arora 2012; Fratila et al. 2015; Mohapatra et al. 2015). The biocompatibility studies of 
rod-shaped iron oxide showed 70 % cell death at high concentration 250 µg.mL-1. The 
biocompatibility studies were largely on time and concentration dependent. These studies 
were also dependent on the cell type (Lee et al. 2014). The biocompatibility related issued 
were improved by coating with organic materials, where gold, titanium and silver were 
coated with lipids, nucleotides, PEG as core-shell materials, respectively (Troiano et al. 
2014; Salgueiriño-Maceira et al. 2006; Majdalawieh et al. 2014).  
 
Figure 7-1 Schematic diagram of DOX adsorption on FM-ION-RS nanoparticles and FF-FM-
ION-RS nanocomposites 
Mai & Meng 2013 studied the safety related limitation of different nanomaterials. Bare 
Fe2O3 showed oxidative DNA damage, when systematically administered (Nemmar et al. 
2016). The particles size also played an important role in fate of Fe2O3, however small 
size of bare Fe2O3 have shown enhanced permeability and retention effect compared to 
micron-sized particles (Lee et al. 2014). Cytotoxicity based studies revealed the level of 
toxicity was dependent on the shape of different nanoparticles. Among these, the dendritic 
architect of nickel showed higher toxicity compared to spherical structures (Ispas et al. 
2009; Choi et al. 2009). Silver nanoparticles during cytotoxicity studies showed higher 
toxicity with rod-shaped nanoparticles compared to spherical nanoparticles (Stoehr et al. 
2011). After the engineering of nanoparticles, the nanoparticles could behave differently 
compared to the individual constituents of nanoparticles. The shape-dependent bare 
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magnetic nanoparticles cytotoxicity and drug loading and release studies have not been 
investigated so far.  
In this chapter, drug loading and release profile of bare and coated rod-shaped iron oxide 
materials will be studied.  The drug loading release profile was investigated of different 
ratios at different time intervals to find the role of shape and their effect on drug loading 
and release profile.       
7.2 Doxorubicin loading profile of bare and peptide coated rod-shaped 
iron oxide nanoparticles 
Doxorubicin (DOX) was used as a model therapeutic agent to study the loading and 
release profile of rod-shaped bare and peptide coated iron oxide materials. DOX solution 
was prepared 100 µg.mL-1 in DMSO-water. Then 1 mL of the drug was added to different 
ratios of SPIONs (1:25, 1:50, 1:75 and 1:100, respectively). Solution was vortex mixed 
and sonicated for 15 minutes in the ultrasonic bath. The UV-vis absorbance at λ485 nm of 
free drug was recorded at pre-set time intervals via magnetic separation (as discussed in 
B-SPION-SS). The DOX loading quantification was performed using equation 3-1 and 
3-2.  The amount of loaded drug was measured from preestablished standard calibration 
curves in DMSO-water. The calibration curve was prepared of different concentrations 
(20 1, 40, 60, 80 and 100 µg.mL-1). 
7.2.1 Doxorubicin loading into rod-shaped bare iron oxide nanoparticles 
The loading profile of rod-shaped iron oxide was studied in DMSO-water using different 
ratios (1:25, 1:50, 1:75 and 1:100 of DOX:FM-ION-RS). DOX loading capacity in weight 
percentage of rod-shaped iron oxide is shown in Table 7-1. The DOX loading capacity of 
FM-ION-RS for 1:25 was 34, 26 and 13 (micromole per milligram of FM-ION-RS) at 0 
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hours, 24 hours and 48 hours, respectively. The highest loading capacity in weight 
percentage was seen in 1:25 formulation over 48 hours. Similarly, as DOX: iron oxide 
ratio increased, the weight percentage loading capacity was found decreased with the 
consistent trend.     
Table 7-1 DOX -loading capacity of FM-ION-RS over pre-set time interval 
DOX:FM-ION-RS Time of incubation (hours) (micromole per 
milligram) 
(mass:mass) 0.25 24 48 
(1:25) 34 26 13 
(1:50) 16 33 21 
(1:75) 7 23 21 
(1:100) 3 16 15 
FF-FM-ION-RS    3 3 5 
 
Figure 7-2 displayed the time-dependent DOX loading efficiency of different 
formulations. The DOX loading efficiency of (1:25) formulation was nearly 38 % over 
48 hours at 18 °C, this reached to maximum after 24 hours, and up to 48 hours DOX 
started releasing again. This trend was found consistent in all formulations (1:50, 1:75 
and 1:100). However, the loading efficiency was increased in all formulations. The 
loading percentage was reached up to 93 % and 87 % in 1:75 and 1:100 formulations, 
respectively. The maximum percentage loading was seen after 24 hours for all 
formulations. Briefly, the percentage loading was achieved initially, as 37 %, 45, 28 % 
and 20 %, after 24 hours and reached to 47 %, 90 %, 92 % and 87 % and after 48 hours 
and again decreased to 35 %, 58 %, 86 % and 84 % for 1:25, 1:50, 1:75 and 1:100 
formulations, respectively.      
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Figure 7-2 DOX loading capacity of bare SPIONs spheres with reference to incubation time, 
DOX to SPIONs ratio (a) 1:25 (b) 1:50, (c) 1:75 and (d) 1:100 (±SD, no=3) 
7.2.2 Doxorubicin loading into peptide-coated rod-shaped iron oxide 
particles  
The FM-ION-RS Fe2O3 (maghemite) showed good magnetic separation after coating. The 
1:100 formulation was used for drug loading and release experiments. In addition, time-
dependent studies were performed as discussed earlier at 18 °C up to 48 hours.   
The FF-FM-ION-RS showed 31 % loading after 48 hours at 18 °C. This was followed 
via slowly increasing from 17 % (0 hours) to 30 % (after 24 hours) (figure 7-3). After 24 
hours to 48 hours, only 1 % increase was observed. The FF-FM-ION-RS showed lowest 
DOX loading capacity compared to bare iron oxide nanoparticles 31 % and 87 %, 
respectively. 56 % decrease in DOX loading was found in FF-FM-ION-RS 
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nanocomposites. Samples were vortex mixed and sonicated before recording the first 
reading at 0 hours. The maximum time of DOX loading was 24 hours and 48 hours for 
FM-ION-RS nanoparticles and FF-FN-ION-RS nanocomposites, respectively.    
 
Figure 7-3 DOX loading profile of FF-FM-ION-RS at different time intervals (hours) in 
incubation at 18 °C (±SD, no=3) 
7.3 Doxorubicin release profile of bare and peptide coated rod-shaped 
iron oxide nanoparticles 
FM-ION-RS nanoparticles and FF-FM-ION-RS nanocomposites after incorporating 
DOX were dispersed in 1 mL of PBS buffer of pH 7.4 at 37 °C in end-over-end rotation 
in an incubator up to 48 hours. Free DOX solution of different concentrations (20, 40, 60, 
80, and 100 µg.mL-1) was also prepared in PBS for standard calibration curve to quantify 
the DOX released from particles (figure 7-4). The release behaviour was investigated in 
a time-dependent manner at 37 °C of incubation. The absorbance of free DOX was 
recorded at λ485 nm.  
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7.3.1 DOX release behaviour from rod-shaped bare iron oxide nanoparticles   
The DOX-loaded FM-ION-RS nanoparticles were magnetically separated from the free 
drug. The absorbance reading of free drug was recorded at pre-set time intervals of 
different formulations. Figure 7-4 displayed, the drug release behaviour of the FM-ION-
RS nanoparticles at 37 °C up to 48 hours for different formulations (1:25, 1:50, 1:75 and 
1:100). DOX-loaded FM-ION-RS nanoparticles showed slow and homogenous release. 
The total drug was released in 24 hours. Interestingly, The Free DOX was again adsorbed 
on the surface of magnetite after 24 hours. After 12 hours approximately 90 % of total 
drug was released from FM-ION-RS nanoparticles. The final DOX release after 48 hours 
was somewhat similar to the amount of DOX released after 12 hours particularly in 1:25 
and 1:50 formulations.      
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Figure 7-4 DOX release profile of FM-ION-RS with reference to incubation time, DOX to FM-
ION-RS ratio (a) 1:25 (b) 1:50, (c) 1:75 and (d) 1:100, respectively (±SD, no=3) 
In zero hour time after sonication and vortex mixing, approximately 38 %, 23 %, 20 % 
and 21 % DOX release (as burst effect) was seen for (1:25, 1:50, 1:75 and 1:100, 
respectively) formulations. The release trend was consistent up to 6 hours in all 
formulations. In 1:25 and 1:50 formulations, the maximum release was found after 12 
hours of incubation at 37 °C. DOX release was reached at maximum after 6 hours for 
1:75 formulations. Similar trend of DOX release was observed in 1:100 formulations. B-
SPION-SS showed burst release, which possibly was due to lower loading capacity of 
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FM-ION-RS nanoparticles. However, the DOX possibly be adsorbed on the surface of 
rods similarly as in the case of B-SPION-SS.  
7.3.2 Doxorubicin release behaviour of rod-shaped peptide-coated iron oxide 
nanoparticles      
Tubular diphenylalanine peptide (FF) was coated to rod-shaped bare iron oxide (FM-
ION-RS to enhance the sutained release of DOX, increased biocompatibility and reduced 
aggregation. The coatings on the FM-ION-RS nanoparticles form a barrier facilitating the 
slow release of DOX. The shape of particles had significant influence on the releasing 
behaviour of cargo. DOX-loaded FF-FM-ION-RS nanocomposites were incubated at 37 
°C up to 48 hours, to study the release behaviour in PBS (pH 7.4). The time-dependent 
release behaviour was monitored by recording the UV-vis absorbance at λ485 nm at pre-
set time intervals during 48 hours of incubation. The slow release pattern was seen in 
initial 12 hours then in next 12 hours; it reached to a maximum release (100 %) (figure 7-
5). This unusual behaviour of DOX release from FF-FM-ION-RS core-shells 
nanocomposites were found possibly due to the interactions of peptide tubes with DOX. 
In general, it was clear that FF-FM-ION-RS could be used to slow the burst release effect 
of DOX after optimising the peptide DOX interactions.       
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Figure 7-5 DOX release profile of FF-FM-ION-RS nanocomposites at different time intervals 
(±SD, no=3) 
Figure 7-5 showed the release behaviour of FF-FM-ION-RS; the release behaviour was 
found increasing after 6 hours, 12 hours and 24 hours (40 %, 49 % and 99 %, 
respectively). The graph curve revealed the total release of DOX went to plateau after 24 
hours to 48 hours. The physically adsorbed molecules without layers of coatings could be 
release in a burst effect; the peptide layer has influenced the burst release by slowing 
down the pattern of release up to 24 hours. The slow DOX release could be due to the 
weakening of hydrophobic and ionic interactions of DOX and peptide phenylalanine rings 
and ionic charge of iron oxide. Hence time in losing of these interactions facilitate the 
slow release and steady release.  
The mechanism of DOX release from its carriers was fundamental to understand how the 
drug releases from surface or layers of coatings. The binding with the carrier will be too 
strong to leak drug, however weak binding is not suitable for sustainable release. This 
study has provided the simple kinetics of loading and release behaviour of DOX to bare, 
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and peptide coated iron oxide nanoparticles. Studies performed on gold nanorods coated 
with CTAB layers showed incorporation of small molecules on the gold surface under a 
thick layer of CTAB (Alkilany et al. 2008). The results suggested that in nM 
concentration of gold particle could adsorb the µM concentration of drugs. Meanwhile, 
drug incorporation to gold rods was dependent on length of nanorods. Their data revealed 
the incorporation of drug molecules in the layer of metallic particles (Alkilany et al. 
2008). The studies on releasing behaviour of drugs from the coated magnetic materials 
are still in initial phase. However, these rod-shaped base materials for drug delivery 
applications are still in initial phases.  
The solvent effect of drug release with similar poly(lactic-co-glycolic acid) sphere was 
also studied (Huang & Brazel 2001), where they have used double emulsion solvent 
system using fluorescence tagged drug. The hydrophobic polymer lowered the inner 
hydrophobic phase volume, which could avoid the uneven distribution of small 
molecules, causing the burst release. Polymers, where drug distributed non-uniformly in 
matrices, the release rate could be increased due to the higher diffusion distances that 
cause the hindrances (Lee 1984; Machín et al. 2013). The non-uniform distributed drug 
in the polymer matrices improved the sustained release, where higher loading could 
attribute to the central part of the carriers (Lee 1984). The sustained release could also be 
improved by increasing the concentration gradient. The researchers also have focused on 
the designing of non-uniform distribution of drugs to achieve a zero-order release, where 
they use multi-laminae polymers (Zhao et al. 2015).    
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7.4 Conclusions         
In this work, novel magnetically targeting nanocarriers were prepared with possibilities 
of improved controlled release mechanism for drug delivery. FM-ION-RS and FF-FM-
ION-RS nanocomposites were loaded with DOX.  
The ferromagnetic rod-shaped nanoparticles DOX release was found in burst effect 
manner. Almost 90 % of total DOX loaded was release after 12 hours of incubation in 
PBS at 37 °C.   The peptide-coated materials released the DOX in a sustainable manner, 
where DOX release was found similar in initial 12 hours of incubation. These rod-shaped 
core-shell structures showed sustained DOX release and can be used as thermally 
responsive stimuli material for controlled and magnetic field triggered release.  
Though the coated magnetic particles have reduced the burst effect up to 12 hours, the 
actual mechanism of drug incorporation into core-shells is still unclear. However, in some 
biomedical applications burst release is ideal as long as burst effect is clearly expected. 
The complete removal of burst release is possibly a cost prohibitive, but these results 
could provide the base to enhance the understanding of nanocarriers designs, which 
precisely predict the sustained and control release pattern of drugs based on shape of 
magnetic nanoparticles.  
Moreover, amino and carboxyl groups of the peptide can open the ways for surface 
modifications to attach antibodies for active targeting or subcellular signals for enhanced 
permeability into the targeted cells. The coating could provide better biocompatibility 
more efficiency for sustained release of drug molecules. These multifunctional materials 
could be a base to explore the new horizons for magnetic field targeted for drug delivery 
system to overcome the current limitations.     
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    CHAPTER EIGHT 
8 Magnetic field induced hyperthermia and triggered drug 
release of magnetic nanoparticles  
8.1 Introduction  
Iron oxide nanoparticles have been used as MRI contrast enhancers, hyperthermia 
ablation, drug carriers and targeting materials for diseased tissues using an external 
magnetic field. Magnetic nanoparticles have been investigated as promising tools for 
hyperthermia treatment in cancerous tissues in vitro studies and animal models. The 
initials positive results of magnetic nanoparticles induced hyperthermia have provided 
the impetus for the Phase-I human experiments (Shevtsov & Multhoff 2016). In 
hyperthermia, body temperature was increased to change the structural characteristics of 
cellular functions. In localised hyperthermia treatment the temperature may rise up to 42 
°C; tumour cells do not resist this temperature with sudden changes compared to normal 
cells leading to tumour cells destruction (Cavaliere et al. 1967). The change in the 
temperature alters the structure-function relationship of enzymes and proteins, causing 
cell apoptosis via deregulating the cell growth and differentiation (Sellins & Cohen 1991). 
Hyperthermia triggered alteration of cell membranes caused changes in the transporting 
mechanism of membrane permeability. Cellular studies demonstrated the sudden increase 
in the temperature altered the synthesis and structural conformational of nucleic acids 
also inhibited DNA repair enzymes (Paolini et al. 2015; Wong et al. 1993). The induction 
of hyperthermia can be achieved via numerous techniques, such as microwave or 
electromagnetic radiations (Stahl et al. 1995; Sneed et al. 1998), focused high ultrasound 
waves (Mitsumori et al. 1996) or electrical energy (Wismeth et al. 2010). Even though 
these techniques generate sufficient heat however they failed to provide uniform 
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distribution and deep penetration of heat for therapeutic applications in tumours sites. 
Hence, insufficient or nonhomogeneous distribution of heat in tumour sites causes a 
temperature rise in only surface sites. Another important factor is excessive and 
uncontrolled heat induction that causes the peritumoral cell damage. Nanoparticles 
induced magnetic hyperthermia has somewhat addressed these issues.  
Magnetic induced hyperthermia applications were initially reported in Gilchrist et al. 
(1957). A series of research papers were published for studying the potential application 
as hyperthermia ablation therapy. However, consistent studies for therapeutic based 
applications were published after the 1990s. Still fewer studies are available in animal 
models (Hoopes et al. 2015; Thiesen & Jordan 2008; Attaluri et al. 2015). More studies 
are needed to adress the limitations, toxicity, selectivity and efficiency for effective and 
safe treatment of tumours. The mechanism of magnetic hyperthermia involves the 
systematic administration of magnetic materials. After applied external magnetic field 
magnetic materials can increase temperature in targeted region (Kashevsky et al. 2015). 
Currently, magnetic hyperthermia stands for the non-invasive, effective and comparable 
uniform and deeply penetrating technique for regions where accessibility is limited, 
specific to targeted regions and have enhanced rate of heat transfer.  
Magnetic hyperthermia efficiency depends on the various properties of nanoparticles such 
as size, shape, saturation magnetisation value and Curie point (Tc). Curie point is critical 
which provides the control of heat transfer to avoid excess heating (Tang et al. 2017). 
Another important factor for controlling the desired temperature is the tunable strength 
and frequency of the magnetic field. The efficiency of induced heat of magnetic materials 
was measured as the specific absorption rate (SAR). SAR reflects the heat transformation 
from magnetic energy, which is characteristic of Brownian rotation and Nėel relaxation 
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phenomenon. In Brownian rotation, the particles rotate physically within the dispersion 
medium. In Nėel relaxation mechanism, particle`s magnetic moment at atomic level 
rotates within the particles. The Brownian rotation and Nėel rotation processes are 
revealed as relaxation times (TB and TN) respectively. In hyperthermia studies, SAR 
values are dependent on the particles internal (Nėel) characteristics such as (size, shape, 
elemental composition, functional modifications and additives) and the external 
(Brownian) characteristics reflect the strength (H) and frequency of the magnetic field. 
The following equation can define the SAR:  
𝑆𝐴𝑅 =
𝑐
𝑀mnp
(
𝛥𝑇
𝛥𝑡
)                                   Equation 8-1 
where c is specific heat capacity of the medium and 
𝛥𝑇
𝛥𝑡
 reflects the initial slope of 
temperature change during the heat induction and Mmnp is mass of nanoparticles (mg) 
(Hervault & Thanh 2014).  
The initial study of magnetic hyperthermia based treatment in vivo was performed using 
dextran-coated SPIONs with a core size of approximately 3 nm (Jordan et al. 1997). 
Dextran coated SPIONs were systematically administered into tumour tissues and 
subsequently the magnetic field was applied. Applied magnetic fields frequency and 
strength, tissues selection and conductivity should be taken into consideration to avoid 
possible harmful effects. The magnetic field frequency of 0.1-1.5 MHz and 0-17 kA.m-1 
strength is considered safe for in vivo application (Schmid 2011). A variety of trials have 
been conducted by different companies such as MagForce Nanotechnologies (Germany) 
and NanoTherm (UK), showing the efficiencies of magnetic hyperthermia based 
treatments of localised solid tumours by reducing the discomfort or harms to normal cells 
(Maier-Hauff et al. 2011). This treatment involved killing cells using induction heating. 
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Heating was generated by SPIONs via Brownian rotation or Nėel relaxation on 
subsequent applied magnetic field. This mechanism comprises of different modules; 
SPIONs, magnetic field and incorporated drugs. Due to the SPIONs ultra-small size and 
exposure to the applied magnetic field, they are localised inside the tumours and generate 
concentrated and uniform heat in selected sites (figure 8-1)                
 
Figure 8-1 Depiction of localised magnetic field triggered nanoparticles thermo-chemotherapy 
This research work was derived from the concept of engineering of hyperthermia-
responsive peptide coated drug loaded iron oxide nanoparticles, which can increase the 
internal temperature when exposed to external magnetic field and trigger drug release. 
This study has investigated the effects of different iron oxide nanoparticle concentration 
on the hyperthermia of bare and peptide-coated particles. The magnetic field triggered 
drug release system may provide an ideal system in cancer treatment by simultaneously 
exploiting both chemotherapy and hyperthermia ablation therapy (figure 8-1).  
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8.2 Magnetic nanoparticles induced hyperthermia  
8.2.1 Magnetic field induced hyperthermia of spherical bare 
superparamagnetic iron oxide nanoparticles    
Spherical iron oxide nanoparticles synthesised via co-precipitation method were studied 
to investigate the concentration effects in water. Four different concentrations (2.5 
mg.mL-1, 5 mg.mL-1, 7.5 mg.mL-1 and 10 mg.mL-1) were used. Magnetic field with a 
frequency of 406 kHz and strength of 200 G was kept constant in all of the experiments. 
Spherical core materials (B-SPION-SS) of different concentrations from 2.5 mg.mL-1 to 
10 mg.mL-1 showed slowest and fastest induced heating rate, respectively upon exposure 
to the alternate magnetic field (figure 8-2). The results of magnetic field induced 
hyperthermia were highly concentration dependent. The 2.5 mg.mL-1 showed slowest 
temperature increase and reached 42 °C in 20 minutes of exposure to the AC magnetic 
field. In the 5 mg.mL-1 solution the temperature was increased sharply compared to 2.5 
mg.mL-1. It reached 50 °C in approximately 10 minutes. Similarly, 7.5 mg.mL-1 took only 
4 minutes to achieve 50 °C. The fastest heating pattern was seen for 10 mg.mL-1 of B-
SPION-SS taking only 3.5 minutes to reach 50 °C. These results were consistent with 
previous studies (Frimpong et al. 2010; Ghosh et al. 2011), where they found a sharp 
increase in the temperature using constant magnetic field strength and frequency. The 
mechanism of heat induction from synthesised nanoparticles could be due to the 
Brownian rotation and Nėel relaxation of Fe3O4 nature of the nanoparticles with low 
conductivity (ρ = 102 Ω cm, resistivity), hence Eddy current heat induction may be 
negligible (Ghosh et al. 2011). VSM and XRD data also confirmed the superparamagnetic 
nature of the nanoparticles, the heat induction from hysteresis loss may also be negligible. 
The main source of heat induction will only be contributed to the Brownian rotation or 
Nėel relaxation.  
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Figure 8-2 B-SPION-SS temperature increase curves after exposure to AC magnetic field on (a) 
2.5 mg.mL-1, (b) 5 mg.mL-1, (c) 7.5 mg.mL-1 and (d) 10 mg.mL-1 (graphs are representative of 
three independent experiments) 
 The specific absorption rate (SAR) was measured using equation 8-1. For all studies 
(figure 8-2 (a –d)), initial slope 
𝛥𝑇
𝛥𝑡
 was calculated from first minute of applied magnetic 
field. The calculated SAR values are shown in table 8-1 for all concentrations. The highest 
SAR value (63 W.g-1) was found for the 2.5 mg.mL-1 with the magnetic field strength and 
frequency. However, this value was higher compared to previous study (Ma et al. 2004), 
where the sized dependent effect of SAR calculation was studied. For iron oxide with size 
of approximately 20 nm, SAR value was 40 W.g-1. In a similar SPIONs size distribution 
of as this study the SAR value was 63 W.g-1. The minimum SAR value found in this study 
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was 22 W.g-1. These results were consistent with previous studies (Zhang et al. 2007; 
Müller et al. 2005; Behdadfar et al. 2012; Frimpong et al. 2010).               
Table 8-1 Experimental SAR values calculated for spherical iron oxide nanoparticle  
Concentration (mg.mL-1) SAR (W.g-1) 
2.5 63 
5 36 
7.5 30 
10 22 
BOC-SPION-SS 78 
 
The kinetic studies on the effects of temperature showed a sharp increase for higher 
concentrations. The SAR values were in reverse in order to the concentration. The highest 
SAR value was obtained for lowest concentration. The possible reason behind the fast 
increase of temperature and lower SAR value is the retention of the particles Brownian 
and relaxation effect in lower concentrations. Higher concentrations of B-SPION-SS 
facilitated the formation of large aggregates. Other studies confirmed the good 
dispersions of B-SPION-SS showing higher SAR value via better Brownian rotation and 
Nėel relaxation effects (Rao 2014; Pawar 2013). The 5-10 mg.mL-1 of B-SPION-SS were 
found to be effective and safe for hyperthermia treatment of tumour tissues (Dobson 
2003). Figure 8-2 (a-d) showed concentration-dependent heat induction of B-SPION-SS 
where the temperatures were set in between the minimum of 42 °C and a maximum of 55 
°C in water as a medium of dispersion. These results confirmed that the concentration 
from 2.5 mg.mL-1 to 10 mg.mL-1 could increase the temperature 42 °C – 55 °C using 406 
kHz frequency and 200 G. Table 8-1 shows the SAR values as a function of the 
concentration of B-SPION-SS. The SAR results obtained in this study are comparable to 
computer simulated SAR values, where SAR values were found higher in lower 
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concentration (Salon 2012). This was also common for lower concentration, where 
particles in suspension were expected as individuals rather than as aggregates after the 
application of a magnetic field. However, larger aggregates tend to sediment and less 
exposed to the magnetic field. In a similar study, where SAR was calculated using 
different volume vials showed lower volume vials have three times higher SAR values 
than the value obtained with larger volume vials (Salon 2012). This difference may be 
attributed to exposure of applied magnetic field to individual nanoparticles in a 
suspension.  
8.2.2 Magnetic field induced hyperthermia of silica-coated iron oxide 
nanoparticles  
Figure 8-3 revealed the silica-coated magnetic nanoparticles (Si-SPION-SS) induced 
heating curves of four concentrations in water of 2.5 mg.mL-1, 5 mg.mL-1, 7.5 mg.mL-1 
and 10 mg.mL-1 using a frequency of 406 kHz and a magnetic field strength of 200 G. 
The higher concentration of silica-coated iron oxide nanoparticles showed a sharp 
increase and higher maximum temperature compared to lower concentrations. Each 
formulation reached a plateau temperature within 25 minutes of exposure of magnetic 
field. In 2.5 mg.mL-1, the graph did not display the temperature increase in the first 4-5 
minutes. This time possibly indicates a lag phase where Si-SPION-SS heating occurs 
firstly in the cores and then dissipates to the shell and finally to the medium, where 
temperature probe was attached. After this time, heating could be seen clearly, requiring 
23 minutes to raise 5 °C (figure 8-3 a). In figure 8-3 (c-d) heating curves (5 mg.mL-1 – 10 
mg.mL-1) showed the sharp temperature increase from the first minute of exposure of the 
magnetic field, however, in first four minutes, the heating trend was somewhat slower 
than in later time up to 20 or 23 minutes. This trend also confirmed the presence of 
coating, where initial heat dissipation occurred in shell than it transferred to medium, 
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where temperature probe was located. 5 mg.mL-1 solutions took 23 minutes to raise 9 °C 
reaching 37 °C (figure 8-3 (b)). Higher concentration of 7.5 mg.mL-1 showed an increase 
in the temperature up to 43 °C by raising 15 °C in 20 minutes (figure 8-3 c). However, 
the fastest and maximum heat induction was seen for 10 mg.mL-1 concentration, where a 
maximum temperature was observed at 46 °C by raising 18 °C, over exposure of 20 
minutes magnetic field (figure 8-3 (d)).              
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Figure 8-3 Si-SPION-SS hyperthermia effect after exposure to AC magnetic field (a) 2.5 
mg.mL-1 (b) 5 mg.ml-1, (c) 7.5 mg.mL-1 and (d) 10 mg.mL-1 (graphs are representative of three 
independent experiments) 
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Table 8-2 Experimental SAR values calculated for spherical silica coated iron oxide 
nanoparticle  
Concentration (mg.mL-1)  SAR (W.g-1) 
2.5 131 
5 117 
7.5 54 
10 30 
BOC-Si-SPION-SS 39 
 
8.2.3 Magnetic field induced hyperthermia of peptide-coated iron oxide and 
peptide-capped silica-coated iron oxide nanoparticles   
The experimental heating ability of peptide coated iron oxide nanocomposites (BOC-
SPION-SS) and peptide-capped silica-coated iron oxide nanocomposites (BOC-Si-
SPION-SS) is shown in figures 8-4 (a) and (b) respectively. Hyperthermia induction 
graph trend showed that the temperature increased, where peptide coated iron oxide 
nanoparticles increased the temperature up to 39 °C, over 10 minutes of exposure of 
magnetic field (figure 8-4 a). BOC-Si-SPION-SS nanocomposites could raise the 
temperature by 5 °C reaching 32 °C in 20 minutes (figure 8-4 (b)). Pure peptide on 
exposure to magnetic field curve is shown in figure 8-5. In both formulations, BOC-
SPION-SS nanocomposites and BOC-Si-SPION-SS nanocomposites, temperature 
changes were altered significantly, it is possibly due to the presence of different layers on 
magnetic cores. This also confirmed the deposition of relatively thick layers on the core 
magnetite, which affected the Brownian rotation and Nėel relaxation behaviour of 
SPIONs. This assumption was supported by the size distribution variation of B-SPION-
SS, BOC-SPION-SS and BOC-Si-SPION-SS. Hyperthermia induction of SPIONs under 
magnetic field in composites could also be a consequence of hysteresis loss, physical 
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rotation via Brownian relaxation inside the medium and magnetic moment inside the 
particles overcoming the energy barrier (Allam et al. 2013).                  
 
Figure 8-4 Magnetic field induced heating behaviour of (a) BOC-SPION-SS and (b) BOC-Si-
SPION-SS nanocomposites (graphs are representative of three independent experiments) 
 
Figure 8-5 Applied magnetic field to BOC-FF spheres (graph is representative of three 
independent experiments) 
 
  
184 
 
8.2.4 Magnetic field induced hyperthermia of bare rod-shaped iron oxide 
nanoparticles 
The shape of SPIONs is an important factor effecting the magnetic capabilities and 
hyperthermia response. B-SPION-SS were synthesised via the co-precipitation of iron 
(II), and iron (III) method. This method is simpler with less complications and better 
magnetic capabilities. The Rod-shaped iron oxide nanoparticles (FM-ION-RS) prepared 
using ferrous sulphate as iron source method showed elongated structures. Magnetic 
measurement revealed non-superparamagnetic behaviour. Hyperthermia performance 
was investigated following the similar procedure as discussed earlier. Figure 8-6 showed 
the heating behaviour at different concentration of FM-ION-RS nanoparticles using 
consistent magnetic field strength 200 G and frequency 406 kHz. FM-ION-RS 
nanoparticles showed less heating effect compared to the B-SPION-SS for concentrations 
studied (2.5 mg.mL-1, 5 mg.mL-1, 7.5 mg.mL-1 and 10 mg.mL-1). The maximum and fast 
heat generation was found in B-SPION-SS when temperature was raised to 50 °C in 2.5 
minutes. The FM-ION-RS nanoparticles took 20 minutes to reach 45 °C. The difference 
in the heating behaviour of both materials may be explained by using the total surface to 
volume ratio of both shapes since the thermal response represents the unit of heat 
induction of source (heating materials) and unit of the surface to volume ratio (Taloub et 
al. 2016). The heat distribution of FM-ION-RS nanoparticles was related to the 
concentration in dispersion, which is a similar trend seen in the case of spherical SPIONs. 
The total temperature increase for 2.5 mg.mL-1 was nearly 2 °C, over 23 minutes of 
magnetic field exposure. The similar trend obtained in the case of 5 mg.mL-1 and 7.5 
mg.mL-1, however, temperature change was seen 4 °C and 7 °C, respectively over the 
same period of exposure to the magnetic field. Rod-shaped morphologies have a lower 
surface to volume ratio (as discussed in BET section) compared to spherical SPIONs, 
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which reflects the smaller number of disordered spins with low energy. However, spheres 
have more ordered spins (Noh et al. 2012). The morphological effect on hyperthermia 
was further confirmed, when the chemical composition was optimised to develop 
enhanced hyperthermia effect using zinc iron oxide nanoparticles of cubic and spherical 
shapes (Bauer et al. 2016).      
 
Figure 8-6 FM-ION-RS nanoparticles induced hyperthermia after exposure to applied magnetic 
field (a) 2.5 mg.mL-1 (b) 5 mg.ml-1, (c) 7.5 mg.mL-1 and (d) 10 mg.mL-1 (graphs are 
representative of three independent experiments) 
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SAR values of rod-shaped iron oxide nanoparticles showed a linear relationship with 
increasing concentration (Table 8-3).  The trend was consistent with spherical 
morphologies; however, the heating effect was completely different. The heating effect 
was originating from the Brownian rotation and Nėel relaxation mechanism of 
nanoparticles. This could be attributed to the changes in the alignment of the domains of 
easy axis and magnetic field. Both can influence their alignment resulting in different 
heating performances (Simeonidis et al. 2016). The non-linear heating trend of SAR 
needs more angular based studies. Generally, in both morphologies heating was common, 
however the amount and speed of heating were significantly different. Rod-shaped iron 
oxide has shown hysteresis loss hence they have different magnetisation reversal on 
exposure of magnetic field compared to spherical. Additionally, the difference in reaching 
adjacent energy level may be due the energy barrier in hyperthermia induction (Yanes et 
al. 2007). 
Table 8-3 Experimental SAR values calculated for FM-ION-RS nanoparticle  
Concentration (mg.mL-1)  SAR (W.g-1) 
2.5 10 
5 1.15 
7.5 2.3 
10 2.1 
 
 The applied magnetic field strength and frequency were similar in all hyperthermia 
experiment performed in this study. Hence, the chances for magnetic field strength or 
frequency could effect on the heating behaviour were negligible. Other factors can trigger 
the reorientation to a complete reversal should be taken into consideration, however, these 
are out of the scope of this work.  
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8.2.5 Magnetic field induced hyperthermia of peptide-coated rod-shaped 
iron oxide nanoparticles                  
The peptide coated iron oxide (FF-FM-ION-RS) nanoparticles induced hyperthermia 
capability was investigated using frequency of 406 kHz and magnetic strength field of 
200 G. Briefly, 1 mL of the sample in a vial attached to the temperature probe was placed 
in designed space between iron cores. The cuvette surrounded the insulating chamber in 
order to avoid heat transfer. Temperature of the electromagnets was controlled using 
circulating tap water. Hyperthermia ability of sample was studied for 10 mg.mL-1 in 
ethanol-water. The data was recorded as temperature versus time using applied magnetic 
field and at regular steps for up to 23 minutes. Figure 8-7 displays the temperature 
recorded against time of exposure to the external magnetic field for peptide-coated iron 
oxide rods. Figure 8-7 reflected the zero temperature changes after the coating. The curve 
was similar to that obtained for the pure peptide (figure 8-5).  
 
Figure 8-7 Heating behaviour of FF-FM-ION-RS nanocomposites over exposure to AC 
magnetic field (graph is representative of three independent experiments) 
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8.3 Magnetic field triggered drug release of spherical magnetic 
nanoparticles  
8.3.1 Bare superparamagnetic iron oxide nanoparticles and peptide-coated 
superparamagnetic iron oxide nanoparticles  
DOX was loaded into the B-SPION-SS to investigate magnetic field triggered release 
properties. DOX was loaded into B-SPION-SS and BOC-SPION-SS, where SPIONs 
cores induced hyperthermia via Brownian rotation and Nėel relaxation mechanism. DOX-
loaded nanoparticles solution was placed in between the magnetic field coils; thermal 
insulation jacket was used to reduce the effects of the surrounded temperature. 
Additionally, water circulation was used to control environmental and thermal effect of 
the coils. The magnetic field strength and frequency were set 200 G and 406 kHz, 
respectively for all the experiments conducted. The colour of DOX was seen clearly after 
release experiments as free DOX after exposure of applied magnetic field. Figure 8-8 
showed the DOX release behaviour under applied magnetic field and without the 
magnetic field. The release values were dependent on B-SPION-SS concentration; this 
was possibly due to the higher heating influence of B-SPION-SS, a similar pattern was 
also reported in Bi et al. 2016. Figure 8-8 demonstrated different concentrations of 2.5 
mg.mL-1, 5 mg.mL-1, 7.5 mg.mL-1 and 10 mg.mL-1 used to investigate the release 
behaviour. In case of BOC-SPION-SS and BOC-Si-SPION-SS, the concentration was 
kept at 5 mg.mL-1. All experiments were repeated at least three times. The release 
percentage reached up to 60 % for 10 mg.mL-1. The presence of greater amount of 
particles induces more and rapid heat, which ultimately enhances the DOX release. The 
effect of BOC-SPION-SS displayed relatively lower DOX release compared to B-
SPION-SS of the same concentration.             
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Figure 8-8 Magnetic field triggered drug release from B-SPION-SS without magnetic field 
exposure (black dots) and applied magnetic field (grey lines) (±SD, no=3) 
8.3.2 Silica-coated superparamagnetic iron oxide nanoparticles and peptide-
capped silica-coated superparamagnetic iron oxide nanoparticles 
Silica-coated SPIONs (Si-SPION-SS) and peptide-capped silica-coated SPIONs (BOC-
Si-SPION-SS) DOX release behaviour was investigated in presence and absence of 
magnetic field. Figure 8-9 showed increase trend of DOX release after exposure of 
magnetic field in all samples. This release behaviour was in good agreement with 
previously published studies for poly(trimethylene carbonate) poly(l-glutamate) coated 
SPIONs (Sanson et al. 2011), , poly(propyl acrylamide) coated SPIONs (Thévenot et al. 
2013), PEG-capped silica coated SPIONs (Saint-Cricq et al. 2015) and bare SPIONs 
(Oliveira et al. 2013). In all of the above studies, different polymer coated SPIONs could 
increase the drug releasing efficiency up to two-fold on applied magnetic field strength 
(figure 8-10). As shown in the figure 8-9 in lower concentrations 2.5 mg.mL-1, 5 mg.mL-
1 and 7.5 mg.mL-1, the release behaviour was reduced possibly reflecting the sustained 
release of drug from mesoporous silica shell.        
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Figure 8-9 Magnetic field triggered drug release Si-SPION-SS (a) 2.5 mg.mL-1 (b) 5 mg.mL-1, 
(c) 7.5 mg.mL-1 and (d) 10 mg.mL-1 without magnetic field exposure (black) and applied 
magnetic field (grey) (±SD, no=3) 
8.3.3 Magnetic field triggered drug from rod-shaped iron oxide and peptide 
coated iron oxide nanoparticles 
In vitro DOX release from loaded rod-shaped magnetic nanoparticles (FM-ION-RS) was 
studied using magnetic field strength (200 G) and frequency (406 kHz) depicted in figure 
8-10. Low DOX release profile was obtained for all elongated structures compared to 
spherical samples.  Figure 8-10 showed bare rod-shaped iron oxide of 7.5 mg.mL-1 and 
10 mg.mL-1 magnetic field triggered drug release behaviour. However, for lower 
concentrations 2.5 mg.mL-1 and 5 mg.mL-1 magnetic field triggered DOX release effect 
was not found. Similar results were also found for FF-FM-ION-RS, where applied 
magnetic field could not trigger the DOX release. Taking into consideration of magnetic 
properties, these materials are multi-domain particles having considerable hysteresis. As 
a result, their hyperthermia ability was compromised as shown in figure 8-5. Due to lower 
heat of induction, these materials could not trigger the DOX release.            
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Figure 8-10 Magnetic field triggered drug release from FM-ION-RS without exposure to 
magnetic field (black dots) and with applied magnetic field (grey lines) (±SD, no=3) 
All core-shell structures suspensions were also heated to confirm the breakage of peptide 
from SPIONs. Simply, 15 mL of particles suspension in a beaker was heated on heating 
plates. The temperature was checked by coupling thermometer and then supernatant 
sample, cleaved from magnetic materials was taken for SEM images to confirm the 
presence of free peptide structures.  
To achieve a better response from the magnetic field ideally nanoparticles should have a 
larger magnetic moment. FM-ION-RS nanoparticles which undergo non-coherent reverse 
phenomenon could not be an ideal source for hyperthermia (Ivanov et al. 2013). For ideal 
hyperthermia effect the magnetic materials possess some properties such as single domain 
magnetic moment, higher surface to volume ratio and coherent reverse path. The B-
SPION-SS showed enhanced and sharp heating ability than rods. For rods, wire or 
elongated materials the energy loss was higher as already reported (Dutz & Hergt 2014). 
Thus, elongated structures showed lower heating ability whereas spherical structures 
were found promising for magnetic hyperthermia.   
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8.4 Conclusions 
This study demonstrates the heating abilities of bare spherical SPIONs and rod-shaped 
iron oxide nanoparticles. Spherical superparamagnetic particles synthesised via iron (II) 
and (III) co-precipitation method have shown good hyperthermia ability on exposure of 
magnetic field by increasing the temperature up to 50 °C in 3.5 minutes. Rod-shaped iron 
oxide nanoparticles induce heat up to 42 °C approximately in 23 minutes on exposure to 
similar magnetic field. This chapter also showed peptide coating on magnetic materials 
can control the heating of magnetic materials. Currently, the applications of bare magnetic 
materials are limited, due to their high amount of direct heat induction to targeted sites. 
This study provides the strategy that DOX-loaded peptide-coated SPIONs can be 
triggered by applying a magnetic field to achieve better control release. Spherical iron 
oxide increased the DOX release up to 65 % over exposure of magnetic field where 
without application magnetic field DOX was 10 % released. In silica-coated SPIONs up 
to 32 % DOX was released with magnetic field while without magnetic field it was only 
19 %. The magnetic field can also be tuned according to the requirement of temperature, 
location and amount of cargo release. These results suggesting the peptide coated SPIONs 
could be a better alternative for triggered and controlled release drug delivery system with 
dual thermos-chemotherapy action along MRI contrast capability.        
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CHAPTER NINE  
9 Conclusions and future work 
9.1 Conclusions  
Spherical and rod-shaped shaped core-shell nanocomposites have been synthesised using 
template-mediated coating of silica and peptide shells. Spherical SPIONs cores (B-
SPION-SS) of approximately 10-35 nm were synthesised via co-precipitation of iron (II) 
and iron (III) chloride. A novel method was used to prepare Rod-shape iron oxide 
nanoparticles cores (FM-ION-RS), which was comparably simple, cost effective from 
iron (II) sulphate. This method yields nanoparticles with 10 nm in width. Spherical 
peptide nanoparticles were prepared using BOC-FF in ethanol-water (1:1) with average 
size up to 1 µm in diameter. Tubular peptide nanoparticles were prepared using FF in 
ethanol-water (1:1) with 300 nm to 1 µm in width and several micrometres in length. 
After detailed characterisation of individual components and method optimisation, 
several fundamental factors influencing the self-assemblies were investigated. These 
factors included solvent effect, concentration effect, template mediation and one-pot 
fabrication.   
These two shaped magnetic nanostructures were used as cores for further silica and/or 
peptide shell coating. Encapsulated iron oxide cores in self-assembling peptides were 
prepared by seeding cores in a peptide solution via vortex mixing and ultra-sonication 
combination. Possibly peptide achieved the encapsulation affinity via carboxyl and iron 
ions interactions on core material where peptide self-assembled around the magnetite 
cores.  
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The peptide coated iron oxide (BOC-SPION-SS and FF-FM-ION-RS) nanocomposites 
were used for drug loading and release studies for controlled release drug delivery system. 
Several drug delivery systems were known for controlled release in cancer treatment. 
Some of them could have stimuli-response, while most of them lacked the target 
specificity. Other delivery systems that can externally directed to targeted sites but had 
zero release ability. Hence, by firstly coating the spheres using mesoporous silica the drug 
could be stored up to 90 % in 6 hours of incubation. These could be directed to target sites 
via applied external magnetic field, due to presence of iron oxide cores. This system was 
capable of triggering the drug release using an applied external magnetic field. Capping 
with the peptide improved the sustained drug release up to 48 hours. Spherical composite 
demonstrated the hyperthermia ability by reaching to 40 and 35 °C for BOC-SPION-SS 
and BOC-SI-SPION-SS, respectively.  
FM-ION-RS nanoparticles showed the magnetic response when magnet was applied 
during separation. This system failed to show the control release behaviour even the 
exposure of magnetic field. The system could not have control over the cargo release from 
FM-ION-RS and FF-FM-ION-RS nanomaterials. However, these materials at higher 
concentration could induce the hyperthermia when magnetic field was applied. The 
tunable magnetic field strength and frequency could be a valid trigger for hyperthermia 
and drug release in localised treatment of cancer. The novel approach to coat the metals 
using short length peptide molecules could serves as promising tools to reduce the 
aggregation, improve biocompatibility while preserving the native properties of core 
materials. Peptide coated particles have provided a starting point to overcome the 
limitations arising in coating of iron oxide nanoparticles of different shapes.  The bare 
iron oxide nanoparticles tend to aggregate; hence, these can be easily eliminated from 
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body. The coating to nanoparticles had prevented the aggregation, which can improve the 
biological stability (Tombácz et al. 2016). The novel peptide coated spherical composites 
system could be a valid step towards magnetic field guided hyperthermia and 
chemotherapy combination of cancer treatment.  
Finally, it could be concluded that the peptide based coatings approach for metallic 
structure is promising in all fields of nanomedicine. In addition, novel spherical and 
tubular materials could open new horizon to develop safe, effective, tuneable and low 
cost drug carriers for improved cancer thermo-chemotherapy along possible MRI 
imaging.        
9.2 Original contribution to research 
Magnetic nanoparticles are promising tools for biomedical application. These materials 
received great attention due to their tunable size and shape properties. However, due to 
limitations such as aggregation has reduced their performances. The coating of SPIONs 
with polymers to reduce the aggregation and increased biocompatibility like issues is of 
huge interest (Laurent et al. 2008). Therefore, two shapes; spherical and rod-shaped iron 
oxide nanoparticles were prepared using coprecipitation method. The synthesis of rod-
shaped iron oxide using ferrous sulphate as iron source is novel method. The suggested 
method is simple, quick and cost effective compared to already published methods. Both 
morphologies were then coated with naturally occurring diphenylalanine (Phe-Phe) as in 
native form and tert-butyloxycarbonyl (BOC) modified BOC-diphenylalanine. This work 
has focused on synthesis of novel core-shell spherical and tubular structure of peptide 
shell and SPIONs cores. The core-shell materials were then exploited for novel properties 
such as for drug loading and release profile, hyperthermia and magnetic field triggered 
drug release system.  
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9.3 Future work  
The results achieved in this research can lead to further various experiments in different 
directions. Some of these directions are as follows;       
i) Biocompatibility, immunogenicity and enzymatic stability    
The limitation of this work includes the unknown immunogenicity of peptide-coated 
materials. In order to improve this novel drug delivery system, effect of peptide coating 
content on SPIONs for enzymatic biodegradation and clearance from blood circulation 
could be investigated. The in vitro enzymatic (trypsin) degradation of peptide could be 
assessed using published method (Gunasekaran et al. 2007). Removal from blood 
circulation can be studies using method (Genové et al. 2005).  
As a novel drug delivery system, the toxicity of peptide coated spherical or tubular 
structures and peptides as alone need to be more deeply investigated (Teow et al. 2013). 
The initial studies of our group on iron based spherical nanoparticles showed lower 
toxicity against SVGP-12 and U87 cell lines (data not published yet). Moreover, further 
studies in animal model could reveal the organ based cytotoxicity of these materials.  
ii) As imaging agent for diagnosis purposes  
Magnetic resonance imaging is a non-invasive technique providing the structural details 
and deep resolution images of tissues. Despite of a huge numbers of contrast agents 
available for MRI, still there is need for more sensitive compared to radioactive or 
fluorescence imaging. While, in deep tissue fluorescence imaging could not overcome 
the MRI resolution. Hence, integration of magnetic resonance and optical fluorescence 
characteristics as single material can overcome both limitations of individual techniques. 
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In recent years, several studies have focused on the MRI-FI imaging system for the 
biomedical applications (Jiang et al. 2016; Li et al. 2016; Chen et al. 2016). The materials 
developed in this work by coating of magnetic cores and fluorescence shell (silica and 
presence of DOX) could be used as biocompatible agents for duel MRI-FI imaging. 
Further studies can reveal the relaxivity, quantum yield and bioavailability of peptide-
coated materials.  
iii) Active targeting         
The target specific drug carrier could improve the bioavailability of loaded drugs to 
desired sites, while reducing their contact with normal tissues. Generally, tumour 
associated cells are targeted, alternatively other markers, which are overexpressed on 
effected cell could be targeted. The ligands such as peptides (RGD) could specifically 
bind with αvβ3 integrin. RGD ligand can be conjugated with free carboxyl group of 
phenylalanine to amine group of lysine of RGD.  
iv) As dual agent for drug delivery and imaging system 
The fabrication of mesoporosity of magnetic nanoparticles can be tuned in order to 
increase the payload and diversity of drugs. The use of surfactant can also key point to 
achieve better colloidal stability of desired materials. Iron oxide nanoparticles have 
shown another promising ability to be seen at cellular and molecular level interactions 
that can be used as contrast agents for MRI, while using them as drug delivery carrier. 
After coating with peptide and fluorescence loading of DOX, the applicability and 
efficiency has been improved. In next phase along coating of peptide they need to be 
studied for their contrast ability according to method published (Kohler et al. 2006).  
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v) In vitro drug delivery system 
Degradation kinetics of these novels magnetic materials in water, cellular media and 
serum based biological systems can be investigated. This study could further reveals the 
role of coating materials (peptide) on magnetic nanoparticles at normal pH.  
The internalisation of coated materials in tumour cells (U87, SVGP12 etc) by tagging 
with fluorescence dye. These experiments could be performed with cytotoxicity studies 
using MTT or CytoTox-Fluor assays. These results will further reveal the 
biocompatibility of novel coated magnetic materials by comparing with uncoated once. 
The biocompatibility of magnetic nanoparticles to red blood cell was found shape-
dependent (Yu et al. 2011). Hence, the haemolytic comparison of both spherical and rod-
shaped nanostructures would be an important for the potential administration these 
materials.     
 From in vitro drug release and cytotoxicity studies, the results will also lead to effect of 
nanoparticles in drug resistant tumours. However, in vitro drug release experiments and 
cytotoxicity results do not always reflects similar to in vivo efficiency. In addition, more 
studies will also assess the in vivo drug efficiency in multi-drug resistance tumour models.                                             
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Pérez-Arnaiz, C. et al., 2014. New insights into the mechanism of the DNA/doxorubicin 
interaction. The Journal of Physical Chemistry B, 118(5), pp.1288–1295. 
Petitjean, A. et al., 2002. Cation‐promoted hierarchical formation of supramolecular 
assemblies of self‐organized helical molecular components. Angewandte Chemie, 41(7), 
pp.1195–1198. 
Petros, R.A. & DeSimone, J.M., 2010. Strategies in the design of nanoparticles for 
therapeutic applications. Nature Reviews Drug Discovery, 9(8), pp.615–627. 
  
214 
 
Pettigrew, R.T. et al., 1974. Clinical effects of whole-body hyperthermia in advanced 
malignancy. British Medical Journal, 4(5946), pp.679–682. 
Ping, Z.H. et al., 2001. States of water in different hydrophilic polymers—DSC and FTIR 
studies. Polymer, 42(20), pp.8461–8467. 
Van der Poll, D.G. et al., 2010. Design, synthesis, and biological evaluation of a robust, 
biodegradable dendrimer. Bioconjugate Chemistry, 21(4), pp.764–773. 
Polshettiwar, V., Baruwati, B. & Varma, R.S., 2009. Self-assembly of metal oxides into 
three-dimensional nanostructures: synthesis and application in catalysis. Acs Nano, 3(3), 
pp.728–736. 
Putnam, D. & Kopeček, J., 1995. Polymer conjugates with anticancer activity. In N. 
Peppas & R. Langer, eds. Biopolymers II. Springer Berlin Heidelberg, pp. 55–123. 
Qu, L. & Tie, S., 2009. Mesoporous silica-coated superparamagnetic magnetite 
functionalized with CuO and its application as a desulfurizer. Microporous and 
Mesoporous Materials, 117(1), pp.402–405. 
Quinto, C.A. et al., 2015. Multifunctional superparamagnetic iron oxide nanoparticles for 
combined chemotherapy and hyperthermia cancer treatment. Nanoscale, 7(29), 
pp.12728–12736. 
Rad-Malekshahi, M. et al., 2015. Biomedical applications of self-assembling peptides. 
Bioconjugate Chemistry, 27(1), pp.3–18. 
Rajabi, F., Kakeshpour, T. & Saidi, M.R., 2013. Supported iron oxide nanoparticles: 
Recoverable and efficient catalyst for oxidative SS coupling of thiols to disulfides. 
Catalysis Communications, 40, pp.13–17. 
Rao, M.K.S. and R.D. and M.S.R., 2014. Realization of highest specific absorption rate 
near superparamagnetic limit of CoFe2O4 colloids for magnetic hyperthermia 
applications. Materials Research Express, 1(2), p.26107. 
Ray, S. et al., 2006. A short water-soluble self-assembling peptide forms amyloid-like 
fibrils. Chemical Communications, (40), pp.4230–4232. 
Reches, M. & Gazit, E., 2003. Casting metal nanowires within discrete self-assembled 
peptide nanotubes. Science, 300(5619), pp.625–627. 
Reches, M. & Gazit, E., 2005. Self‐assembly of peptide nanotubes and amyloid‐like 
structures by charged‐termini‐capped diphenylalanine peptide analogues. Israel journal 
of chemistry, 45(3), pp.363–371. 
Richard, S., Boucher, M., Lalatonne, Y., Mériaux, S. and Motte, L., 2017. Iron oxide 
nanoparticle surface decorated with cRGD peptides for magnetic resonance imaging of 
brain tumors. Biochimica et Biophysica Acta, 1861(6), pp.1515-1520. 
Riley, J.M. et al., 2009. Bioproduction and characterization of a pH responsive self‐
assembling peptide. Biotechnology and Bioengineering, 103(2), pp.241–251. 
  
215 
 
Ringler, P. & Schulz, G.E., 2003. Self-assembly of proteins into designed networks. 
Science, 302(5642), pp.106–109. 
Rutgers, A.J. & De Smet, M., 1947. Electrosmosis, streaming potentials and surface 
conductance. Transactions of the Faraday Society, 43, pp.102–111. 
Šafařík, I. & Šafaříková, M., 2002. Magnetic nanoparticles and biosciences. Monatshefte 
für Chemie/Chemical Monthly, 133(6), pp.737–759. 
Saha, R.N. et al., 2010. Nanoparticulate drug delivery systems for cancer chemotherapy. 
Molecular Membrane Biology, 27(7), pp.215–231. 
Saikia, C. et al., 2017. Evaluation of folic acid tagged aminated starch/ZnO coated iron 
oxide nanoparticles as targeted curcumin delivery system. Carbohydrate Polymers, 157, 
pp.391–399. 
Saint-Cricq, P. et al., 2015. Magnetic field activated drug delivery using 
thermodegradable azo-functionalised PEG-coated core–shell mesoporous silica 
nanoparticles. Nanoscale, 7(31), pp.13168–13172. 
Sakulkhu, U. et al., 2014. Protein corona composition of superparamagnetic iron oxide 
nanoparticles with various physico-chemical properties and coatings. Scientific reports, 
4, p.5020. 
Sakurai, M., Koley, P. & Aono, M., 2014. A new approach to molecular self-assembly 
through formation of dipeptide-based unique architectures by artificial supersaturation. 
Chemical Communications, 50(83), pp.12556–12559. 
Salgueiriño-Maceira, V. et al., 2006. Bifunctional gold-coated magnetic silica spheres. 
Chemistry of Materials, 18(11), pp.2701–2706. 
Salim, M. et al., 2014. Amphiphilic designer nano-carriers for controlled release: from 
drug delivery to diagnostics. MedChemComm, 5(11), pp.1602–1618. 
Salon, S.H. and S.-Y.W. and A.G. and D.-A.B.-T. and S.J., 2012. On the measurement 
technique for specific absorption rate of nanoparticles in an alternating electromagnetic 
field. Measurement Science and Technology, 23(3), p.35701. 
Sanson, C. et al., 2011. Doxorubicin loaded magnetic polymersomes: theranostic 
nanocarriers for MR imaging and magneto-chemotherapy. ACS Nano, 5(2), pp.1122–
1140. 
Santhosh, P.B. & Ulrih, N.P., 2013. Multifunctional superparamagnetic iron oxide 
nanoparticles: promising tools in cancer theranostics. Cancer Letters, 336(1), pp.8–17. 
Santra, S. et al., 2001. Synthesis and characterization of silica-coated iron oxide 
nanoparticles in microemulsion: the effect of nonionic surfactants. Langmuir, 17(10), 
pp.2900–2906. 
Sarawade, P. et al., 2014. Size‐and shape‐controlled synthesis of hexagonal bipyramidal 
crystals and hollow self‐assembled al‐mof spheres. ChemSusChem, 7(2), pp.529–535. 
  
216 
 
Sayed, F.N. & Polshettiwar, V., 2015. Facile and sustainable synthesis of shaped iron 
oxide nanoparticles: effect of iron precursor salts on the shapes of iron oxides. Scientific 
Reports, 5. 
Schmid, G., 2011. Nanoparticles: from theory to application, John Wiley & Sons. 
Seip, C.T. & O’Connor, C.J., 1999. The fabrication and organization of self-assembled 
metallic nanoparticles formed in reverse micelles. Nanostructured Materials, 12(1), 
pp.183–186. 
Sellins, K.S. & Cohen, J.J., 1991. Hyperthermia induces apoptosis in thymocytes. 
Radiation Research, 126(1), pp.88–95. 
Sen, T., 2016. Meet the nanomachines that could drive a medical revolution. The 
Conversation. 
Sen, T. et al., 2012. Simple one-pot fabrication of ultra-stable core-shell 
superparamagnetic nanoparticles for potential application in drug delivery. RSC 
Advances, 2(12), p.5221. 
Sen, T. & Bruce, I.J., 2009. Mesoporous silica–magnetite nanocomposites: Fabrication, 
characterisation and applications in biosciences. Microporous and Mesoporous 
Materials, 120(3), pp.246–251. 
Sen, T., Sebastianelli, A. & Bruce, I.J., 2006. Mesoporous silica−magnetite 
nanocomposite:  fabrication and applications in magnetic bioseparations. Journal of the 
American Chemical Society, 128(22), pp.7130–7131. 
Shao, H. & Parquette, J.R., 2009. Controllable peptide–dendron self‐assembly: 
interconversion of nanotubes and fibrillar nanostructures. Angewandte Chemie, 48(14), 
pp.2525–2528. 
Sharifabad, M.E. et al., 2014. Enzyme immobilised novel core-shell superparamagnetic 
nanocomposites for enantioselective formation of 4-(R)-hydroxycyclopent-2-en-1-(S)-
acetate. Chemical Communications, 50(76), pp.11185–11187. 
Shen, R.-N. et al., 1994. Influence of elevated temperature on natural killer cell activity, 
lymphokine-activated killer cell activity and lectin-dependent cytotoxicity of human 
umbilical cord blood and adult blood cells. International Journal of Radiation Oncology* 
Biology* Physics, 29(4), pp.821–826. 
Shevtsov, M. & Multhoff, G., 2016. Recent developments of magnetic nanoparticles for 
theranostics of brain tumor. Current Drug Metabolism, 17(8), pp.737–744. 
Simeonidis, K. et al., 2013. Fe-based nanoparticles as tunable magnetic particle 
hyperthermia agents. Journal of Applied Physics, 114(10), p.103904. 
Simeonidis, K. et al., 2016. In-situ particles reorientation during magnetic hyperthermia 
application: Shape matters twice. Scientific Reports, 6. 
 
  
217 
 
Simões, S. et al., 2004. On the formulation of pH-sensitive liposomes with long 
circulation times. Advanced Drug Delivery Reviews, 56(7), pp.947–965. 
Sneed, P.K. et al., 1998. Survival benefit of hyperthermia in a prospective randomized 
trial of brachytherapy boost±hyperthermia for glioblastoma multiforme. International 
Journal of Radiation Oncology* Biology* Physics, 40(2), pp.287–295. 
Song, Y. et al., 2004. Synthesis of peptide-nanotube platinum-nanoparticle composites. 
Chemical Communications, (9), pp.1044–1045. 
Stahl, H. et al., 1995. The use of an early postoperative interstitial-hyperthermia 
combination therapy in malignant gliomas. Strahlentherapie und Onkologie: Organ der 
Deutschen Rontgengesellschaft...[et al], 171(9), pp.510–524. 
Stoehr, L.C. et al., 2011. Shape matters: effects of silver nanospheres and wires on human 
alveolar epithelial cells. Particle and Fibre Toxicology, 8(1), p.36. 
Strable, E. et al., 2001. Synthesis and characterization of soluble iron oxide-dendrimer 
composites. Chemistry of Materials, 13(6), pp.2201–2209. 
Strebhardt, K. & Ullrich, A., 2008. Paul Ehrlich’s magic bullet concept: 100 years of 
progress. Nature Reviews Cancer, 8(6), pp.473–480. 
Sukhanova, A. et al., 2016. Nanosized fluorescent diagnostic probes consisting of single-
domain antibodies conjugated with quantum dots. Materials Today: Proceedings, 3(2), 
pp.518–522. 
Sun, C., Lee, J.S.H. & Zhang, M., 2008. Magnetic nanoparticles in MR imaging and drug 
delivery. Advanced drug delivery reviews, 60(11), pp.1252–1265. 
Świerniak, A. et al., 2016. Cell cycle as an object of control. In System Engineering 
Approach to Planning Anticancer Therapies. Springer, pp. 9–54. 
Takeuchi, H. et al., 2001. Evaluation of circulation profiles of liposomes coated with 
hydrophilic polymers having different molecular weights in rats. Journal of Controlled 
Release, 75(1–2), pp.83–91. 
Talelli, M. et al., 2009. Superparamagnetic iron oxide nanoparticles encapsulated in 
biodegradable thermosensitive polymeric micelles: Toward a targeted nanomedicine 
suitable for image-guided drug delivery. Langmuir, 25(4), pp.2060–2067. 
Taloub, S. et al., 2016. FEM Investigation of coated magnetic nanoparticles for 
hyperthermia. Nanoscience and Nanotechnology, 6(1A), pp.55–61. 
Tang, Y., Flesch, R.C.C. & Jin, T., 2017. A method for increasing the homogeneity of the 
temperature distribution during magnetic fluid hyperthermia with a Fe-Cr-Nb-B alloy in 
the presence of blood vessels. Journal of Magnetism and Magnetic Materials, 432, 
pp.330–335. 
Teow, H.M. et al., 2013. Delivery of paclitaxel across cellular barriers using a dendrimer-
based nanocarrier. International Journal of Pharmaceutics, 441(1–2), pp.701–711. 
  
218 
 
Thévenot, J. et al., 2013. Magnetic responsive polymer composite materials. Chemical 
Society Reviews, 42(17), pp.7099–7116. 
Thiesen, B. & Jordan, A., 2008. Clinical applications of magnetic nanoparticles for 
hyperthermia. International Journal of Hyperthermia, 24(6), pp.467–474. 
Tietze, R. & Alexiou, C., 2017. Improving cancer imaging with magnetic nanoparticles: 
where are we now?. Furure Medicines  
Tolcher, A.W. et al., 1999. Randomized Phase II study of br96-doxorubicin conjugate in 
patients with metastatic breast cancer. Journal of Clinical Oncology, 17(2), p.478. 
Tombácz, E. et al., 2016. Polyelectrolyte coating on superparamagnetic iron oxide 
nanoparticles as interface between magnetic core and biorelevant media. Interface Focus, 
6(6). 
Torchilin, V.P. et al., 2001. Amphiphilic poly-N-vinylpyrrolidones:: synthesis, properties 
and liposome surface modification. Biomaterials, 22(22), pp.3035–3044. 
Troiano, J.M. et al., 2014. Direct probes of 4 nm diameter gold nanoparticles interacting 
with supported lipid bilayers. The Journal of Physical Chemistry C, 119(1), pp.534–546. 
Ulbrich, K. et al., 2016. Targeted drug delivery with polymers and magnetic 
nanoparticles: covalent and noncovalent approaches, release control, and clinical studies. 
Chemical reviews, 116(9), pp.5338–5431. 
Unsoy, G. et al., 2014. Synthesis of Doxorubicin loaded magnetic chitosan nanoparticles 
for pH responsive targeted drug delivery. European Journal of Pharmaceutical Sciences, 
62, pp.243–250. 
Valéry, C. et al., 2003. Biomimetic organization: Octapeptide self-assembly into 
nanotubes of viral capsid-like dimension. Proceedings of the National Academy of 
Sciences, USA.100(18), pp.10258–10262. 
Varon, J. & Acosta, P., 2008. Therapeutic hypothermia: past, present, and future. Chest 
Journal, 133(5), pp.1267–1274. 
Vaupel, P., Kallinowski, F. & Okunieff, P., 1989. Blood flow, oxygen and nutrient 
supply, and metabolic microenvironment of human tumors: a review. Cancer Research, 
49(23), pp.6449–6465. 
Vayssieres, L. et al., 2005. One‐dimensional quantum‐confinement effect in α‐Fe2O3 
ultrafine nanorod arrays. Advanced Materials, 17(19), pp.2320–2323. 
Wahajuddin & Arora, S., 2012. Superparamagnetic iron oxide nanoparticles: magnetic 
nanoplatforms as drug carriers. International Journal of Nanomedicine, 7, pp.3445–3471. 
Wang, J. et al., 2004. Magnetic-field-induced growth of single-crystalline Fe3O4 
nanowires. Advanced Materials, 16(2), pp.137–140. 
 
 
  
219 
 
Wang, K., Keasling, J.D. & Muller, S.J., 2005. Effects of the sequence and size of non-
polar residues on self-assembly of amphiphilic peptides. International Journal of 
Biological Macromolecules, 36(4), pp.232–240. 
Wang, S. et al., 2003. Peptides with selective affinity for carbon nanotubes. Nature 
Materials, 2(3), pp.196–200. 
Wang, X. et al., 2008. Application of nanotechnology in cancer therapy and imaging. CA: 
A Cancer Journal For Clinicians, 58(2), pp.97–110. 
Wang, X. et al., 2013. Particle-size-dependent toxicity and immunogenic activity of 
mesoporous silica-based adjuvants for tumor immunotherapy. Acta Biomaterialia, 9(7), 
pp.7480–7489. 
Wang, Y.D. et al., 2007. Synthesis and room temperature photoluminescence of 
ZnO/CTAB ordered layered nanocomposite with flake-like architecture. Journal of 
luminescence, 126(2), pp.661–664. 
Wei, X. et al., 2015. Polymorphous transformation of rod-shaped iron oxides and their 
catalytic properties in selective reduction of NO by NH3. RSC Advances, 5(81), 
pp.66141–66146. 
Whiteman, K.R. et al., 2001. POly(Hpma)-Coated Liposomes Demonstrate Prolonged 
Circulation in Mice. Journal of Liposome Research, 11(2-3), pp.153–164. 
Wilcoxon, J.P. & Provencio, P.P., 1999. Use of surfactant micelles to control the 
structural phase of nanosize iron clusters. The Journal of Physical Chemistry B, 103(45), 
pp.9809–9812. 
Wismeth, C. et al., 2010. Transcranial electro-hyperthermia combined with alkylating 
chemotherapy in patients with relapsed high-grade gliomas: phase I clinical results. 
Journal of Neuro-Oncology, 98(3), pp.395–405. 
Wong, R.S.L. et al., 1993. Critical steps for induction of chromosomal aberrations in 
CHO cells heated in S phase. Radiation Research, 133(1), pp.52–59. 
Woo, K. et al., 2003. Sol–gel mediated synthesis of Fe2O3 nanorods. Advanced Materials, 
15(20), pp.1761–1764. 
Woźniak, E. et al., 2017. Stabilization of aqueous dispersions of poly (methacrylic acid)-
coated iron oxide nanoparticles by double hydrophilic block polyelectrolyte poly 
(ethylene oxide)-block-poly (N-methyl-2-vinylpyridinium iodide). Colloids and Surfaces 
A: Physicochemical and Engineering Aspects, 514, pp.32–37. 
Wu, M. et al., 2011. Release of hydrophobic anticancer drug from a newly designed self-
assembling peptide. Mol Biosyst, 7(6), pp.2040–2047. 
Wu, R. et al., 2016. Doxorubicin toxicity changes myocardial energy metabolism in rats. 
Chemico-Biological Interactions, 244, pp.149–158. 
 
  
220 
 
Wu, W. et al., 2005. Targeted delivery of amphotericin b to cells by using functionalized 
carbon nanotubes. Angewandte Chemie International Edition, 44(39), pp.6358–6362. 
Wu, W., He, Q. & Jiang, C., 2008. Magnetic iron oxide nanoparticles: synthesis and 
surface functionalization strategies. Nanoscale Research Letters, 3(11), pp.397–415. 
Wust, P. et al., 2002. Hyperthermia in combined treatment of cancer. The Lancet 
Oncology, 3(8), pp.487–497. 
Xie, X. et al., 2009. Low-temperature oxidation of CO catalysed by Co3O4 nanorods. 
Nature, 458(7239), pp.746–749. 
Xu, C. et al., 2004. Nitrilotriacetic acid-modified magnetic nanoparticles as a general 
agent to bind histidine-tagged proteins. Journal of the American Chemical Society, 
126(11), pp.3392–3393. 
XU, K., 2011. Characterization and Utilization of Self-Assembled Diphenylalanine 
Nanotubes. Diss. University of Nottingham 
Xu, T. et al., 2011. Subnanometer porous thin films by the co-assembly of nanotube 
subunits and block copolymers. ACS Nano, 5(2), pp.1376–1384. 
Xu, Z.Z. et al., 2004. Encapsulation of nanosized magnetic iron oxide by polyacrylamide 
via inverse miniemulsion polymerization. Journal of Magnetism and Magnetic Materials, 
277(1), pp.136–143. 
Yan, X. et al., 2007. Transition of cationic dipeptide nanotubes into vesicles and 
oligonucleotide delivery. Angewandte Chemie, 119(14), pp.2483–2486. 
Yan, X., Zhu, P., Fei, J., et al., 2010. Self-assembly of peptide-inorganic hybrid spheres 
for adaptive encapsulation of guests. Advanced Materials, 22(11), pp.1283–1287. 
Yan, X., Zhu, P. & Li, J., 2010a. Self-assembly and application of diphenylalanine-based 
nanostructures. Chemical Society Reviews, 39(6), pp.1877–1890. 
Yanes, R. et al., 2007. Effective anisotropies and energy barriers of magnetic 
nanoparticles with Néel surface anisotropy. Physical Review B, 76(6), p.64416. 
Yang, Y. et al., 2008. Preparation of polymer-coated mesoporous silica nanoparticles 
used for cellular imaging by a “graft-from” method. Journal of Materials Chemistry, 
18(47), pp.5731–5737. 
Yatvin, M.B. et al., 1980. pH-sensitive liposomes: possible clinical implications. Science, 
210(4475), pp.1253–1255. 
Yu, T., Malugin, A. & Ghandehari, H., 2011. Impact of silica nanoparticle design on 
cellular toxicity and hemolytic activity. ACS Nano, 5(7), pp.5717–5728. 
Zhang, L., He, R. & Gu, H.-C., 2006. Oleic acid coating on the monodisperse magnetite 
nanoparticles. Applied Surface Science, 253(5), pp.2611–2617. 
 
  
221 
 
Zhang, L.-Y., Gu, H.-C. & Wang, X.-M., 2007. Magnetite ferrofluid with high specific 
absorption rate for application in hyperthermia. Journal of Magnetism and Magnetic 
Materials, 311(1), pp.228–233. 
Zhao, Y. et al., 2015. Dynamic layer-by-layer films: a platform for zero-order release. 
Biomacromolecules, 16(7), pp.2032–2039. 
Zheng, C. et al., 2013. Environmentally compatible synthesis of superparamagnetic 
magnetite (fe3o4) nanoparticles with prehydrolysate from corn stover, BioResources 
9(1), pp.589-601 
 
 
 
Web References  
Bachem, 2016. Boc-diphenylalanine. MSDS. Available at: http://msds.bachem.com/A-
3205.pdf [Accessed January 31, 2016].  
SubsTech  
SubsTech, 2016. Knowledge Source on Materials Engineering. Available at: 
http://www.substech.com/dokuwiki/doku.php?id=scanning_electron_microscope 
[Accessed August 1, 2016]. 
Horiba, 2016. Measurement Techniques.  Available at: 
http://www.horiba.com/scientific/products/particle-characterization/particle-size-
analysis/details/sz-100-7245/ [Accessed August 1, 2016].  
  
222 
 
Appendices  
Appendix A 
Zeta potential of boc-diphenylalanine in water (black) and ethanol-water (1:1) mixture 
(grey)  
 
Zeta potential of diphenylalanine in water (black) and ethanol-water (1:1) mixture 
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